Email address,Domain name,Organization,Country,State,City,Postal code,Street,Confidence score,Type,Number of sources,Pattern,First name,Last name,Department,Position,Twitter handle,LinkedIn URL,Phone number,Source 1,Source 2,Source 3,Source 4,Source 5,Source 6,Source 7,Source 8,Source 9,Source 10,Source 11,Source 12,Source 13,Source 14,Source 15,Source 16,Source 17,Source 18,Source 19,Source 20,Source 21,Source 22,Source 23,Source 24,Source 25,Source 26,Source 27,Source 28,Source 29,Source 30
sabrina.bouchard@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,2,{first}.{last},Sabrina,Bouchard,,,,,,http://nrbhss.ca/sites/default/files/documentations/palivizumab_csi_2017_2018_fr.pdf,http://nrbhss.ca/sites/default/files/documentations/palivizumab_cstu_2017_2018_fr.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
jill.wetter@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,4,{first}.{last},Jill,Wetter,,,,,,http://dmd.aspetjournals.org/content/dmd/early/2023/05/04/dmd.123.001249.full.pdf,http://dmd.aspetjournals.org/content/early/2023/05/04/dmd.123.001249/tab-article-info,http://dmd.aspetjournals.org/content/early/2023/05/04/dmd.123.001249/tab-e-letters,http://dmd.aspetjournals.org/content/early/2023/05/04/dmd.123.001249,,,,,,,,,,,,,,,,,,,,,,,,,
alexandra.smith@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,3,{first}.{last},Alexandra,Smith,,,,,,http://primatevets.org/media/28763b0a-1739-4888-9459-85f154c9a89f/fo-eow/apv/news/2022%20travel%20grants/epv%20member%20call.pdf,http://primatevets.org/media/341c910e-2e16-4f87-9557-eaf9d35062f1/ilsxlq/apv/news/2022%20travel%20grants/vet%20student%20call.pdf,http://primatevets.org/media/5f690713-97aa-4aac-b4fa-178163f1ae8c/o5lojq/apv/news/2022%20travel%20grants/resident%20call%20apv.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,
janet.churchill@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,2,{first}.{last},Janet,Churchill,,,,,,http://ispn-psych.org/2021-sponsorship---exhibitor-opportunities,http://ispn.memberclicks.net/2021-sponsorship---exhibitor-opportunities,,,,,,,,,,,,,,,,,,,,,,,,,,,
thomas.hudson@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Thomas,Hudson,,"","","","",http://jitc.bmj.com/content/6/1/50,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chad.cassie@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Chad,Cassie,,"","","","",http://apg.org/event/southeast-regional-meeting-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lily.fragoso@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,2,{first}.{last},Lily,Fragoso,,"","","","",http://cknby.com/who-we-are/our-stories/putting-our-people-first-abbvies-family-benefits.html,http://cknby.com/who-we-are/our-stories/working-parents-2022-passion-in-face-hardship.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
sabrina.bluemel@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,4,{first}.{last},Sabrina,Bl√ºmel,,,,,,http://news.abbvie.de/contact_people/tag/gesundheit-und-versorgung,http://news.abbvie.de/contact_people/tag/science-rocks,http://news.abbvie.de/contact_people,http://abbvie-germany.mynewsdesk.com/contact_people,,,,,,,,,,,,,,,,,,,,,,,,,
janel.villamor@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Janel,Villamor,,Regulatory Affairs,"","","",http://mann.usc.edu/program/fellowship-programs/current-fellows,,,,,,,,,,,,,,,,,,,,,,,,,,,,
diane.kang@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Diane,Kang,,Regulatory Affairs,"","","",http://mann.usc.edu/program/fellowship-programs/current-fellows,,,,,,,,,,,,,,,,,,,,,,,,,,,,
emma.haas@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,4,{first}.{last},Emma,Haas,Writing & communication,Corporate Communication,"","","",http://news.abbvie.de/contact_people/tag/gesundheit-und-versorgung,http://news.abbvie.de/contact_people/tag/science-rocks,http://abbvie-germany.mynewsdesk.com/contact_people,http://news.abbvie.de/contact_people,,,,,,,,,,,,,,,,,,,,,,,,,
andrew.shaw@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,3,{first}.{last},Andrew,Shaw,,,,,,"http://greatplacetowork.ie/workplace/item/702/abbvie+cork,+dublin,+sligo",http://sligosciencefestival.ie/useful-information,http://greatplacetowork.ie/workplace/item/702/abbvie+ireland,,,,,,,,,,,,,,,,,,,,,,,,,,
xiaohong.huang@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Xiaohong,Huang,,"","","","",http://icsa.org/membership/midwest-chapter,,,,,,,,,,,,,,,,,,,,,,,,,,,,
david.samayoa@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},David,Samayoa,,"",com,"","",http://mygcsg.com/gcsg-2021-us-virtual-conference/speakers,,,,,,,,,,,,,,,,,,,,,,,,,,,,
thomas.baierl@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Thomas,Baierl,,Regulatory Affairs,"","","",http://jusmeum.de/profile/dr_thomas_baierl,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jodi.walker@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Jodi,Walker,Management,Field Director,"","","",http://sciencediscoverycenter.org/board-of-directors,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sara.sanders@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,6,{first}.{last},Sara,Sanders,,"","","",+1 973 307 6145,http://ksautomn.com/news/skyrizi-risankizumab-rzaa-receives-fda-approval-as-the-first-and,http://news.abbvie.com/news/press-releases/therapeutic-area/general-medicine/abbvie-to-showcase-depth-gastroenterology-portfolio-and-pipeline-at-digestive-disease-week.htm,http://news.abbvie.com/news/press-releases/abbvie-submits-regulatory-applications-to-fda-and-ema-for-upadacitinib-rinvoq-in-crohns-disease.htm,http://news.abbvie.com/news/press-releases/rinvoq-upadacitinib-receives-fda-approval-for-treatment-adults-with-moderately-to-severely-active-ulcerative-colitis.htm,http://news.abbvie.com/news/press-releases/abbvie-submits-application-for-risankizumab-skyrizi-in-moderate-to-severe-crohns-disease-to-european-medicines-agency-ema.htm,http://news.abbvie.com/news/press-releases/upadacitinib-rinvoq-achieved-primary-and-key-secondary-endpoints-in-first-phase-3-induction-study-in-patients-with-crohns-disease.htm,,,,,,,,,,,,,,,,,,,,,,,
diane.l.smith@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,2,{first}.{last},Diane,Smith,,,,,,http://9eg.profiles.exposed/diane.long4040@att.net,http://9eg.profiles.exposed/diane.long@furman.edu,,,,,,,,,,,,,,,,,,,,,,,,,,,
tam.nguyen@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Tam,Nguyen,Medical & health,Clinical Development,"","","",http://mann.usc.edu/program/fellowship-programs/current-fellows,,,,,,,,,,,,,,,,,,,,,,,,,,,,
edwina.elliott@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Edwina,Elliott,Writing & communication,Senior Corporate Communications Manager,"","","",http://abbvie.co.nz/media.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
frank.benenati@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,16,{first}.{last},Frank,Benenati,Executive,CEO,"","",+44 12 2360 7340,http://capsida.com/abbvie-and-capsida-biotherapeutics-expand-strategic-collaboration-to-develop-targeted-genetic-medicines-for-eye-diseases-with-high-unmet-need,http://news.abbvie.com/news/press-releases/abbvie-university-chicago-extend-research-collaboration-to-support-preclinical-oncology-research-through-2025.htm,http://affiliatedailynews.com/2021/06/market-gears-up-for-biosimilar-boom-in-2023-as-humira-exclusivity-draws-to-a-close,http://pharmasalmanac.com/articles/abbvie-and-anima-biotech-announce-collaboration-for-the-discovery-and-development-of-mrna-biology-modulators-against-oncology-and-immunology-targets,http://leave-russia.org/abbvie,http://hotspotthera.com/press_release/abbvie-launches-strategic-collaboration-with-hotspot-therapeutics-to-further-expand-immunology-pipeline-2,http://animabiotech.com/sites/default/files/news/pr/abbvie-and-anima-biotech-announce-collaboration-discovery-and-development-mrna-biology-modulators.pdf,http://vivesfund.com/en/news/vives-portfolio-company-syndesi-therapeutics-acquired-abbvie,http://stjude.org/media-resources/news-releases/2023-medicine-science-news/st-jude-unveils-45000-square-foot-family-commons.html,http://hotspotthera.com/press_release/abbvie-launches-strategic-collaboration-with-hotspot-therapeutics-to-further-expand-immunology-pipeline,http://news.abbvie.com/news/press-releases/abbvie-and-calico-announce-second-extension-collaboration-focused-on-aging-and-age-related-diseases.htm,http://vivesfund.com/fr/news/syndesi-therapeutics-une-societe-du-portefeuille-de-vives-acquise-par-abbvie,http://missiontherapeutics.com/mission-and-abbvie-collaboration-in-alzheimers-and-parkinsons-diseases-reaches-next-milestone,http://biotech-365.com/author/biotech365,http://biotech-365.com/category/business-wire,http://news.abbvie.com/news/press-releases/abbvie-to-present-at-rbc-capital-markets-global-healthcare-conference.htm,,,,,,,,,,,,,
jeanna.polacek@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,2,{first}.{last},Jeanna,Polacek,Education,Specialist,"","","",http://h1bdata.com/page/2,http://h1bdata.com,,,,,,,,,,,,,,,,,,,,,,,,,,,
jeanna.dudley@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,2,{first}.{last},Jeanna,Dudley,Education,Research And Development,"","","",http://h1bdata.com/page/2,http://h1bdata.com,,,,,,,,,,,,,,,,,,,,,,,,,,,
matthew.graaf@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Matthew,Graaf,Writing & communication,Technical Editor,"","","",http://electrochem.org/publications/focus-issues/organic-and-inorganic-molecular-electrochemistry,,,,,,,,,,,,,,,,,,,,,,,,,,,,
julia.heinz@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,13,{first}.{last},Julia,Heinz,Writing & communication,Director Public Affairs,"","",+49 151 1403 8139,http://news.abbvie.de/contact_people/tag/gesundheit-und-versorgung,http://mynewsdesk.com/de/abbvie/pressreleases/digitalkooperation-bessere-versorgung-fuer-patienten-mit-schmerzhafter-hauterkrankung-2388564,http://news.abbvie.de/contact_people/tag/science-rocks,http://news.abbvie.de/pressreleases/sag-ichs-chronisch-krank-im-job-2644371,http://news.abbvie.de/pressreleases/abbvie-ausgezeichnet-im-wettbewerb-deutschlands-beste-arbeitgeber-3174813,http://news.abbvie.de/contact_people,http://abbvie-germany.mynewsdesk.com/contact_people,http://abbvie-germany.mynewsdesk.com/pressreleases/abbvie-ausgezeichnet-im-wettbewerb-deutschlands-beste-arbeitgeber-3174813,http://abbvie-germany.mynewsdesk.com/pressreleases/abbvie-deutschland-belegt-platz-1-beim-corporate-health-award-2021-3149273,http://abbvie-germany.mynewsdesk.com/pressreleases/digitalkooperation-bessere-versorgung-fuer-patienten-mit-schmerzhafter-hauterkrankung-2388564,http://abbvie-germany.mynewsdesk.com/pressreleases/sag-ichs-chronisch-krank-im-job-2644371,http://mynewsdesk.com/de/pressroom/abbvie,http://presseportal.de/pm/112983/4624698,,,,,,,,,,,,,,,,
fernando.bastos@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,7,{first}.{last},Fernando,Bastos,Management,Director,"","","",http://noticias.abbvie.pt/pressreleases/abbvie-promove-8a-edicao-da-conferencia-sustentabilidade-em-saude-2955241,http://noticias.abbvie.pt/pressreleases/conheca-os-resultados-do-indice-saude-sustentavel-2020-slash-21-3108976,http://noticias.abbvie.pt/pressreleases/ja-e-conhecido-o-juri-da-8-dot-a-edicao-do-premio-healthcare-excellence-3117240,http://noticias.abbvie.pt/pressreleases/associacao-aldeias-humanitar-vence-premio-healthcare-excellence-2955255,http://noticias.abbvie.pt/pressreleases/premio-healthcare-excellence-vai-distinguir-projetos-desenvolvidos-no-ambito-da-resposta-a-pandemia-3005185,http://mynewsdesk.com/pt/abbvie-portugal,http://mynewsdesk.com/pt/abbvie-portugal/pressreleases/reumanizar-abbvie-apoia-campanha-da-sociedade-portuguesa-de-reumatologia-2980288,,,,,,,,,,,,,,,,,,,,,,
catherine.rivera@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Catherine,Rivera,Education,Research Associate,"","","",http://hepfree.nyc/hep-free-nyc-webinar-e-meeting-highlights-03-18-2020,,,,,,,,,,,,,,,,,,,,,,,,,,,,
eric.nelson@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Eric,Nelson,,"","","","",http://ramonvidaliart.com/contact,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pascal.apostolides@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,2,{first}.{last},Pascal,Apostolides,,,,,,http://amcham.gr/author/mara/page/56,http://amcham.gr/amchamgr-members/abbvie-pharmaceuticals-s-a-2,,,,,,,,,,,,,,,,,,,,,,,,,,,
jennifer.lagunas@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Jennifer,Lagunas,,"","","","",http://lcldnet.org/about/corporation-membership/laura-schumacher,,,,,,,,,,,,,,,,,,,,,,,,,,,,
bjoern.tews@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,2,{first}.{last},Bj√∂rn,Tews,Education,Research Staff,"","","",http://clinicaltrials.gov/show/nct03342144,http://clinicaltrials.gov/ct2/show/nct03342144,,,,,,,,,,,,,,,,,,,,,,,,,,,
annie.claggett@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,5,{first}.{last},Annie,Claggett,,"","","",+1 224 813 0935,http://nationaleczema.org/abbvie-11422,http://lifesciencesbc.ca/members/u-s-fda-approves-second-indication-for-skyrizi-risankizumab-rzaa-to-treat-adults-with-active-psoriatic-arthritis,http://news.abbvie.com/news/press-releases/us-fda-approves-rinvoq-upadacitinib-to-treat-adults-and-children-12-years-and-older-with-refractory-moderate-to-severe-atopic-dermatitis.htm,http://news.abbvie.com/news/press-releases/third-pivotal-phase-3-study-shows-rinvoq-upadacitinib-plus-topical-corticosteroids-improves-skin-and-itch-symptoms-in-atopic-dermatitis-patients.htm,http://news.abbvie.com/news/press-releases/rinvoq-upadacitinib-monotherapy-shows-improvement-in-skin-clearance-and-itch-in-first-phase-3-study-for-atopic-dermatitis.htm,,,,,,,,,,,,,,,,,,,,,,,,
simone.turek@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Simone,Turek,Writing & communication,Patient Relations,"","","",http://publichealth.at/portfolio-items/hepc,,,,,,,,,,,,,,,,,,,,,,,,,,,,
michael.foley@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Michael,Foley,,Safety Scientist,"","","",http://frontiersin.org/articles/10.3389/fphys.2012.00490/full,,,,,,,,,,,,,,,,,,,,,,,,,,,,
rajeev.menon@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,5,{first}.{last},Rajeev,Menon,Medical & health,Infectious Disease,"","","",http://hepatitis-c-initiative.eu/archive/images/pdf_resources/12pdf/abbvie_drug_interactions.pdf,http://cdksignal.com/index.php/ombitasvir,http://vegfrsignaling.com/dasabuvir,http://plk-receptor.com/index.php/paritaprevir,http://journals.lww.com/drug-monitoring/abstract/2016/10000/pharmacokinetics_of_tacrolimus_and_cyclosporine_in.13.aspx,,,,,,,,,,,,,,,,,,,,,,,,
natalia.kwon@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Natalia,Kwon,,"","","","",http://hepfree.nyc/project-succeed-hiv-hcv-meeting-highlights-10-11-18-2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
brittany.seagraves@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,6,{first}.{last},Brittany,Seagraves,,"","","",+1 224 229 2144,http://news.abbvie.com/news/press-releases/abbvie-to-showcase-scientific-innovation-and-research-advancements-across-dermatology-portfolio-at-2019-aad-annual-meeting.htm,http://news.abbvie.com/news/press-releases/us-fda-approves-rinvoq-upadacitinib-to-treat-adults-and-children-12-years-and-older-with-refractory-moderate-to-severe-atopic-dermatitis.htm,http://news.abbvie.com/news/press-releases/abbvie-presents-late-breaking-data-on-risankizumab-skyrizi-in-psoriatic-arthritis-at-30th-european-academy-dermatology-and-venereology-eadv-congress.htm,http://nationaleczema.org/abbvie-11422,http://news.abbvie.com/news/press-releases/abbvie-announces-new-data-from-its-dermatology-portfolio-and-pipeline-at-28th-european-academy-dermatology-and-venereology-eadv-congress.htm,http://news.abbvie.com/news/press-releases/new-two-year-data-at-24th-world-congress-dermatology-shows-skyrizi-risankizumab-maintains-complete-skin-clearance.htm,,,,,,,,,,,,,,,,,,,,,,,
james.marek@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,2,{first}.{last},James,Marek,,Process Development,"","","",http://aiche.cha0s.io/community/sites/divisions/process-development/areas,http://aiche.org/community/sites/divisions/process-development/areas,,,,,,,,,,,,,,,,,,,,,,,,,,,
paola.lembo@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Paola,Lembo,Education,Research Staff,"","","",http://clinicaltrials.gov/show/nct03310190,,,,,,,,,,,,,,,,,,,,,,,,,,,,
daniela.haertel@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,4,{first}.{last},Daniela,H√§rtel,Writing & communication,Patient Relations,"","",+43 120 589 146,http://welldone.at/print/article/101,http://welldone.at/print/article/116,http://welldone.at/presse/artikel/frueherkennung-und-aufklaerung-fuer-besseren-umgang-mit-chronisch-entzuendlichen-darmerkrankungen-ced,http://welldone.at/presse/artikel/mit-poesie-mehr-bewusstsein-schaffen,,,,,,,,,,,,,,,,,,,,,,,,,
anja.moeller@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Anja,M√∂ller,,"","","",+49 30 2025 3153,http://politdir.de/listings/abbvie-deutschland-gmbh-co-kg-2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kevin.mchugh@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Kevin,Mchugh,,"","","",+1 514 832 7438,http://clinicaltrials.gov/show/nct02506179,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sarah.beck@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,5,{first}.{last},Sarah,Beck,Writing & communication,Senior Communications,"","",+44 78 1842 8111,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/skyriziv-risankizumab-receives-nice-positive-technology-appraisal-guidance-for-the-treatment-of-plaque-psoriasis-in-adults-2908347,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/abbvies-skyriziv-risankizumab-accepted-for-use-within-nhs-scotland-2928830,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/results-from-upadacitinib-phase-3-select-compare-study-published-in-arthritis-and-rheumatology-2896790,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/abbvies-duodopa-r-levodopa-carbidopa-intestinal-gel-recommended-for-use-within-nhs-wales-2460807,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/nice-issues-positive-final-appraisal-document-for-skyriziv-risankizumab-for-the-treatment-of-plaque-psoriasis-in-adults-2897106,,,,,,,,,,,,,,,,,,,,,,,,
jordana.sekula@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Jordana,Sekula,,"","","","",http://clisp.fr/2018/08/07/modele-offre-emploi-7,,,,,,,,,,,,,,,,,,,,,,,,,,,,
james.purcell@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},James,Purcell,Medical & health,Clinical Development,"","","",http://frontiersin.org/articles/10.3389/fimmu.2013.00505/full,,,,,,,,,,,,,,,,,,,,,,,,,,,,
libby.holman@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,5,{first}.{last},Libby,Holman,,"","","",+1 847 935 9361,http://news.abbvie.com/news/abbvie-launches-good-morning-hypothyroidism-to-help-hypothyroid-patients-manage-their-life-long-condition-through-education-and-sense-community.htm,http://news.abbvie.com/news/abbvie-announces-plans-to-proceed-to-phase-3-evaluation-elagolix-in-patients-with-uterine-fibroids.htm,http://news.abbvie.com/news/abbvie-announces-positive-top-line-results-from-second-phase-3-study-investigating-elagolix-in-patients-with-endometriosis.htm,http://news.abbvie.com/news/abbvie-cf-scholarship-now-accepting-applications-from-students-with-cystic-fibrosis-for-2016-2017-academic-school-year.htm,http://news.abbvie.com/news/cast-your-vote-for-2015-thriving-undergraduate-and-graduate-scholars-to-help-grant-two-20500-abbvie-scholarships-to-students-with-cystic-fibrosis.htm,,,,,,,,,,,,,,,,,,,,,,,,
teresa.k.oberlander@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,5,{first}.{last},Teresa,Oberlander,,"","","","",http://wthsbands.org/band-blog/field-crew-and-uniform-volunteers-needed,http://wthsbands.org/band-blog/reminders-for-july-2015,http://wthsbands.org/band-blog/july-24th-2015,http://wthsbands.org/band-blog/updates-reminders-week-of-aug-22-2016,http://wthsbands.org/band-blog/august-09th-2016,,,,,,,,,,,,,,,,,,,,,,,,
patricia.bentley@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,5,{first}.{last},Patricia,Bentley,,"","","","",http://worldwidescience.org/topicpages/a/adaptive+bolus+chasing.html,http://worldwidescience.org/topicpages/s/sphingolipids+studies+defining.html,http://worldwidescience.org/topicpages/c/cardiac+mitochondrial+compromise.html,http://worldwidescience.org/topicpages/s/suboptimal+bolus+injection.html,http://worldwidescience.org/topicpages/a/anthracyclines.html,,,,,,,,,,,,,,,,,,,,,,,,
andrey.potapov@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,2,{first}.{last},Andrey,Potapov,Medical & health,Senior Clinical Project Manager,"","","",http://epidemiology-journal.ru/en/archive/article/36336,http://epidemiology-journal.ru/ru/archive/article/36336,,,,,,,,,,,,,,,,,,,,,,,,,,,
george.haig@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,3,{first}.{last},George,Haig,Management,Executive Director,"","","",http://isctm.org/15th-annual-scientific-meeting-speakers-corner-2,http://isctm.org/14th-annual-scientific-meeting-speakers-corner,http://isctm.org/autumn-2018-speakers-corner,,,,,,,,,,,,,,,,,,,,,,,,,,
joakim.hauge@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Joakim,Hauge,,"","","","",http://rop.no/kontakt/kontaktpersoner/joakim-hauge,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anil.vasudevan@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Anil,Vasudevan,Medical & health,Medicinal Chemistry,"","","",http://axial.acs.org/2017/09/25/medicinal-chemistry-technology,,,,,,,,,,,,,,,,,,,,,,,,,,,,
stephanie.weinstein@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,4,{first}.{last},Stephanie,Weinstein,,"","","",+1 514 832 7268,http://crohnetcolite.ca/news-events/news-releases/more-canadians-have-access-to-humira%c2%ae-adalimumab,http://crohnsandcolitis.ca/news-events/news-releases/more-canadians-have-access-to-humira%c2%ae-adalimumab,http://newswire.ca/fr/news-releases/plus-de-canadiens-ont-acces-a-humira-adalimumab-pour-le-traitement-de-la-colite-ulcereuse-642101233.html,http://newswire.ca/news-releases/more-canadians-have-access-to-humira-adalimumab-for-the-treatment-of-ulcerative-colitis-uc-642101133.html,,,,,,,,,,,,,,,,,,,,,,,,,
nathalie.foucault@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Nathalie,Foucault,Education,Research Staff,"","",+1 514 832 7702,http://clinicaltrials.gov/ct2/show/nct02896985,,,,,,,,,,,,,,,,,,,,,,,,,,,,
james.sawicki@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,3,{first}.{last},James,Sawicki,,,,,,http://yoon.chem.wisc.edu/former-group-members,http://yoon.chem.wisc.edu/staff/sawicki-jim,http://yoon.chem.wisc.edu/content/sawicki,,,,,,,,,,,,,,,,,,,,,,,,,,
ahmad.sheikh@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Ahmad,Sheikh,,"","","","",http://pubs.rsc.org/en/content/articlelanding/2013/ce/c3ce26878k,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jorge.colin@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,2,{first}.{last},Jorge,Colin,,,,,,http://kbarlist.blogspot.com/2016/02/k-bar-list-jobs-7-feb-2016.html,http://kbarlist.blogspot.com/2016_01_31_archive.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
mary.santangelo@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,2,{first}.{last},Mary,Santangelo,Education,Study Director,"","",+1 847 938 6703,http://hepatitiscresearchandnewsupdates.blogspot.com/2013/11/clinical-trial-study-to-evaluate-safety.html,http://hepatitiscresearchandnewsupdates.blogspot.com/2013_11_26_archive.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
jasmina.marjanovic@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,2,{first}.{last},Jasmina,Marjanovic,,"","","","",http://pubs.rsc.org/en/content/articlelanding/md/2017/c7md00049a,http://pubs.rsc.org/en/content/articlelanding/2017/md/c7md00049a,,,,,,,,,,,,,,,,,,,,,,,,,,,
antoinette.haubert@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,13,{first}.{last},Antoinette,Haubert,Management,"","","",+1 847 936 5382,http://cknby.com/who-we-are/our-stories/day-in-life-meet-engineer-promoting-diversity-within-manufacturing.html,http://cknby.com/who-we-are/our-stories/why-delivering-science-based-targets-are-key-to-sustainable-grow.html,http://news.abbvie.com/news/abbvie-receives-us-fda-approval-orilissa-elagolix-for-management-moderate-to-severe-pain-associated-with-endometriosis.htm,http://news.abbvie.com/news/abbvie-announces-positive-topline-results-from-second-phase-3-study-evaluating-investigational-elagolix-in-women-with-uterine-fibroids.htm,http://news.abbvie.com/news/abbvie-receives-us-fda-priority-review-for-investigational-oral-treatment-elagolix-for-management-endometriosis-with-associated-pain.htm,http://news.abbvie.com/news/abbvie-announces-positive-phase-2b-data-demonstrating-investigational-medicine-elagolix-significantly-reduced-heavy-menstrual-bleeding-in-women-with-uterine-fibroids.htm,http://biospace.com/article/releases/abbvie-announces-positive-topline-results-from-second-phase-3-study-evaluating-investigational-elagolix-in-women-with-uterine-fibroids,http://cleanroomconnect.com/abbvie-receives-u-s-fda-priority-review-investigational-oral-treatment-elagolix-management-endometriosis-associated-pain,http://news.abbvie.com/news/press-releases/abbvie-receives-us-fda-approval-orilissa-elagolix-for-management-moderate-to-severe-pain-associated-with-endometriosis.htm,http://cleanroomcompanydirectory.com/abbvie-receives-u-s-fda-priority-review-investigational-oral-treatment-elagolix-management-endometriosis-associated-pain,http://pharmaadvancement.com/drug-development/fda-approvals/abbvie-receives-u-s-fda-priority-review-for-investigational-oral-treatment-elagolix,http://businesswire.com/news/home/20180122005794/en/sheknows-media-takes-underrepresented-women%e2%80%99s-health-conditions,http://businesswire.com/news/home/20170620006274/en/sheknows-media-takes-health-wellness-theme-blogher17,,,,,,,,,,,,,,,,
fanny.allaire@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,2,{first}.{last},Fanny,Allaire,,"",rcomsante,"","",http://news.abbvie.com/news/abbvie-news-briefs/marking-route-to-sustainable-health-care.htm,http://news.abbvie.com/news/abbvie-news-briefs/spreading-smart-care-across-europe.htm,,,,,,,,,,,,,,,,,,,,,,,,,,,
dale.j.kempf@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Dale,Kempf,,"","","","",http://journals.iucr.org/f/issues/2017/03/00/tt5093/index.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
angela.deluca@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,1,{first}.{last},Angela,Deluca,,"","","",+1 847 936 3354,http://onkonytt.no/kliniske-onkologiske-studier-i-norge,,,,,,,,,,,,,,,,,,,,,,,,,,,,
melissa.cook@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,2,{first}.{last},Melissa,Cook,,,,,,http://hepatitiscresearchandnewsupdates.blogspot.com/2013/07/a-study-to-evaluate-chronic-hepatitis-c.html,http://hepatitiscresearchandnewsupdates.blogspot.com/2013_07_04_archive.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
alissa.bolton@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,12,{first}.{last},Alissa,Bolton,Writing & communication,Communications Head,"","",+1 847 937 2644,http://cknby.com/who-we-are/our-stories/be-change-you-want-to-see.html,http://cknby.com/who-we-are/our-stories/beyond-accessibility-meet-next-generation-disability-advocates.html,http://cknby.com/who-we-are/our-stories/latinx-professionals-speak-up-time-is-ahora.html,http://cknby.com/who-we-are/our-stories/voices-abbvie-reflecting-on-decade-impact.html,http://cknby.com/who-we-are/our-stories/working-parents-2021-why-their-families-are-centered-on-service.html,http://confixxlogin.info/webmail-abbvie,http://news.abbvie.com/news/abbvies-humira-adalimumab-receives-us-food-and-drug-administration-approval-to-treat-adults-with-non-infectious-intermediate-posterior-and-panuveitis.htm,http://news.abbvie.com/alert-topics/immunology/abbvie-announces-positive-phase-2-study-results-for-upadacitinib-abt-494-an-investigational-jak1-selective-inhibitor-in-crohns-disease.htm,http://news.abbvie.com/news/abbvie-announces-positive-phase-2-study-results-for-upadacitinib-abt-494-an-investigational-jak1-selective-inhibitor-in-crohns-disease.htm,http://news.abbvie.com/alert-topics/immunology/abbvies-upadacitinib-abt-494-meets-all-primary-and-ranked-secondary-endpoints-in-phase-3-study-in-rheumatoid-arthritis.htm,http://news.abbvie.com/news/media-statements/abbvies-open-public-hearing-comments-at-fda-arthritis-advisory-committee-meeting-july-12-2016-for-abp-501.htm,http://worldpharmatoday.com/news/abbvies-research-commitment-to-helping-people-living-with-rheumatologic-diseases-highlighted-annual-eular-2016,,,,,,,,,,,,,,,,,
jack.hirschfield@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,8,{first}.{last},Jack,Hirschfield,,,,,,http://news.abbvie.com/news/press-releases/abbvie-announces-us-fda-lifts-partial-clinical-hold-on-phase-3-study-venetoclax-in-patients-with-multiple-myeloma-positive-for-t1114-genetic-abnormality.htm,http://news.abbvie.com/news/press-releases/abbvie-provides-update-on-venclextavenclyxto-venetoclax-multiple-myeloma-program.htm,http://news.abbvie.com/news/minimal-residual-disease-negativity-data-measure-undetectable-disease-added-to-venclexta-venetoclax-tablets-label.htm,http://news.abbvie.com/news/abbvie-provides-update-on-venclextavenclyxto-venetoclax-multiple-myeloma-program.htm,http://news.abbvie.com/news/press-releases/abbvie-provides-update-on-depatuxizumab-mafodotin-depatux-m-an-investigational-medicine-for-newly-diagnosed-glioblastoma-an-aggressive-form-brain-cancer.htm,http://pharmashots.com/press-releases/abbvie-provides-update-on-depatuxizumab-mafodotin-depatux-m-an-investigational-medicine-for-newly-diagnosed-glioblastoma-an-aggressive-form-of-brain-cancer,http://pharmaadvancement.com/drug-development/research-development/abbvie-receives-u-s-fda-rare-pediatric-disease-designation-for-investigational-abt,http://businesswire.com/news/home/20180302005168/en/biogen%c2%a0and-abbvie-announce%c2%a0the-voluntary%c2%a0worldwide-withdrawal-marketing-authorizations,,,,,,,,,,,,,,,,,,,,,
adrian.hobson@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,3,{first}.{last},Adrian,Hobson,Education,Research Fellow,"","","",http://adcreview.com/articles/registration-antibody-drug-conjugates,http://adcreview.com/registration-antibody-drug-conjugates-figure-2-0,http://adcreview.com/registration-antibody-drug-conjugates-figure-8-0,,,,,,,,,,,,,,,,,,,,,,,,,,
francisco.rausa@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,3,{first}.{last},Francisco,Rausa,Education,Research And Development,"","","",http://disruptsf2015.devpost.com/forum_topics/5159-abbvie-challenge-1-wearable-to-monitor-people-suffering-from-neurological-diseases,http://disruptsf2015.devpost.com/forum_topics/5160-abbvie-challenge-3-platform-the-integrated-multiple-sources-of-data-to-rapidly-identify-emerging-research-or-novel-treatments,http://disruptsf2015.devpost.com/forum_topics/5161-abbvie-challenge-2-a-gamified-patient-experience-to-empower-people-living-with-chronic-disease,,,,,,,,,,,,,,,,,,,,,,,,,,
deanne.f.stolarik@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,5,{first}.{last},Deanne,Stolarik,,,,,,http://worldwidescience.org/topicpages/i/ii+renal+allographs.html,http://worldwidescience.org/topicpages/r/renal+terminal+em.html,http://worldwidescience.org/topicpages/r/renal+artery+interventions.html,http://worldwidescience.org/topicpages/p/prevenir+falla+renal.html,http://worldwidescience.org/topicpages/a/angiomiolipoma+renal+complicado.html,,,,,,,,,,,,,,,,,,,,,,,,
gregory.miley@abbvie.com,abbvie.com,AbbVie,US,,,,,94,personal,7,{first}.{last},Gregory,Miley,,,,,,http://biospace.com/article/releases/abbott-vascular-s-b-abbvie-b-officially-launches-with-creation-of-175-jobs-patients-,http://news.abbvie.com/news/abbvie-celebrates-launch-as-new-biopharmaceutical-company-with-employees-patients.htm,http://newswire.ca/news-releases/abbvie-celebrates-launch-as-new-biopharmaceutical-company-with-employees-patients-511779981.html,http://biospace.com/news/abbott-vasculars-abbvie-officially-launches-with/283344/source=yesterdaysmostpopular,http://biospace.com/news/abbott-laboratoriess-abbvie-officially-launches/283344/source=topbreaking,http://biospace.com/news/abbott-vasculars-abbvie-officially-launches-with/283344,http://biospace.com/news/abbott-laboratoriess-abbvie-officially-launches/283344/source=yesterdaysmostpopular,,,,,,,,,,,,,,,,,,,,,,
jessica.hoskins@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,3,{first}.{last},Jessica,Hoskins,,,,,,http://asms.org/docs/default-source/workshop-reports/2021-interest-group-fall-workshop_program.pdf,http://asms.org/docs/default-source/workshop-reports/2022-asms-conference-workshop_program.pdf,http://asms.org/docs/default-source/workshop-reports/2022_ig-polymer-report_2022--asms-polymer-workshop-report.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,
fredrik.holmboe@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,3,{first}.{last},Fredrik,Holmboe,,,,,,http://nyemetoder.no/documents/bestillerforum%20rhf%20-%20%28%20innkallinger%20og%20referater%29/bestillerforum%20rhf%2022.03.2021%20sakspapirer%20offentlige.pdf,http://nyemetoder.no/documents/bestillerforum%20rhf%20-%20%28%20innkallinger%20og%20referater%29/sakspapirer%20bestillerforum%2017.01.2022_offentlige.pdf,http://nyemetoder.no/documents/bestillerforum%20rhf%20-%20%28%20innkallinger%20og%20referater%29/sakspapirer%20bestillerforum%2021.06.21%20offentlig%20utgave_siste.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,
benedikt.braun@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,4,{first}.{last},Benedikt,Braun,,,,,,http://vermietung.schallware.de/en/rental/805,http://vermietung.schallware.de/rental/805,http://schallware.de/en/rental/805,http://schallware.de/rental/805,,,,,,,,,,,,,,,,,,,,,,,,,
dominique.touchette@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,3,{first}.{last},Dominique,Touchette,,,,,,http://lifesciencesbc.ca/members/canadian-migraine-sufferers-have-new-treatment-option-health-canada-approves-ubrelvy-ubrogepant-tablet,http://lifesciencesbc.ca/members/qulipta-now-approved-by-health-canada-for-the-preventive-treatment-of-episodic-migraine-in-adults,http://newswire.ca/fr/news-releases/les-personnes-atteintes-de-migraine-au-canada-disposent-d-une-nouvelle-option-de-traitement-sante-canada-approuve-ubrelvy-r-comprimes-d-ubrogepant--829820399.html,,,,,,,,,,,,,,,,,,,,,,,,,,
mouna.ghoul@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,3,{first}.{last},Mouna,Ghoul,Writing & communication,Associate Director Communications And Public Relations,"","","",http://jdec2022.com/medias/content/jdec22_programme_final.pdf,http://jdec2021.com/medias/content/files/jdec2021_progfinal_20211117_vf.pdf,http://allerganaesthetics.fr/a-propos/actualites,,,,,,,,,,,,,,,,,,,,,,,,,,
anne.brenner@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Anne,Brenner,Medical & health,Health System Executive,"","","",http://hepfree.nyc/hawaii-midwest-strategies-effective-hep-b-c-response-event-highlights,,,,,,,,,,,,,,,,,,,,,,,,,,,,
daniel.fortin@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,3,{first}.{last},Daniel,Fortin,,"","","","",http://armrs.com/compagnies,http://armrs.com/recherche-avancee,http://armrs.com/nos-membres,,,,,,,,,,,,,,,,,,,,,,,,,,
christina.khoury@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Christina,Khoury,,Regulatory Affairs,"","","",http://mann.usc.edu/program/fellowship-programs/current-fellows,,,,,,,,,,,,,,,,,,,,,,,,,,,,
natalie.rhodes@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Natalie,Rhodes,Medical & health,Medical Affairs,"","","",http://mann.usc.edu/program/fellowship-programs/current-fellows,,,,,,,,,,,,,,,,,,,,,,,,,,,,
linda.tsan@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Linda,Tsan,Medical & health,Medical Affairs,"","","",http://mann.usc.edu/program/fellowship-programs/current-fellows,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jane.zhang@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Jane,Zhang,Management,Office Manager,"","","",http://icsa.org/about/past-leadership,,,,,,,,,,,,,,,,,,,,,,,,,,,,
wendy.tai@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,2,{first}.{last},Wendy,Tai,,,,,,http://lycheegroup.com/abbvie-chinese,http://lycheegroup.com/abbvie,,,,,,,,,,,,,,,,,,,,,,,,,,,
aaron.steinbrecher@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Aaron,Steinbrecher,Management,Project Manager,com,"","",http://mygcsg.com/gcsg-2021-us-virtual-conference/speakers,,,,,,,,,,,,,,,,,,,,,,,,,,,,
fernando.tatsch@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Fernando,Tatsch,,"","","","",http://elsevier.es/en-revista-annals-hepatology-16-estadisticas-s1665268119322574,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kathrin.kuntz@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,8,{first}.{last},Kathrin,Kuntz,Writing & communication,Corporate Communication,"","","",http://news.abbvie.de/contact_people/tag/gesundheit-und-versorgung,http://temedica.com/en/press/launch-ibd-digial-companion-temedica-abbvie,http://mastertraders.de/newsticker/dgap-news-merkur-bank-schliet-bernahme-wesentlicher-teile-des-bankgeschfts-der-bank-schilling-ab/554370,http://bereitschaftspraxen.de/augen-auf-fuer-die-schoenen-lebensmomente,http://natko.de/augen-auf-fuer-die-schoenen-lebensmomente,http://news.abbvie.de/contact_people/tag/science-rocks,http://abbvie-germany.mynewsdesk.com/contact_people,http://news.abbvie.de/contact_people,,,,,,,,,,,,,,,,,,,,,
josue.samayoa@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,5,{first}.{last},Josue,Samayoa,Education,"","","","",http://jitc.bmj.com/content/6/1/63.info,http://jitc.bmj.com/content/6/1/63.responses,http://jitc.bmj.com/content/6/1/63.share,http://jitc.bmj.com/content/6/1/50,http://jitc.bmj.com/content/6/1/63,,,,,,,,,,,,,,,,,,,,,,,,
kate.birrenkott@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Kate,Birrenkott,,"","","",+1 612 804 5413,http://ce.mayo.edu/content/abbvie%c2%a0-virtual-exhibit-hall-2021-mayo-clinic-oncology-review-livestream,,,,,,,,,,,,,,,,,,,,,,,,,,,,
amber.landis@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,6,{first}.{last},Amber,Landis,,,,,,http://cknby.com/who-we-are/our-stories/making-it-migraine-friendly-why-were-reimagining-workplace.html,http://cknby.com/who-we-are/our-stories/the-math-of-migraine.html,http://news.abbvie.com/news/press-releases/abbvie-submits-marketing-authorization-application-to-ema-for-atogepant-for-preventive-treatment-migraine.htm,http://news.abbvie.com/news/press-releases/new-england-journal-medicine-publishes-12-week-results-from-study-evaluating-atogepant-for-preventive-treatment-migraine.htm,http://news.abbvie.com/news/press-releases/abbvie-to-present-data-across-its-robust-neuroscience-portfolio-at-2021-american-academy-neurology-aan-annual-meeting.htm,http://news.abbvie.com/news/press-releases/us-fda-accepts-abbvies-new-drug-application-for-atogepant-for-preventive-treatment-migraine.htm,,,,,,,,,,,,,,,,,,,,,,,
julie.ciardiello@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,6,{first}.{last},Julie,Ciardiello,Management,Director,"","",+1 732 429 4909,http://cknby.com/who-we-are/our-stories/the-math-of-migraine.html,http://news.abbvie.com/news/press-releases/us-fda-approves-qulipta-atogepant-for-adults-with-chronic-migraine.htm,http://news.abbvie.com/news/press-releases/abbvie-to-showcase-breadth-neuroscience-portfolio-and-pipeline-at-american-academy-neurology-aan-2022-annual-meeting.htm,http://news.abbvie.com/news/press-releases/new-england-journal-medicine-publishes-12-week-results-from-study-evaluating-atogepant-for-preventive-treatment-migraine.htm,http://news.abbvie.com/news/press-releases/abbvie-to-present-data-across-its-robust-neuroscience-portfolio-at-2021-american-academy-neurology-aan-annual-meeting.htm,http://news.abbvie.com/news/press-releases/us-fda-accepts-abbvies-new-drug-application-for-atogepant-for-preventive-treatment-migraine.htm,,,,,,,,,,,,,,,,,,,,,,,
moiz.diwan@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,2,{first}.{last},Moiz,Diwan,Operations & logistics,Program Chair,"","","",http://aiche.org/community/sites/aiche-program-committee/program-chairs,http://aiche.org/community/sites/committees/program-committee/program-chairs-0,,,,,,,,,,,,,,,,,,,,,,,,,,,
mallory.morrison@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,2,{first}.{last},Mallory,Morrison,Education,Specialist,"","","",http://h1bdata.com/page/2,http://h1bdata.com,,,,,,,,,,,,,,,,,,,,,,,,,,,
brian.bautista@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,3,{first}.{last},Brian,Bautista,,"","","","",http://hackerschicago.com/home/archives/06-2013,http://hackerschicago.com/home/category/all,http://hackerschicago.com,,,,,,,,,,,,,,,,,,,,,,,,,,
eric.moschetta@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,4,{first}.{last},Eric,Moschetta,,"","","","",http://aiche.org/conferences/aiche-annual-meeting/2018/proceeding/paper/558g-on-line-ftir-accurate-fundamental-kinetic-analysis-real-time-process-monitoring-and-process,http://aiche.org/conferences/aiche-annual-meeting/2017/proceeding/paper/507d-heuristics-implementing-photoredox-catalysis-flow-reactors,http://aiche.org/conferences/aiche-annual-meeting/2019/proceeding/paper/126e-scale-continuous-extraction-process-equilibrium-limited-reaction,http://aiche.org/conferences/aiche-annual-meeting/2017/proceeding/paper/79g-chemical-reaction-engineering-principles-continuous-flow-photoredox-catalysis,,,,,,,,,,,,,,,,,,,,,,,,,
daniel.shappee@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,5,{first}.{last},Daniel,Shappee,,,,,,http://hepfree.nyc/ny-hep-c-telemedicine-workgroup-meeting-notes-11-19-2020,http://hepfree.nyc/nys-hep-c-telemedicine-workgroup-meeting-notes-8-20-20,http://hepfree.nyc/telemedicine-workgroup-meeting-highlights-1-21-21,http://hepfree.nyc/telemedicine-workgroup-meeting-highlights-5-20-21,http://hepfree.nyc/telemedicine-workgroup-meeting-highlights-3-18-21,,,,,,,,,,,,,,,,,,,,,,,,
victor.klang@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Victor,Klang,,"","","","",http://program.almedalsveckan.info/event/user-view/54486,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jaquelin.pacelli@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,4,{first}.{last},Jaquelin,Pacelli,,,,,,http://news.abbvie.com/news/press-releases/abbvie-to-present-at-bank-america-securities-healthcare-conference.htm,http://news.abbvie.com/news/press-releases/abbvie-announces-extension-review-for-supplemental-new-drug-application-upadacitinib-for-treatment-moderate-to-severe-atopic-dermatitis.htm,http://news.abbvie.com/news/press-releases/abbvie-announces-extension-review-for-supplemental-new-drug-application-upadacitinib-for-treatment-adults-with-active-psoriatic-arthritis.htm,http://news.abbvie.com/pr-contacts,,,,,,,,,,,,,,,,,,,,,,,,,
belen.lopez@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Belen,Lopez,Writing & communication,Communications Head,"","","",http://news.abbvie.com/pr-contacts,,,,,,,,,,,,,,,,,,,,,,,,,,,,
vivian.veltri@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,2,{first}.{last},Vivian,Veltri,Executive,Regional Director,"","",+1 561 901 0048,http://amga.org/getmedia/0c6602b0-0351-4cfa-95f7-1d18af3e786d/amga_2022_industry_partners_directory.pdf,http://amga.org/membership-partners/industry-support/corporate-partner-profiles/abbvie,,,,,,,,,,,,,,,,,,,,,,,,,,,
arlene.nugent@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,2,{first}.{last},Arlene,Nugent,Education,Phd Candidate,"",https://www.linkedin.com/in/arlene-nugent-73574222/,"",http://theta.utoronto.ca/arlene-nugent-phd-candidate,http://thetacollaborative.ca/arlene-nugent-phd-candidate,,,,,,,,,,,,,,,,,,,,,,,,,,,
karen.bodie@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Karen,Bodie,,"","","","",http://unboundmedicine.com/medline/citation/27020044/biomarker_evaluation_of_skeletal_muscle_toxicity_following_clofibrate_administration_in_rats_,,,,,,,,,,,,,,,,,,,,,,,,,,,,
stacy.flannery@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Stacy,Flannery,Education,Research Staff,"","",+1 847 283 8955,http://clinicaltrials.gov/ct2/show/nct03982394,,,,,,,,,,,,,,,,,,,,,,,,,,,,
olga.hesselink@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Olga,Hesselink,,"","","","",http://pdfslide.net/documents/abbvie-in-de-top-van-best-workplaces-van-great-place-to-work-plaats-in-de-great.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anup.upadhyay@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Anup,Upadhyay,,"","","","",http://journals.iucr.org/f/issues/2017/03/00/tt5093/index.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
franz.schmitting@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,2,{first}.{last},Franz,Schmitting,Operations & logistics,"","","","",http://journal.pda.org/content/early/2016/10/21/pdajpst.2016.006999,http://journal.pda.org/content/early/2016/10/21/pdajpst.2016.006999.abstract,,,,,,,,,,,,,,,,,,,,,,,,,,,
sabine.karl@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,6,{first}.{last},Sabine,Karl,Writing & communication,Corporate Communication,"","","",http://waschen-wie-walter.de/abbvie-deutschland-belegt-platz-1-beim-corporate-health-award-2021,http://gateo.de/abbvie-deutschland-belegt-platz-1-beim-corporate-health-award-2019-foto-1775423.html,http://presseportal.de/pm/112983/4454631,http://deine-nachrichten.de/abbvie-deutschland-belegt-platz-1-beim-corporate-health-award-2019-foto,http://finanznachrichten.de/nachrichten-2019-03/46219427-abbvie-belegt-platz-1-beim-wettbewerb-deutschlands-beste-arbeitgeber-007.htm,http://presseportal.de/pm/112983/4219203,,,,,,,,,,,,,,,,,,,,,,,
amit.khatri@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Amit,Khatri,Medical & health,Health Science,"","","",http://hepatology.pro/farmakokinetika-i-bezopasnost-kombinatsii-paritaprevira-s-ritonavirom-ombitasvirom-i-dasabuvirom-pri-narushenii-funktsii-pecheni,,,,,,,,,,,,,,,,,,,,,,,,,,,,
mohan.rao@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,2,{first}.{last},Mohan,Rao,,"","","","",http://frontiersin.org/articles/10.3389/fgene.2018.00636/full,http://frontiersin.org/articles/10.3389/fgene.2018.00636/abstract,,,,,,,,,,,,,,,,,,,,,,,,,,,
brian.calimlim@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Brian,Calimlim,,"","","","",http://medicaljournals.se/acta/content/html/10.2340/00015555-3012,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ivan.chan@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Ivan,Chan,,"","","","",http://degruyter.com/view/j/scid,,,,,,,,,,,,,,,,,,,,,,,,,,,,
bruce.glazer@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,5,{first}.{last},Bruce,Glazer,Sales,Account Executive,"","","",http://hepfree.nyc/meeting-highlights-hep-free-nyc-advocacy-committee-09-23-2020,http://hepfree.nyc/hep-free-nyc-meeting-highlights-09-14-2022,http://hepfree.nyc/hep-c-task-force-meeting-highlights-09-25-2019,http://hepfree.nyc/hep-c-task-force-meeting-highlights-9-12-18,http://hepfree.nyc/hep-c-task-force-meeting-highlights-6-27-18,,,,,,,,,,,,,,,,,,,,,,,,
peter.bacher@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,5,{first}.{last},Peter,Bacher,Management,Area Lead,"","","",http://ssom.luc.edu/pharmacology/people/faculty,http://ssom.luc.edu/pharmacology/facultyandstaff/affiliatefaculty/kellyalangert,http://ssom.luc.edu/pharmacology/facultyandstaff/graduatestudents,http://ssom.luc.edu/pharmacology/people/affiliate_faculty,http://ssom.luc.edu/pharmacology/facultyandstaff/affiliatefaculty,,,,,,,,,,,,,,,,,,,,,,,,
torben.neelands@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,2,{first}.{last},Torben,Neelands,,Senior Scientist,"","","",http://neuroscience.med.umich.edu/directory/alumnus/torben-neelands,http://neuroscience.med.umich.edu/directory/n,,,,,,,,,,,,,,,,,,,,,,,,,,,
patrick.dorr@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,2,{first}.{last},Patrick,Dorr,Medical & health,Medical Director,"","","",http://epidemiology-journal.ru/en/archive/article/36336,http://epidemiology-journal.ru/ru/archive/article/36336,,,,,,,,,,,,,,,,,,,,,,,,,,,
gabrielle.tarbert@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,6,{first}.{last},Gabrielle,Tarbert,,"","","",+1 224 244 0111,http://news.abbvie.com/pr-contacts,http://news.abbvie.com/news/press-releases/therapeutic-area/immunology/abbvie-and-scripps-research-announce-collaboration-to-develop-broad-range-new-therapeutics.htm,http://news.abbvie.com/news/press-releases/new-survey-offers-perspective-on-mental-and-emotional-journey-for-patients-diagnosed-with-slow-growing-blood-cancer.htm,http://news.abbvie.com/news/press-releases/abbvie-and-scripps-research-announce-collaboration-to-develop-broad-range-new-therapeutics.htm,http://mbcbiolabs.com/mbc-biolabs-news/abbvie-and-mbc-biolabs-team-up-to-support-life-science-startups-in-the-san-francisco-bay-area,http://mbcbiolabs.com/media/release/abbvie-and-mbc-biolabs-team-up-to-support-life-science-startups-in-the-san-francisco-bay-area,,,,,,,,,,,,,,,,,,,,,,,
stevan.w.djuric@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Stevan,Djuric,Medical & health,Medicinal Chemistry,"","","",http://axial.acs.org/2017/09/25/medicinal-chemistry-technology,,,,,,,,,,,,,,,,,,,,,,,,,,,,
michael.breitenstein@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,2,{first}.{last},Michael,Breitenstein,,,,,,http://dac2017.de/ausstellerverzeichnis.php,http://dac2018.de/ausstellerverzeichnis.php,,,,,,,,,,,,,,,,,,,,,,,,,,,
christian.naylor@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,2,{first}.{last},Christian,Naylor,,,,,,http://hepatitiscresearchandnewsupdates.blogspot.com/2013/11/clinical-trial-study-to-evaluate-safety.html,http://hepatitiscresearchandnewsupdates.blogspot.com/2013_11_26_archive.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
lloyd.lam@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,3,{first}.{last},Lloyd,Lam,,,,,,http://cancerci.biomedcentral.com/articles/10.1186/s12935-014-0151-3,http://bmccancer.biomedcentral.com/articles/10.1186/s12885-017-3383-5,http://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-015-0397-y,,,,,,,,,,,,,,,,,,,,,,,,,,
hong.liu@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Hong,Liu,Medical & health,"","","","",http://dmd.aspetjournals.org/content/early/2016/12/19/dmd.116.071613,,,,,,,,,,,,,,,,,,,,,,,,,,,,
dana.harville@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,7,{first}.{last},Dana,Harville,Writing & communication,Communications Head,"","",+1 847 935 0580,http://news.abbvie.com/news/press-releases/abbvie-announces-new-data-from-its-dermatology-portfolio-and-pipeline-at-28th-european-academy-dermatology-and-venereology-eadv-congress.htm,http://news.abbvie.com/news/press-releases/new-two-year-data-at-24th-world-congress-dermatology-shows-skyrizi-risankizumab-maintains-complete-skin-clearance.htm,http://news.abbvie.com/news/press-releases/rinvoq-upadacitinib-receives-us-fda-approval-for-active-psoriatic-arthritis.htm,http://cknby.com/who-we-are/our-stories/connecting-patients-with-care-3-lessons-learned-during-covid-19.html,http://news.abbvie.com/news/press-releases/abbvie-highlights-innovative-research-from-its-rheumatology-portfolio-at-acr-convergence-2021.htm,http://news.abbvie.com/pr-contacts,http://worldpharmatoday.com/news/abbvies-research-commitment-to-helping-people-living-with-rheumatologic-diseases-highlighted-annual-eular-2016,,,,,,,,,,,,,,,,,,,,,,
lisa.ramsey@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Lisa,Ramsey,Writing & communication,Vp Corporate Communications,bobpearson1845,"","",http://prnewsonline.com/pr-pros-still-see-writing-key-success-analytics-digital-business-skills-also-important,,,,,,,,,,,,,,,,,,,,,,,,,,,,
eric.mohler@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,5,{first}.{last},Eric,Mohler,Writing & communication,Social Media Coordinator,"","",+1 847 735 6040,http://chicagosfn.org/chapter-information/executive-committee-2020-2021,http://chicagosfn.org/chapter-information/executive-committee-2016-2017-2,http://chicagosfn.org/chapter-information/executive-committee-2017-2018-2,http://chicagosfn.org/chapter-information/executive-committee-2018-2019-2,http://chicagosfn.org/chapter-information/executive-committee-2019-2020-2,,,,,,,,,,,,,,,,,,,,,,,,
eric.cardwell@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,5,{first}.{last},Eric,Cardwell,,,,,,http://edmrefmodel.com/device-ref-model-forum/next-devices-subgroup-call-9-apr-2015-1700-cest-11am-et,http://edmrefmodel.com/device-ref-model-forum/next-devices-subgroup-call-16-july-2015-1700-cest-11am-edt,http://edmrefmodel.com/device-ref-model-forum/next-devices-subgroup-call-21-may-2015-1700-cest-11am-edt,http://edmrefmodel.com/device-ref-model-forum/next-devices-subgroup-call-distribution-list-8-oct-2015,http://edmrefmodel.com/device-ref-model-forum/next-devices-subgroup-call-rescheduled-to-27-aug-2015-1700-cest-11am-edt,,,,,,,,,,,,,,,,,,,,,,,,
jianwei.shen@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,5,{first}.{last},Jianwei,Shen,,"","","","",http://dmd.aspetjournals.org/content/suppl/2016/05/13/dmd.115.067488.dc1,http://dmd.aspetjournals.org/content/suppl/2016/05/13/dmd.115.067496.dc1,http://dmd.aspetjournals.org/content/suppl/2016/05/13/dmd.115.067512.dc1,http://dmd.aspetjournals.org/content/early/2016/05/13/dmd.115.067488.abstract,http://dmd.aspetjournals.org/content/early/2016/05/13/dmd.115.067496.abstract,,,,,,,,,,,,,,,,,,,,,,,,
maren.nienstedt@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,16,{first}.{last},Maren,Nienstedt,Writing & communication,Senior Communication Manager,"","",+49 611 1720 2382,http://thueringer-allgemeine.de/wirtschaft/presseportal/welt-neurodermitis-tag-2022-digitale-kunstaktion-perspektivwechsel-soll-verschiedene-gesichter-der-neurodermitis-zeigen-id236353445.html,http://news.abbvie.de/contact_people/tag/gesundheit-und-versorgung,http://de.knews.media/nachrichten/digitale-kunstaktion-perspektivwechsel-soll-verschiedene-gesichter-der-neurodermitis-zeigen,http://abbvie-germany.mynewsdesk.com/pressreleases/abbvie-und-turnstone-biologics-geben-weltweite-zusammenarbeit-bei-viro-immuntherapien-in-der-onkologie-bekannt-2233555,http://news.abbvie.de/pressreleases/abbvie-und-turnstone-biologics-geben-weltweite-zusammenarbeit-bei-viro-immuntherapien-in-der-onkologie-bekannt-2233555,http://abbvie-germany.mynewsdesk.com/contact_people,http://abbvie-germany.mynewsdesk.com/pressreleases/neue-webseite-unterstutzt-menschen-mit-neurodermitis-beim-erreichen-selbst-gesteckter-behandlungsziele-3127472,http://medizin-aspekte.de/dkk-berlin-nicht-nachweisbare-minimale-resterkrankung-als-zukuenftiges-ziel-bei-cll-100226,http://medizin-aspekte.de/nutzer-befragung-belegt-ced-app-foerdert-arzt-patienten-kommunikation-91358,http://schattenblick.de/infopool/medizin/gesund/m3ar1430.html,http://nachrichten.idw-online.de/2018/04/17/dkk-berlin-nicht-nachweisbare-minimale-resterkrankung-als-zukuenftiges-ziel-bei-cll,http://nachrichten.idw-online.de/2018/01/17/cll-venetoclax-erreicht-gutes-ansprechen-und-hohe-mrd-negativitaets-raten-nach-ibrutinib-versagen,http://idw-online.de/de/news692645,http://prmaximus.blogspot.com/2016/07,http://presseportal.de/pm/112983/2854636,http://presseportal.de/pm/112983/3280273,,,,,,,,,,,,,
carolin.crockett@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,14,{first}.{last},Carolin,Crockett,Writing & communication,Corporate Communication,"","",+49 17 2866 1759,http://shilfa.com/switzerland/three-things-that-many-people-in-germany-do-not-know,http://presseportal.de/pm/112983/4276528,http://iinews.de/hepatitis-c-drei-dinge-die-viele-menschen-in-deutschland-nicht-wissen-foto-1722387.html,http://tocuz.com/switzerland/there-are-three-things-that-many-people-in-germany-do-not-know,http://deine-nachrichten.de/hepatitis-c-drei-dinge-die-viele-menschen-in-deutschland-nicht-wissen-foto,http://gateo.de/hepatitis-c-drei-dinge-die-viele-menschen-in-deutschland-nicht-wissen-foto-1722387.html,http://presseportal.de/pm/112983/3867022,http://innovations-intelligenz.de/abbvie-deutschland-launcht-neue-unternehmenswebseite-und-arbeitgeber-kampagne-foto-1634310.html,http://mynewsdesk.com/de/abbvie/pressreleases/digitalkooperation-bessere-versorgung-fuer-patienten-mit-schmerzhafter-hauterkrankung-2388564,http://abbvie-germany.mynewsdesk.com/pressreleases/digitalkooperation-bessere-versorgung-fuer-patienten-mit-schmerzhafter-hauterkrankung-2388564,http://innovations-intelligenz.de/bessere-versorgung-fuer-patienten-mit-schmerzhafter-hauterkrankung-digitalkooperation-zwischen-schwenninger-krankenkasse-und-abbvie-deutschland-foto-1572752.html,http://news.abbvie.de/pressreleases/digitalkooperation-bessere-versorgung-fuer-patienten-mit-schmerzhafter-hauterkrankung-2388564,http://politikexpress.de/abbvie-auf-platz-2-der-top-arbeitgeber-in-deutschland-2016-foto-1323184.html,http://presseportal.de/pm/112983/3180399,,,,,,,,,,,,,,,
jane.woo@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,11,{first}.{last},Jane,Woo,Writing & communication,Media Contact,"","",+1 847 937 4754,http://cknby.com/who-we-are/our-stories/they-wont-back-down.html,http://cknby.com/who-we-are/our-stories/unlocking-the-next-level-of-protein-degradation.html,http://news.abbvie.com/pr-contacts,http://news.abbvie.com/news/press-releases/abbvie-announces-approval-maviret-glecaprevirpibrentasvir-for-treatment-chronic-hepatitis-c-in-all-major-genotypes-gt1-6-in-japan.htm,http://news.abbvie.com/news/abbvies-viekirax-ombitasvirparitaprevirritonavir-tablets-receives-approval-in-japan-for-treatment-genotype-1-chronic-hepatitis-c.htm,http://news.abbvie.com/news/abbvie-granted-priority-review-in-japan-for-its-investigational-regimen-glecaprevirpibrentasvir-gp-for-treatment-all-major-genotypes-chronic-hepatitis-c.htm,http://news.abbvie.com/news/press-releases/biogen-and-abbvies-once-monthly-zinbryta-daclizumab-approved-in-european-union-for-treatment-multiple-sclerosis.htm,http://hepatitiscadvocate.blogspot.com/2015/09/efficacy-and-safety-of.html,http://pharmaadvancement.com/pharma-news/ec-grants-abbvie-s-maviret-marketing-authorization-for-the-treatment-of-chronic-hepatitis-c,http://hcvadvocatenews.blogspot.com/2015/09,http://hcvadvocatenews.blogspot.com/2015/09/efficacy-and-safety-of.html,,,,,,,,,,,,,,,,,,
patricia.santanna@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Patricia,Santanna,,"","","","",http://prnewswire.com/news-releases/funcionarios-da-abbvie-doam-mais-de-26000-horas-de-trabalho-em-uma-unica-semana-em-beneficio-de-comunidades-ao-redor-do-mundo-630887113.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kristof.chwalisz@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Kristof,Chwalisz,Education,Research And Development,"","","",http://thieme-connect.com/products/ejournals/abstract/10.1055/s-0037-1606302,,,,,,,,,,,,,,,,,,,,,,,,,,,,
florian.dieckmann@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,15,{first}.{last},Florian,Dieckmann,Writing & communication,Director Public Affairs,"","",+1 224 440 1509,http://headquartersof.com/abbvie-headquarters,http://vfa.de/download/forschung-fuer-das-leben-2015.pdf,http://headquartersof.com/abbvie-headquarters-info-email-format-and-hr-phone-number,http://news.abbvie.com/alert-topics/immunology/abbvie-receives-fda-approval-rinvoq-upadacitinib-an-oral-jak-inhibitor-for-treatment-moderate-to-severe-rheumatoid-arthritis.htm,http://news.abbvie.com/news/abbvies-upadacitinib-shows-positive-results-as-monotherapy-in-phase-3-rheumatoid-arthritis-study-meeting-all-primary-and-key-secondary-endpoints.htm,http://news.abbvie.com/alert-topics/immunology/abbvies-upadacitinib-abt-494-meets-all-primary-and-ranked-secondary-endpoints-in-phase-3-study-in-rheumatoid-arthritis.htm,http://news.abbvie.com/news/press-releases/abbvie-to-showcase-scientific-innovation-and-research-advancements-across-dermatology-portfolio-at-2019-aad-annual-meeting.htm,http://news.abbvie.com/news/abbvie-announces-new-phase-2-data-for-upadacitinib-showing-clinical-and-endoscopic-outcomes-in-crohns-disease-at-52-weeks.htm,http://biospace.com/article/upadacitinib-meets-all-primary-and-ranked-secondary-endpoints-including-superiority-versus-adalimumab-in-phase-3-study-in-rheumatoid-arthritis,http://biospace.com/article/releases/upadacitinib-meets-all-primary-and-ranked-secondary-endpoints-including-superiority-versus-adalimumab-in-phase-3-study-in-rheumatoid-arthritis,http://krebs-nachrichten.de/pharma-details/antikoerper-wirkstoff-konjugate-praezise-vernichtung-von-krebszellen.html,http://presseportal.de/pm/112983/2930624,http://presseportal.de/pm/112983/3073244,http://presseportal.de/pm/112983/3439634,http://politikexpress.de/abbvie-healthcare-monitor-erhebt-ab-sofortoffentliche-meinung-zu-gesundheits-und-versorgungsthemen-foto-1404472.html,,,,,,,,,,,,,,
ahmed.negm@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Ahmed,Negm,,"","","","",http://news.abbvie.com/news/press-releases/abbvie-completes-new-licensing-agreement-to-address-growing-demand-for-hiv-treatments-in-africa.htm,,,,,,,,,,,,,,,,,,,,,,,,,,,,
fiona.olivier@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,1,{first}.{last},Fiona,Olivier,Writing & communication,Communications Head,"","","",http://news.abbvie.com/news/abbvie-news-briefs/doctors-channel-wins-most-valuable-patient-initiative.htm,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kelli.teno@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,5,{first}.{last},Kelli,Teno,,"","","",+1 847 935 9593,http://news.abbvie.com/news/abbvie-news-briefs/five-breast-cancer-facts-you-should-know.htm,http://news.abbvie.com/news/abbvie-news-briefs/five-things-to-know-about-lung-cancer.htm,http://news.abbvie.com/news/abbvie-news-briefs/five-important-facts-about-glioblastoma-you-should-know.htm,http://news.abbvie.com/news/abbvie-news-briefs/our-commitment-to-most-common-adult-leukemia.htm,http://news.abbvie.com/news/abbvies-leadership-in-immunology-featured-at-2014-american-college-rheumatology-annual-meeting-with-new-data-on-investigational-medicines-and-humira-adalimumab.htm,,,,,,,,,,,,,,,,,,,,,,,,
krystal.loewe@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,6,{first}.{last},Krystal,Loewe,Writing & communication,Media Contact,"","",+1 847 937 4072,http://news.abbvie.com/news/press-releases/abbvie-announces-us-fda-lifts-partial-clinical-hold-on-phase-3-study-venetoclax-in-patients-with-multiple-myeloma-positive-for-t1114-genetic-abnormality.htm,http://news.abbvie.com/news/press-releases/abbvie-provides-update-on-depatuxizumab-mafodotin-depatux-m-an-investigational-medicine-for-newly-diagnosed-glioblastoma-an-aggressive-form-brain-cancer.htm,http://news.abbvie.com/news/abbvie-demonstrates-leadership-in-gastroenterology-and-hepatology-with-new-data-and-late-breaking-studies-to-be-presented-at-digestive-disease-week.htm,http://pharmashots.com/press-releases/abbvie-provides-update-on-depatuxizumab-mafodotin-depatux-m-an-investigational-medicine-for-newly-diagnosed-glioblastoma-an-aggressive-form-of-brain-cancer,http://news.abbvie.com/news/abbvies-upadacitinib-abt-494-meets-primary-endpoint-in-phase-2b-study-in-atopic-dermatitis.htm,http://news.abbvie.com/news/abbvies-humira-adalimumab-receives-first-and-only-us-food-and-drug-administration-approval-for-moderate-to-severe-hidradenitis-suppurativa.htm,,,,,,,,,,,,,,,,,,,,,,,
elizabeth.hoff@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,13,{first}.{last},Elizabeth,Hoff,Education,Research And Development,"","",+1 847 935 4236,http://news.abbvie.com/news/md-anderson-abbvie-connect-to-advance-cancer-immunotherapy.htm,http://news.abbvie.com/news/abbvie-to-present-late-breaking-results-from-turquoise-ii-study-in-chronic-hepatitis-c-patients-with-cirrhosis-at-2014-international-liver-congress.htm,http://hepatitiscresearchandnewsupdates.blogspot.com/2014/01,http://hepatitiscresearchandnewsupdates.blogspot.com/2014/05,http://hepatitiscresearchandnewsupdates.blogspot.com/2014_06_17_archive.html,http://hepatitiscresearchandnewsupdates.blogspot.com/2014_01_31_archive.html,http://hepatitiscresearchandnewsupdates.blogspot.com/2013_12_10_archive.html,http://hepatitiscnewdrugs.blogspot.com/2013/12/abbvie-demonstrates-96-percent-svr12.html,http://news.abbvie.com/news/abbvie-demonstrates-96-percent-svr12-in-its-phase-iii-study-treatment-experienced-patients-with-genotype-1-hepatitis-c.htm,http://news.abbvie.com/news/abbvie-submits-new-drug-application-to-us-fda-for-its-investigational-all-oral-interferon-free-therapy-for-treatment-hepatitis-c.htm,http://hepatitiscnewdrugs.blogspot.com/2014_03_01_archive.html,http://news.abbvie.com/news/abbvie-to-present-detailed-results-from-phase-iii-studies-in-patients-with-chronic-hepatitis-c-at-2014-international-liver-congress.htm,http://hepatitiscnewdrugs.blogspot.com/2014/03,,,,,,,,,,,,,,,,
elizabeth.shea@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,14,{first}.{last},Elizabeth,Shea,,"","","",+1 847 935 2211,http://news.abbvie.com/news/biogen-and-abbvie-receive-fda-approval-once-monthly-zinbryta-daclizumab-for-multiple-sclerosis.htm,http://hepatitiscresearchandnewsupdates.blogspot.com/2014_03_24_archive.html,http://biospace.com/news/positive-survival-data-for-bristol-myers-squibb/300109,http://news.abbvie.com/news/press-releases/biogen-and-abbvies-once-monthly-zinbryta-daclizumab-approved-in-european-union-for-treatment-multiple-sclerosis.htm,http://hepatitiscnewdrugs.blogspot.com/2014_03_01_archive.html,http://hepatitiscresearchandnewsupdates.blogspot.com/2014_01_31_archive.html,http://hepatitiscresearchandnewsupdates.blogspot.com/2014/01,http://hepatitiscnewdrugs.blogspot.com/2013/12/abbvie-demonstrates-96-percent-svr12.html,http://hepatitiscresearchandnewsupdates.blogspot.com/2013_11_18_archive.html,http://hepatitiscresearchandnewsupdates.blogspot.com/2013_12_10_archive.html,http://news.abbvie.com/news/abbvie-completes-largest-phase-iii-program-an-all-oral-interferon-free-therapy-for-treatment-hepatitis-c-genotype-1.htm,http://news.abbvie.com/news/abbvie-demonstrates-96-percent-svr12-in-its-phase-iii-study-treatment-experienced-patients-with-genotype-1-hepatitis-c.htm,http://news.abbvie.com/news/abbvie-to-present-detailed-results-from-phase-iii-studies-in-patients-with-chronic-hepatitis-c-at-2014-international-liver-congress.htm,http://hepatitiscnewdrugs.blogspot.com/2014/03,,,,,,,,,,,,,,,
javier.boix@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,14,{first}.{last},Javier,Boix,Writing & communication,Communications Head,"","",+1 847 937 6113,http://hepatitiscresearchandnewsupdates.blogspot.com/2014/01,http://news.abbvie.com/news/abbvie-to-present-results-from-phase-2-pearl-i-study-in-genotype-4-chronic-hepatitis-c-patients-at-liver-meeting-2014.htm,http://hepatitiscresearchandnewsupdates.blogspot.com/2013_12_10_archive.html,http://hepatitiscresearchandnewsupdates.blogspot.com/2014/05,http://hepatitiscresearchandnewsupdates.blogspot.com/2014_01_31_archive.html,http://hepatitiscresearchandnewsupdates.blogspot.com/2014_06_17_archive.html,http://hcvadvocatenews.blogspot.com/2015/01/european-commission-grants-marketing.html,http://hepatitiscnewdrugs.blogspot.com/2015/04,http://hcvadvocatenews.blogspot.com/2015/06/abbvie-announces-new-phase-3b-results.html,http://hcvadvocatenews.blogspot.com/search/label/compensated%20cirrhosis,http://hepatitiscnewdrugs.blogspot.com/2013/12/abbvie-demonstrates-96-percent-svr12.html,http://hepatitiscnewdrugs.blogspot.com/2015_04_01_archive.html,http://hepatitiscadvocate.blogspot.com/2015/01/european-commission-grants-marketing.html,http://hepatitiscnewdrugs.blogspot.com/2014/03,,,,,,,,,,,,,,,
carlos.taveras@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,12,{first}.{last},Carlos,Taveras,Management,Senior Director,"","",+1 847 938 3253,http://news.abbvie.com/news/abbvie-announces-new-art-gallery-designed-to-provide-perspectives-on-impact-chronic-inflammatory-diseases.htm,http://news.abbvie.com/news/press-releases/abbvie-discontinues-rovalpituzumab-tesirine-rova-t-research-and-development-program.htm,http://news.abbvie.com/news/abbvie-announces-new-data-evaluating-venetoclax-in-variety-hematologic-malignancies-at-22nd-european-hematology-association-congress.htm,http://news.abbvie.com/news/abbvie-receives-chmp-positive-opinion-for-venclyxto-venetoclax-tablets-for-appropriate-patients-with-difficult-to-treat-chronic-lymphocytic-leukaemia.htm,http://news.abbvie.com/news/minimal-residual-disease-negativity-data-measure-undetectable-disease-added-to-venclexta-venetoclax-tablets-label.htm,http://hcvadvocatenews.blogspot.com/2015/01/european-commission-grants-marketing.html,http://pharmaadvancement.com/pharma-news/ec-grants-abbvie-s-maviret-marketing-authorization-for-the-treatment-of-chronic-hepatitis-c,http://hcvadvocatenews.blogspot.com/2015/06/abbvie-announces-new-phase-3b-results.html,http://hcvadvocatenews.blogspot.com/search/label/compensated%20cirrhosis,http://hepatitiscadvocate.blogspot.com/2015/01/european-commission-grants-marketing.html,http://hcvadvocatenews.blogspot.com/2015/06,http://hepatitiscadvocate.blogspot.com/2015/06/abbvie-announces-new-phase-3b-results.html,,,,,,,,,,,,,,,,,
judy.low@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,11,{first}.{last},Judy,Low,,,,,,http://hcvadvocatenews.blogspot.com/2015/01/abbvie-announces-top-line-results-from.html,http://hcvadvocatenews.blogspot.com/search/label/ribavirin-free,http://hepatitiscadvocate.blogspot.com/2015/09/efficacy-and-safety-of.html,http://news.abbvie.com/news/abbvie-presents-new-data-for-its-investigational-hepatitis-c-treatment-in-japanese-patients-with-and-without-cirrhosis.htm,http://hepatitiscadvocate.blogspot.com/2015/01/abbvie-announces-top-line-results-from.html,http://hcvadvocatenews.blogspot.com/2015/01,http://hcvadvocatenews.blogspot.com/2015/09,http://news.abbvie.com/news/abbvie-announces-top-line-results-from-phase-3-study-all-oral-treatment-for-hepatitis-c-in-japan.htm,http://news.abbvie.com/news/abbvie-submits-new-drug-application-in-japan-for-its-investigational-all-oral-treatment-for-chronic-hepatitis-c.htm,http://news.abbvie.com/news/abbvies-viekirax-ombitasvirparitaprevirritonavir-tablets-receives-approval-in-japan-for-treatment-genotype-1-chronic-hepatitis-c.htm,http://hcvadvocatenews.blogspot.com/2015/09/efficacy-and-safety-of.html,,,,,,,,,,,,,,,,,,
liz.shea@abbvie.com,abbvie.com,AbbVie,US,,,,,93,personal,11,{first}.{last},Liz,Shea,Writing & communication,Media Contact,"","",+1 847 935 2211,http://news.abbvie.com/news/abbvie-and-calico-announce-extension-groundbreaking-collaboration.htm,http://biospace.com/article/releases/abbvie-characterizes-evolving-hepatitis-c-hcv-patient-landscape-in-the-united-states-using-comprehensive-dataset,http://news.abbvie.com/news/abbvie-receives-us-fda-approval-orilissa-elagolix-for-management-moderate-to-severe-pain-associated-with-endometriosis.htm,http://biospace.com/article/releases/abbvie-and-neurocrine-biosciences-announce-pdufa-target-date-of-q3-2018-for-elagolix-in-endometriosis-associated-pain,http://hepatitiscresearchandnewsupdates.blogspot.com/2014/05/abbvie-submits-for-eu-marketing.html,http://hepatitiscresearchandnewsupdates.blogspot.com/2015,http://investorideas.com/news/2018/biotech/06251nyseabbv.asp,http://scripps.edu/news-and-events/press-room/2018/20180625-calibr-abbvie.html,http://ipharmatrials.com/abbvie-oncology,http://biospace.com/news/abbott-laboratoriess-abbvie-officially-launches/283344/source=yesterdaysmostpopular,http://biospace.com/news/abbott-vasculars-abbvie-officially-launches-with/283344,,,,,,,,,,,,,,,,,,
chantal.braun@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,4,{first}.{last},Chantal,Braun,,,,,,http://news.abbvie.de/contact_people/tag/gesundheit-und-versorgung,http://news.abbvie.de/contact_people,http://news.abbvie.de/contact_people/tag/science-rocks,http://abbvie-germany.mynewsdesk.com/contact_people,,,,,,,,,,,,,,,,,,,,,,,,,
hiroshi.kitaoka@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,2,{first}.{last},Hiroshi,Kitaoka,,,,,,http://sasebo-ishikai.com/member/kenshukai-koenkai,http://choringi.or.jp/wp-content/uploads/2023_minami_mt07_01.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
andrew.nguyen@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,4,{first}.{last},Andrew,Nguyen,,,,,,http://omixys.pl/files/products/232/34-color-3-lasers-with-spectral-cytometry.pdf,http://omixys.pl/files/products/233/34-color-3-lasers-with-spectral-cytometry.pdf,http://accela.eu/files/products/232/34-color-3-lasers-with-spectral-cytometry.pdf,http://accela.eu/files/products/233/34-color-3-lasers-with-spectral-cytometry.pdf,,,,,,,,,,,,,,,,,,,,,,,,,
tolga.turan@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Tolga,Turan,,"","","","",http://jitc.bmj.com/content/6/1/50,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kyle.halliwill@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Kyle,Halliwill,,"","","","",http://jitc.bmj.com/content/6/1/50,,,,,,,,,,,,,,,,,,,,,,,,,,,,
richard.gonzalez@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,6,{first}.{last},Richard,Gonzalez,,,"","","",http://ceoexecutive1.com/richard-a-gonzalez,http://headquartersof.com/abbvie-headquarters,http://boycottrussia.info/all-companies,http://listofceo.com/pharma/abbvie-ceo-email-net-worth-richard-gonzalez,http://boardofdirectorssalary.com/richard-a-gonzalez,http://headquartersof.com/abbvie-headquarters-info-email-format-and-hr-phone-number,,,,,,,,,,,,,,,,,,,,,,,
yixin.fang@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,2,{first}.{last},Yixin,Fang,,"","","","",http://community.amstat.org/biop/workinggroups/rweswg/rweswg-home,http://community.amstat.org/biop/workinggroups/rweswg/rweswg-whoweare,,,,,,,,,,,,,,,,,,,,,,,,,,,
valerie.acuna@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Valerie,Acuna,Medical & health,Medical Affairs,"","","",http://mann.usc.edu/program/fellowship-programs/current-fellows,,,,,,,,,,,,,,,,,,,,,,,,,,,,
dorian.chen@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Dorian,Chen,Management,Strategy And Project Management,"","","",http://mann.usc.edu/program/fellowship-programs/current-fellows,,,,,,,,,,,,,,,,,,,,,,,,,,,,
stefan.lorenz@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Stefan,Lorenz,Education,Research Staff,"","","",http://clinicaltrials.gov/show/nct03342144,,,,,,,,,,,,,,,,,,,,,,,,,,,,
mark.g.anderson@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Mark,Anderson,Medical & health,Health Guide,"","","",http://bmccancer.biomedcentral.com/articles/10.1186/s12885-021-08403-5,,,,,,,,,,,,,,,,,,,,,,,,,,,,
margaret.burroughs@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,6,{first}.{last},Margaret,Burroughs,Medical & health,Medical Director And Global,"","","",http://leapresources.org/content/margaret-h-burroughs,http://longactinghiv.org/content/margaret-h-burroughs,http://longactinghiv.org/member_directory/vir_hep,http://longactinghiv.org/member_directory,http://leapresources.org/member_directory/vir_hep,http://leapresources.org/member_directory,,,,,,,,,,,,,,,,,,,,,,,
jennifer.kilpatrick@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Jennifer,Kilpatrick,Sales,Business Development Executive,"","",+1 334 549 7021,http://emeraldcoastmedicalassociation.com/preferred-partners,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kristina.hasse@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,4,{first}.{last},Kristina,Ha√üe,,,,,,http://news.abbvie.de/contact_people/tag/gesundheit-und-versorgung,http://news.abbvie.de/contact_people/tag/science-rocks,http://abbvie-germany.mynewsdesk.com/contact_people,http://news.abbvie.de/contact_people,,,,,,,,,,,,,,,,,,,,,,,,,
jeffrey.sava@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,3,{first}.{last},Jeffrey,Sava,,,,,,http://infectiousdiseases.wustl.edu/events/event/id-society-of-st-louis-virtual-exhibit-hall-2,http://infectiousdiseases.wustl.edu/events/event/id-society-of-st-louis-reception-and-meet-our-exhibitors,http://infectiousdiseases.wustl.edu/events/event/id-society-of-st-louis-virtual-exhibit-hall-3,,,,,,,,,,,,,,,,,,,,,,,,,,
brianna.hoover@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Brianna,Hoover,Medical & health,Clinical Development,"","","",http://mann.usc.edu/program/fellowship-programs/current-fellows,,,,,,,,,,,,,,,,,,,,,,,,,,,,
yvonne.barton@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,2,{first}.{last},Yvonne,Barton,,,,,,http://lobbying.wi.gov/who/lobbyistinformation/2023reg/information/10769,http://lobbying.wi.gov/who/principalinformation/2023reg/information/10166,,,,,,,,,,,,,,,,,,,,,,,,,,,
william.eager@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,2,{first}.{last},William,Eager,,,,,,http://volleyverse.com/volleyball-clubs/net-force-volleyball-club,http://greatlakesvolleyball.org/wordpress/boys-clubs,,,,,,,,,,,,,,,,,,,,,,,,,,,
barbara.dimpfl@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Barbara,Dimpfl,,"","","","",http://gpge.eu/termine/pdiatrische-fallkonferenz-charite,,,,,,,,,,,,,,,,,,,,,,,,,,,,
krista.gugliotti@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Krista,Gugliotti,,"","","","",http://news.allerganaesthetics.com/news/details/2021/05/allergan%20aesthetics%20to%20acquire%20soliton%20expanding%20body%20contouring%20portfolio,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jamie.chouinard@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Jamie,Chouinard,Sales,National Sales Manager,"","","",http://ontariorheum.ca/sponsors/abbvie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kathleen.mortell@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Kathleen,Mortell,Management,Project Manager,"","","",http://kiesslinglab.com/kiessling-lab-phd-alumni,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lotta.jonsson@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,2,{first}.{last},Lotta,Jonsson,,,,,,http://shapelink.com/widgets.php/groups/small/id/386/headercolor/9ccb3d,http://twiikapp.com/widgets.php/groups/small/id/386/headercolor/9ccb3d,,,,,,,,,,,,,,,,,,,,,,,,,,,
jenina.nunez@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,10,{first}.{last},Jenina,Nunez,,"",hospitalpronews,"","",http://news.abbvie.com/news/press-releases/abbvie-submits-regulatory-applications-for-skyrizi-risankizumab-in-psoriatic-arthritis-to-fda-and-ema.htm,http://lifesciencesbc.ca/members/abbvie-announces-european-commission-approval-of-skyrizi-risankizumab-for-the-treatment-of-moderate-to-severe-active-crohns-disease,http://woodlandreport.com/2021/10/abbvie-to-showcase-new-data-at-the-united-european-gastroenterology-ueg-week-virtual-2021,http://hospitalprofessionalnews.ie/2022/09/20/european-commission-approves-upadacitinib-for-the-treatment-of-adults-with-moderate-to-severely-active-ulcerative-colitis,http://news.abbvie.com/news/press-releases/abbvie-submits-application-for-risankizumab-skyrizi-in-moderate-to-severe-crohns-disease-to-european-medicines-agency-ema.htm,http://news.abbvie.com/news/press-releases/abbvie-presents-late-breaking-data-on-risankizumab-skyrizi-in-psoriatic-arthritis-at-30th-european-academy-dermatology-and-venereology-eadv-congress.htm,http://news.abbvie.com/news/press-releases/european-commission-approves-rinvoq-upadacitinib-for-treatment-adults-with-moderate-to-severe-ulcerative-colitis.htm,http://news.abbvie.com/news/press-releases/abbvie-submits-regulatory-applications-to-fda-and-ema-for-upadacitinib-rinvoq-in-crohns-disease.htm,http://investingnews.com/news/biotech-investing/abbvie-to-showcase-new-data-at-the-united-european-gastroenterology-week-virtual-2021,http://networkbrokerage.com/abbvie-to-showcase-new-data-at-the-united-european-gastroenterology-ueg-week-virtual-2021,,,,,,,,,,,,,,,,,,,
jacqueline.karis@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,6,{first}.{last},Jacqueline,Karis,,"","","",+1 310 486 4993,http://cknby.com/who-we-are/our-stories/the-math-of-migraine.html,http://news.abbvie.com/news/press-releases/abbvie-and-allergan-aesthetics-to-present-new-data-from-leading-neurotoxin-portfolio-at-toxins-2022-conference.htm,http://news.abbvie.com/news/press-releases/abbvie-to-showcase-breadth-neuroscience-portfolio-and-pipeline-at-american-academy-neurology-aan-2022-annual-meeting.htm,http://news.abbvie.com/news/press-releases/fda-approves-expanded-botox-onabotulinumtoxina-label-to-include-eight-new-muscles-to-treat-adults-with-upper-limb-spasticity.htm,http://news.abbvie.com/news/press-releases/abbvie-to-present-data-across-its-robust-neuroscience-portfolio-at-2021-american-academy-neurology-aan-annual-meeting.htm,http://news.abbvie.com/pr-contacts,,,,,,,,,,,,,,,,,,,,,,,
yuanyuan.duan@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Yuanyuan,Duan,IT / Engineering,Data Analysis,"","","",http://journal.pda.org/content/early/2020/09/30/pdajpst.2020.012096,,,,,,,,,,,,,,,,,,,,,,,,,,,,
stephen.hartman@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Stephen,Hartman,IT / Engineering,Data Analysis,"","","",http://journal.pda.org/content/early/2020/09/30/pdajpst.2020.012096,,,,,,,,,,,,,,,,,,,,,,,,,,,,
daniel.cohen@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,3,{first}.{last},Daniel,Cohen,,,,,,http://leapresources.org/content/daniel-e-cohen-md,http://leapresources.org/member_directory,http://leapresources.org/member_directory/pab,,,,,,,,,,,,,,,,,,,,,,,,,,
vusi.moyo@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,2,{first}.{last},Vusi,Moyo,,"","","",+1 224 200 0009,http://cknby.com/who-we-are/our-stories/precision-medicine-its-not-just-for-oncology-anymore.html,http://cknby.com/who-we-are/our-stories/stronger-together-convergence-minds-and-data.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
mabel.martinez@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,12,{first}.{last},Mabel,Martinez,Management,Director,3d_prints_news,"",+1 224 306 4412,http://jeject.best/article/u-s-fda-approves-vraylar-cariprazine-as-an-adjunctive-treatment-for-major-depressive-disorder-2,http://buyinvest.my.id/amgen-to-host-webcast-investor-call-following-announced-acquisition-of-horizon-therapeutics.html,http://cknby.com/who-we-are/our-stories/discovery-files-vision-for-blood-cancer-patients.html,http://news.abbvie.com/news/press-releases/us-fda-approves-qulipta-atogepant-for-adults-with-chronic-migraine.htm,http://tylergarrett.com/press-article/2022/12/u-s-fda-approves-vraylar-cariprazine-as-an-adjunctive-treatment-for-major-depressive-disorder,http://news.abbvie.com/news/press-releases/abbvie-to-showcase-breadth-neuroscience-portfolio-and-pipeline-at-american-academy-neurology-aan-2022-annual-meeting.htm,http://biotech-365.com/author/biotech365/page/3,http://biotech-365.com/category/business-wire/page/2,http://biotech-365.com/category/business-wire,http://news.abbvie.com/pr-contacts,http://news.abbvie.com/news/abbvie-news-briefs/abbvie-aims-to-support-patients-with-myelofibrosis-rare-blood-cancer.htm,http://news.abbvie.com/news/press-releases/abbvie-data-at-eha-annual-congress-highlight-depth-and-breadth-transformative-blood-cancer-portfolio.htm,,,,,,,,,,,,,,,,,
kayla.azzato@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,4,{first}.{last},Kayla,Azzato,,"","","",+1 847 935 6492,http://news.abbvie.com/news/press-releases/abbvie-celebrates-30th-anniversary-cf-scholarship-with-opening-application-period-for-students-with-cystic-fibrosis.htm,http://news.abbvie.com/news/press-releases/abbvie-to-showcase-breadth-neuroscience-portfolio-and-pipeline-at-american-academy-neurology-aan-2022-annual-meeting.htm,http://news.abbvie.com/news/press-releases/skyrizi-risankizumab-rzaa-now-available-in-us-as-single-150-mg-injection-for-adults-with-moderate-to-severe-plaque-psoriasis.htm,http://news.abbvie.com/news/press-releases/abbvie-submits-regulatory-applications-for-skyrizi-risankizumab-in-psoriatic-arthritis-to-fda-and-ema.htm,,,,,,,,,,,,,,,,,,,,,,,,,
margot.bakker@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,2,{first}.{last},Margot,Bakker,,,,,,http://pharmaforum-sw.de/sites/default/files/2019-10/pf2019_tagungsband_web_0.pdf,http://imi-adapted.eu,,,,,,,,,,,,,,,,,,,,,,,,,,,
steinar.thoresen@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,2,{first}.{last},Steinar,Thoresen,,"","","","",http://tidsskriftet.no/profil/steinar-thoresen,http://tidsskriftet.no/2014/06/kommentar/re-selge-sykdom-0,,,,,,,,,,,,,,,,,,,,,,,,,,,
julius.reyes@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,3,{first}.{last},Julius,Reyes,Education,Research And Development,"","","",http://pubs.rsc.org/en/content/articlelanding/2020/np/c9np00031c,http://pubs.rsc.org/en/content/articlelanding/2020/np/c9np00031c/unauth,http://pubs.rsc.org/en/content/articlelanding/2019/np/c9np00031c/unauth,,,,,,,,,,,,,,,,,,,,,,,,,,
johannes.huelsenbeck@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,2,{first}.{last},Johannes,Huelsenbeck,Education,Research Staff,"","","",http://clinicaltrials.gov/show/nct03342144,http://clinicaltrials.gov/ct2/show/nct03342144,,,,,,,,,,,,,,,,,,,,,,,,,,,
femke.sanders@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Femke,Sanders,,"","","","",http://pdfslide.net/documents/abbvie-in-de-top-van-best-workplaces-van-great-place-to-work-plaats-in-de-great.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
xin.huang@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Xin,Huang,,"","","","",http://community.amstat.org/biop/aboutus/executivecommittee,,,,,,,,,,,,,,,,,,,,,,,,,,,,
humberto.jaimes@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,2,{first}.{last},Humberto,Jaimes,,"","","",+1 847 937 3476,http://news.abbvie.com/news/press-releases/abbvie-employees-to-help-underserved-communities-in-sixth-annual-week-possibilities.htm,http://biospace.com/article/abbvie-employees-to-help-underserved-communities-in-sixth-annual-week-of-possibilities-,,,,,,,,,,,,,,,,,,,,,,,,,,,
natalie.bennett@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,6,{first}.{last},Natalie,Bennett,Writing & communication,Senior Communications,"","","",http://mynewsdesk.com/uk/abbvie-uk/pressreleases/skyriziv-risankizumab-receives-nice-positive-technology-appraisal-guidance-for-the-treatment-of-plaque-psoriasis-in-adults-2908347,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/abbvies-skyriziv-risankizumab-accepted-for-use-within-nhs-scotland-2928830,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/abbvies-duodopa-r-levodopa-carbidopa-intestinal-gel-recommended-for-use-within-nhs-wales-2460807,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/nice-issues-positive-final-appraisal-document-for-skyriziv-risankizumab-for-the-treatment-of-plaque-psoriasis-in-adults-2897106,http://pharmiweb.com/press-release/2019-12-20/rinvoq-upadacitinib-granted-eu-marketing-authorisation-for-the-treatment-of-eligible-adults-with-moderate-to-severe-active-rheumatoid-arthritis,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/results-from-upadacitinib-phase-3-select-compare-study-published-in-arthritis-and-rheumatology-2896790,,,,,,,,,,,,,,,,,,,,,,,
april.bennett@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,3,{first}.{last},April,Bennett,,,,,,http://hepfree.nyc/ny-hep-c-telemedicine-workgroup-meeting-notes-11-19-2020,http://hepfree.nyc/telemedicine-workgroup-meeting-highlights-5-20-21,http://hepfree.nyc/hep-c-task-force-meeting-highlights-12-05-18-2,,,,,,,,,,,,,,,,,,,,,,,,,,
chris.cruz@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,5,{first}.{last},Chris,Cruz,,,,,,http://hepfree.nyc/hep-free-nyc-webinar-e-meeting-highlights-03-18-2020,http://hepfree.nyc/hep-c-task-force-meeting-highlights-4-11-18,http://hepfree.nyc/hep-c-task-force-meeting-highlights-05-01-2019,http://hepfree.nyc/hep-c-task-force-meeting-highlights-12-05-18-2,http://hepfree.nyc/hep-c-task-force-meeting-highlights-9-12-18,,,,,,,,,,,,,,,,,,,,,,,,
joachim.vogt@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Joachim,Vogt,Management,Director,"","","",http://vfa.de/de/verband-mitglieder/biotech-partnering,,,,,,,,,,,,,,,,,,,,,,,,,,,,
rachel.tang@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,2,{first}.{last},Rachel,Tang,,,,,,http://m.cancer123.com/treatment/805,http://m.cancer123.com/treatment/841,,,,,,,,,,,,,,,,,,,,,,,,,,,
melanie.patterson@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Melanie,Patterson,,"","","","",http://frontiersin.org/articles/10.3389/fimmu.2018.02697/full,,,,,,,,,,,,,,,,,,,,,,,,,,,,
peter.nordlund@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Peter,Nordlund,,"","","","",http://legeforeningen.no/foreningsledd/fagmed/norsk-forening-for-dermatologi-og-venerologi/aktuelt/2019/abbie-inviterer-til-fagmote-for-privatpraktiserende-hudleger-12.-og-13.-september-2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sophie.desjardins@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Sophie,Desjardins,Education,Research Staff,"","",+1 514 832 7305,http://clinicaltrials.gov/ct2/show/nct03310190,,,,,,,,,,,,,,,,,,,,,,,,,,,,
petra.grossmann@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,3,{first}.{last},Petra,Gro√ümann,,,,,,http://credoweb.at/event/104840/biologika-circle-sued,http://credoweb.at/event/104630/biologika-circle-ost,http://credoweb.at/event/104727/biologika-circle-mitte,,,,,,,,,,,,,,,,,,,,,,,,,,
david.shaffer@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},David,Shaffer,,"","","",+1 847 937 2485,http://news.abbvie.com/news/abbvie-teams-up-with-leading-nonprofit-organizations-to-give-back-to-underserved-local-communities.htm,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jane.qian@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Jane,Qian,Operations & logistics,Program Chair,"","","",http://community.amstat.org/biop/aboutus/sub-committees/biopfunding,,,,,,,,,,,,,,,,,,,,,,,,,,,,
saurabh.mukhopadhyay@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Saurabh,Mukhopadhyay,,"","","","",http://rdrr.io/cran/bdribs,,,,,,,,,,,,,,,,,,,,,,,,,,,,
rebecca.kohnken@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,3,{first}.{last},Rebecca,Kohnken,Education,Assistant Professor,"","","",http://vet.osu.edu/node/8851,http://vet.osu.edu/about-us/people/rebecca-kohnken,http://vet.osu.edu/biosciences/faculty-directory,,,,,,,,,,,,,,,,,,,,,,,,,,
darren.phillips@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,2,{first}.{last},Darren,Phillips,,"","","","",http://ash.silverchair.com/blood/article-split/doi/10.1182/blood.2022017333/494284/activity-of-eftozanermin-alfa-plus-venetoclax-in,http://ash.silverchair.com/blood/article/doi/10.1182/blood.2022017333/494284/activity-of-eftozanermin-alfa-plus-venetoclax-in,,,,,,,,,,,,,,,,,,,,,,,,,,,
donna.montavon@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Donna,Montavon,Management,Associate Director,"","","",http://sites.bc.edu/amir-hoveyda/former-members,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kate.richards@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,0,{first}.{last},Kate,Richards,Writing & communication,Head Of Corporate Communications Australia,"","",+61 466 420 739,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
carrie.dunn@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,2,{first}.{last},Carrie,Dunn,Sales,Account Specialist,"","","",http://kbarlist.blogspot.com/2014/04/k-bar-list-jobs-8-april-2014.html,http://kbarlist.blogspot.com/2014_04_06_archive.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
sonia.romero@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,2,{first}.{last},Sonia,Romero,,,,,,http://sedene.com/2015/05/12/criteria-enfermeria-guia-para-el-tratamiento-mediante-infusion-intestinal-continua-de-levodopacarbidopa-iiclc-de-la-enfermedad-de-parkinson-avanzada-epa,http://sedene.com/criteria-enfermeria-guia-para-el-tratamiento-mediante-infusion-intestinal-continua-de-levodopacarbidopa-iiclc-de-la-enfermedad-de-parkinson-avanzada-epa,,,,,,,,,,,,,,,,,,,,,,,,,,,
joel.leverson@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,2,{first}.{last},Joel,Leverson,Medical & health,Clinical Development,"","","",http://anti-cancers.com/index.php/a-1155463,http://frontiersin.org/articles/10.3389/fonc.2018.00458/full,,,,,,,,,,,,,,,,,,,,,,,,,,,
camila.silva@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,1,{first}.{last},Camila,Silva,,"","","","",http://capitulouc.weebly.com/praacutecticas-laborales.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kati.nyman@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,8,{first}.{last},Kati,Nyman,Writing & communication,"","","","",http://ibd.fi/kestava-terveydenhuolto-hanke-pitkaaikaissairauden-vuoksi-tekematta-jaava-tyo-aiheuttaa-luultua-suuremmat-kustannukset-osoittaa-uusi-suomalainen-selvitys,http://ibd.fi/kestava-terveydenhuolto-hankkeen-uusi-selvitys-pitkaaikaissairaat-eivat-saa-yhdenvertaista-hoitoa-syyt-taysin-korjattavissa,http://mynewsdesk.com/fi/abbvie/pressreleases/tuore-kyselytutkimus-tekoaely-pelastaa-terveydenhuollon-ammattilaiset-rutiinitoeiltae-ja-vapauttaa-aikaa-potilaan-kohtaamiselle-2587339,http://sitra.fi/uutiset/tuore-kyselytutkimus-tekoaly-pelastaa-terveydenhuollon-ammattilaiset-rutiinitoilta-ja-vapauttaa-aikaa-potilaan-kohtaamiselle,http://mynewsdesk.com/fi/abbvie/pressreleases/tuore-kyselytutkimus-tekoaely-pelastaa-terveydenhuollon-ammattilaiset-rutiinitoeiltae-ja-vapauttaa-aikaa-potilaan-kohtaamiselle-2587334,http://mynewsdesk.com/fi/abbvie/pressreleases/kestaevae-terveydenhuolto-hanke-tuoko-soten-valinnanvapaus-hyoetyae-pitkaeaikaissairaan-hoitoon-1773653,http://mynewsdesk.com/fi/abbvie/pressreleases/euroopan-komissio-on-hyvaeksynyt-humira-r-laeaekevalmisteen-adalimumabi-keskivaikean-ja-vaikean-hidradenitis-suppurativa-sairauden-hoitoon-1209371,http://reumaliitto.fi/fi/reumaliitto/uutiset/kestava-terveydenhuolto-hanke-pitkaaikaissairauden-vuoksi-tekematta-jaava-tyo,,,,,,,,,,,,,,,,,,,,,
elisabet.roslund@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,3,{first}.{last},Elisabet,Roslund,,"","","","",http://ungareumatiker.se/vr-doktorn-starker-patienter-i-motet-med-varden,http://mynewsdesk.com/se/abbvie/pressreleases/vr-doktorn-staerker-patienter-i-moetet-med-vaarden-2834260,http://news.microsoft.com/sv-se/2016/12/15/innovation-race-uppsala-skapar-ideer-att-forbattra-cancervarden-sverige,,,,,,,,,,,,,,,,,,,,,,,,,,
lisa.hazelwood@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,3,{first}.{last},Lisa,Hazelwood,,"","","","",http://aspet.org/aspet/membership-community/divisions/division-for-molecular-pharmacology-(mp)/news-archive/2019/02/06/mol-call-for-symposia-proposals-for-the-aspet-annual-meeting-at-eb-2020,http://aspet.org/aspet/news/news/2019/02/06/mol-call-for-symposia-proposals-for-the-aspet-annual-meeting-at-eb-2020,http://thecatecholaminesociety.org/member-directory,,,,,,,,,,,,,,,,,,,,,,,,,,
phyliss.milligan@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,5,{first}.{last},Phyliss,Milligan,,"","","",+1 847 937 6477,http://news.abbvie.com/news/abbvies-humira-adalimumab-receives-us-fda-approval-for-treatment-pediatric-patients-with-moderately-to-severely-active-crohns-disease.htm,http://news.abbvie.com/news/abbvie-announces-new-art-gallery-designed-to-provide-perspectives-on-impact-chronic-inflammatory-diseases.htm,http://news.abbvie.com/news/abbvie-cf-scholarship-application-for-students-with-cystic-fibrosis-now-available-for-2015-2016-academic-school-year.htm,http://news.abbvie.com/news/abbvie-receives-orphan-drug-designation-for-humira-adalimumab-from-us-food-and-drug-administration-for-investigational-treatment-certain-forms-non-infectious-uveitis.htm,http://mdstrat.com/abbvie-receives-orphan-drug-designation-for-humira,,,,,,,,,,,,,,,,,,,,,,,,
bret.coons@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,6,{first}.{last},Bret,Coons,Writing & communication,Manager Media Relations,"","",+1 847 937 0314,http://news.abbvie.com/news/press-releases/fda-approves-first-oral-medication-for-management-heavy-menstrual-bleeding-due-to-uterine-fibroids-in-pre-menopausal-women.htm,http://heliumradio.com/podcast/inside-mind-neuroimaging-researcher-abbvie-ppn-episode-307,http://news.abbvie.com/news/abbvie-and-johns-hopkins-to-collaborate-on-cancer-research.htm,http://news.abbvie.com/news/abbvie-and-northwestern-universitys-lurie-cancer-center-to-collaborate-on-multi-year-cancer-research-agreement.htm,http://pharmacy586.rssing.com/chan-12110007/all_p14.html,http://news.abbvie.com/news/abbvie-university-chicago-collaborate-to-advance-cancer-research.htm,,,,,,,,,,,,,,,,,,,,,,,
jana.umbreit@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,7,{first}.{last},Jana,Umbreit,,"","","",+1 224 214 8657,http://news.abbvie.com/news/press-releases/european-commission-approves-abbvies-rinvoq-upadacitinib-for-treatment-psoriatic-arthritis-and-ankylosing-spondylitis.htm,http://news.abbvie.com/news/press-releases/new-positive-data-for-rinvoq-upadacitinib-on-signs-and-symptoms-in-patients-with-ankylosing-spondylitis-presented-at-2019-acrarp-annual-meeting.htm,http://news.abbvie.com/news/press-releases/abbvie-submits-regulatory-application-to-fda-for-rinvoq-upadacitinib-for-treatment-adults-with-active-ankylosing-spondylitis.htm,http://revistabalance.com/abbvie-artritis-psoriasica-activa,http://news.abbvie.com/news/press-releases/abbvie-receives-european-commission-approval-rinvoq-upadacitinib-for-treatment-adults-with-moderate-to-severe-active-rheumatoid-arthritis.htm,http://news.abbvie.com/news/press-releases/rinvoq-upadacitinib-meets-primary-and-all-ranked-secondary-endpoints-in-phase-3-study-in-psoriatic-arthritis.htm,http://presseportal.de/pm/112983/3218686,,,,,,,,,,,,,,,,,,,,,,
andrea.arnold@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,6,{first}.{last},Andrea,Arnold,Writing & communication,Lead Corporate Communication,"","",+49 611 1720 2381,http://innovations-intelligenz.de/biopharma-made-in-germany-abbvie-launcht-newsroom-news-abbvie-de-foto-1492102.html,http://presseportal.de/pm/112983/3094014,http://politikexpress.de/abbvie-auf-platz-2-der-top-arbeitgeber-in-deutschland-2016-foto-1323184.html,http://presseportal.de/pm/112983/3555389,http://presseportal.de/pm/112983/3160113,http://presseportal.de/pm/112983/3180399,,,,,,,,,,,,,,,,,,,,,,,
raquel.powers@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,12,{first}.{last},Raquel,Powers,,,,,,http://headquartersof.com/abbvie-headquarters,http://news.abbvie.com/news/press-releases/abbvies-mavyret-glecaprevirpibrentasvir-shows-high-virologic-cure-rates-in-treatment-nave-hepatitis-c-patients-with-compensated-cirrhosis.htm,http://cknby.com/who-we-are/our-stories/how-uterine-fibroids-feel-to-patient-who-is-also-doctor.html,http://thescipreneur.com/abbvie-receives-fda-approval-of-mavyret-for-the-treatment-of-chronic-hepatitis-c,http://headquartersof.com/abbvie-headquarters-info-email-format-and-hr-phone-number,http://pelvicpain.org/news/alliance-for-endometriosis-phase-2-announcement,http://news.abbvie.com/news/il-23-inhibitor-risankizumab-induces-remission-in-phase-ii-study-in-patients-with-moderate-to-severe-crohns-disease.htm,http://news.abbvie.com/news/us-fda-grants-priority-review-to-abbvie-for-its-investigational-regimen-glecaprevirpibrentasvir-gp-for-treatment-chronic-hepatitis-c-in-all-major-genotypes-gt1-6.htm,http://news.abbvie.com/news/press-releases/the-alliance-for-endometriosis-survey-reveals-actions-needed-to-improve-endometriosis-patient-experience.htm,http://endometriosisassn.org/media-page-2,http://biospace.com/article/releases/abbvie-characterizes-evolving-hepatitis-c-hcv-patient-landscape-in-the-united-states-using-comprehensive-dataset,http://news.abbvie.com/pr-contacts,,,,,,,,,,,,,,,,,
ali.siam@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,3,{first}.{last},Ali,Siam,,"","","","",http://disruptsf2015.devpost.com/forum_topics/5159-abbvie-challenge-1-wearable-to-monitor-people-suffering-from-neurological-diseases,http://disruptsf2015.devpost.com/forum_topics/5160-abbvie-challenge-3-platform-the-integrated-multiple-sources-of-data-to-rapidly-identify-emerging-research-or-novel-treatments,http://disruptsf2015.devpost.com/forum_topics/5161-abbvie-challenge-2-a-gamified-patient-experience-to-empower-people-living-with-chronic-disease,,,,,,,,,,,,,,,,,,,,,,,,,,
jillian.griffin@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,7,{first}.{last},Jillian,Griffin,Writing & communication,Media Contact,"","",+1 847 935 9331,http://news.abbvie.com/news/press-releases/third-pivotal-phase-3-study-shows-rinvoq-upadacitinib-plus-topical-corticosteroids-improves-skin-and-itch-symptoms-in-atopic-dermatitis-patients.htm,http://news.abbvie.com/pr-contacts,http://news.abbvie.com/news/abbvie-announces-new-phase-2-data-for-upadacitinib-showing-clinical-and-endoscopic-outcomes-in-crohns-disease-at-52-weeks.htm,http://hepatitiscnewdrugs.blogspot.com/2015/11,http://hepatitiscnewdrugs.blogspot.com/2015_11_01_archive.html,http://newswire.ca/news-releases/biogen-and-abbvie-receive-health-canada-approval-of-once-monthly-zinbryta-daclizumab-beta-for-multiple-sclerosis-605610266.html,http://benzinga.com/pressreleases/16/09/b8461149/new-data-presented-at-ectrims-reinforce-efficacy-of-zinbryta-daclizumab,,,,,,,,,,,,,,,,,,,,,,
matthew.j.rieser@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,5,{first}.{last},Matthew,Rieser,,,,,,http://worldwidescience.org/topicpages/i/ii+renal+allographs.html,http://worldwidescience.org/topicpages/r/renal+terminal+em.html,http://worldwidescience.org/topicpages/r/renal+artery+interventions.html,http://worldwidescience.org/topicpages/p/prevenir+falla+renal.html,http://worldwidescience.org/topicpages/a/angiomiolipoma+renal+complicado.html,,,,,,,,,,,,,,,,,,,,,,,,
andrew.souers@abbvie.com,abbvie.com,AbbVie,US,,,,,92,personal,4,{first}.{last},Andrew,Souers,,,,,,http://cd177signaling.com/navitoclax,http://rcsb.org/structure/4lvt,http://rcsb.org/structure/4man,http://rcsb.org/structure/4lxd,,,,,,,,,,,,,,,,,,,,,,,,,
patrick.seebach@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,2,{first}.{last},Patrick,Seebach,,,,,,http://pharmaforum-sw.de/sites/default/files/2019-10/pf2016_abbvie_0.pdf,http://pharmaforum-sw.de/sites/default/files/2019-10/pf2017_01_abbvie_0.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
david.desmond@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,5,{first}.{last},David,Desmond,,,,,,http://auth.aacc.org/-/media/files/divisions/animal/dacc_apr_2014.pdf,http://auth.aacc.org/-/media/files/divisions/animal/dacc_fall_winter_2014.pdf,http://auth.aacc.org/-/media/files/divisions/animal/dacc_jun_2014.pdf,http://auth.aacc.org/-/media/files/divisions/animal/dacc_spring_2015.pdf,http://auth.aacc.org/-/media/files/divisions/animal/dacc_summer_2015.pdf,,,,,,,,,,,,,,,,,,,,,,,,
samantha.wildeboer@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,5,{first}.{last},Samantha,Wildeboer,,,,,,"http://auth.aacc.org/-/media/files/divisions/animal/2020-dacc-news-vol-36-no,-d-,2-fall-winter-dec-edition-vf.pdf",http://auth.aacc.org/-/media/files/divisions/animal/dacc-newsletter-fall-2018-v2.pdf,http://auth.aacc.org/-/media/files/divisions/animal/dacc-newsletter-fall_winter-2017.pdf,http://auth.aacc.org/-/media/files/divisions/animal/dacc-newsletter-july-2019-final.pdf,http://auth.aacc.org/-/media/files/divisions/animal/dacc-newsletter-may-2020-corrected.pdf,,,,,,,,,,,,,,,,,,,,,,,,
patrice.farrell@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,2,{first}.{last},Patrice,Farrell,,,,,,http://virtualrecruitment.ie/job/snr-global-principal-mechanical-engineer,http://jobsexpo.ie/job/snr-global-principal-mechanical-engineer,,,,,,,,,,,,,,,,,,,,,,,,,,,
doug.kline@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Douglas,Kline,,"","","","",http://jitc.bmj.com/content/6/1/50,,,,,,,,,,,,,,,,,,,,,,,,,,,,
joy.monahan@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,2,{first}.{last},Joy,Monahan,,,,,,http://guitar-wedge-ys66.squarespace.com/blog/2020/11/4/wonder-woman-in-business-joy-monahan,http://freemanmeansbusiness.com/blog/2020/11/4/wonder-woman-in-business-joy-monahan,,,,,,,,,,,,,,,,,,,,,,,,,,,
tino.seidel@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Tino,Seidel,Management,Director,"","","",http://vfa.de/de/patienten/ansprechpartner-der-pharmaunternehmen,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gregory.potts@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Gregory,Potts,IT / Engineering,Data Acquisition,"","","",http://biorxiv.org/node/2370064.external-links.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sarah.doupe@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,4,{first}.{last},Sarah,Doupe,Writing & communication,University Relations,"","","",http://gradireland.com/careers-abbvie-engineering-graduates,http://gradireland.com/careers-abbvie-manufacturing-graduates,http://gradireland.com/careers-abbvie-science-graduates,http://gradireland.com/organisations/abbvie,,,,,,,,,,,,,,,,,,,,,,,,,
valerie.ramdas@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Valerie,Ramdas,Sales,Business Development Manager,"","",+31 61 431 7503,http://allerganaesthetics.nl/partner,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sara.napoli@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,2,{first}.{last},Sara,Napoli,,,,,,http://ccevent.ccexpo.site/2022-06-17-abbvie,http://ccexpo.site/2022-06-17-abbvie,,,,,,,,,,,,,,,,,,,,,,,,,,,
pascal.marcoux@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,3,{first}.{last},Pascal,Marcoux,,"","","","",http://armrs.com/compagnies,http://armrs.com/recherche-avancee,http://armrs.com/nos-membres,,,,,,,,,,,,,,,,,,,,,,,,,,
tim.rombouts@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Tim,Rombouts,,"","","","",http://fitforworknederland.nl/lid/3209,,,,,,,,,,,,,,,,,,,,,,,,,,,,
justin.pearson@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Justin,Pearson,Medical & health,Medical Affairs,"","","",http://mann.usc.edu/program/fellowship-programs/current-fellows,,,,,,,,,,,,,,,,,,,,,,,,,,,,
reece.riddle@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Reece,Riddle,Medical & health,Medical Affairs,"","","",http://mann.usc.edu/program/fellowship-programs/current-fellows,,,,,,,,,,,,,,,,,,,,,,,,,,,,
karyn.tse@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Karyn,Tse,,"","","",+1 224 360 4751,http://swmpa.org/addressing-treatment-in-real-world-gt1-chronic-hcv-patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,
devin.slagle@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Devin,Slagle,Management,Project Manager,com,"","",http://mygcsg.com/the-global-clinical-supplies-group-2022-us-conference/speakers,,,,,,,,,,,,,,,,,,,,,,,,,,,,
susan.sherman@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Susan,Sherman,Sales,Account Specialist,"","",+1 518 542 7012,http://education.baystatehealth.org/content/abbvie-virtual-exhibit-%e2%80%93-40th-annual-richard-b-brown-infectious-disease-symposium,,,,,,,,,,,,,,,,,,,,,,,,,,,,
stephanie.tennessen@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,3,{first}.{last},Stephanie,Tennessen,,"","","",+1 224 214 8638,http://greenshark.info/read/832kcpm4h,http://news.abbvie.com/news/press-releases/abbvie-and-allergan-aesthetics-to-present-new-research-across-dermatology-portfolio-at-2022-aad-annual-meeting.htm,http://lifesciencesbc.ca/members/u-s-fda-approves-second-indication-for-skyrizi-risankizumab-rzaa-to-treat-adults-with-active-psoriatic-arthritis,,,,,,,,,,,,,,,,,,,,,,,,,,
krystal.bruno@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,4,{first}.{last},Krystal,Bruno,Management,Director,"","",+1 847 937 4072,http://cknby.com/who-we-are/our-stories/finding-hope-in-a-pandemic--a-conversation-with-two-hepatitis-c-.html,http://piemagazine.org/a-history-of-discovery-why-abbvie-focuses-on-challenging-eye-care-diseases,http://cakemagazine.org/a-focus-on-eyes-to-help-change-lives,http://news.abbvie.com/pr-contacts,,,,,,,,,,,,,,,,,,,,,,,,,
roland.heym@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Roland,Heym,,"","","","",http://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-021-01292-6,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lisa.kim@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,5,{first}.{last},Lisa,Kim,,,,,,http://news.abbvie.com/news/press-releases/americans-are-frustrated-by-unexpected-blurry-near-vision-issues-new-survey-reveals.htm,http://news.abbvie.com/news/press-releases/now-available-over-counter-lastacaft-provides-eye-allergy-itch-relief-in-minutes-that-lasts-through-16-hours.htm,http://news.abbvie.com/news/press-releases/vuity-pilocarpine-hci-ophthalmic-solution-125-first-and-only-fda-approved-eye-drop-to-treat-age-related-blurry-near-vision-presbyopia-is-now-available.htm,http://news.abbvie.com/news/press-releases/allergan-an-abbvie-company-to-present-new-data-from-its-leading-eye-care-portfolio-at-aao-american-academy-ophthalmology-2021-annual-meeting.htm,http://news.abbvie.com/news/press-releases/new-data-presented-on-safety-and-efficacy-investigational-agn-190584-as-potential-novel-treatment-for-presbyopia-common-and-progressive-eye-condition.htm,,,,,,,,,,,,,,,,,,,,,,,,
ellen.kuehnle@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Ellen,K√ºhnle,,"","","",+1 713 494 0772,http://spnp.enpnetwork.com/nurse-practitioner-news/213792-july-20th-2021-spnpa-metting,,,,,,,,,,,,,,,,,,,,,,,,,,,,
mary.byun@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,3,{first}.{last},Mary,Byun,,"",3d_prints_news,"",+1 646 709 4409,http://jeject.best/article/u-s-fda-approves-vraylar-cariprazine-as-an-adjunctive-treatment-for-major-depressive-disorder-2,http://buyinvest.my.id/amgen-to-host-webcast-investor-call-following-announced-acquisition-of-horizon-therapeutics.html,http://tylergarrett.com/press-article/2022/12/u-s-fda-approves-vraylar-cariprazine-as-an-adjunctive-treatment-for-major-depressive-disorder,,,,,,,,,,,,,,,,,,,,,,,,,,
hannah.martinez@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,5,{first}.{last},Hannah,Martinez,,"","","",+1 224 300 1002,http://woodlandreport.com/2021/10/abbvie-to-showcase-new-data-at-the-united-european-gastroenterology-ueg-week-virtual-2021,http://news.abbvie.com/news/press-releases/upadacitinib-rinvoq-achieved-primary-and-key-secondary-endpoints-in-first-phase-3-induction-study-in-patients-with-crohns-disease.htm,http://investingnews.com/news/biotech-investing/abbvie-to-showcase-new-data-at-the-united-european-gastroenterology-week-virtual-2021,http://networkbrokerage.com/abbvie-to-showcase-new-data-at-the-united-european-gastroenterology-ueg-week-virtual-2021,http://news.abbvie.com/news/press-releases/second-phase-3-induction-study-confirms-upadacitinib-rinvoq-improved-clinical-endoscopic-and-histologic-outcomes-in-ulcerative-colitis-patients.htm,,,,,,,,,,,,,,,,,,,,,,,,
inka.lasser@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,23,{first}.{last},Inka,Lasser,Management,Government Affairs,"","",+49 151 1403 8139,http://doctip.de/welt-ced-tag-am-19-mai-chronisch-entzuendliche-darmerkrankungen-so-gelingt-das-arztgespraech,http://news.abbvie.de/contact_people/tag/gesundheit-und-versorgung,http://bereitschaftspraxen.de/welt-ced-tag-am-19-mai-chronisch-entzuendliche-darmerkrankungen-so-gelingt-das-arztgespraech,http://abbvie-germany.mynewsdesk.com/pressreleases/moeglichst-beschwerdefrei-leben-mit-ced-wie-das-gelingen-kann-und-worauf-patient-stern-innen-achten-sollten-3241994.pdf,http://abbvie-germany.mynewsdesk.com/pressreleases/welt-ced-tag-am-19-mai-chronisch-entzuendliche-darmerkrankungen-so-gelingt-das-arztgespraech-3252277,http://abbvie-germany.mynewsdesk.com/pressreleases/welt-ced-tag-am-19-mai-chronisch-entzuendliche-darmerkrankungen-so-gelingt-das-arztgespraech-3252277.pdf,http://nachrichten-heute.net/318187-chronisch-entzuendliche-darmerkrankungen-jeder-fuenfte.html,http://news.abbvie.de/pressreleases/deutscher-lebertag-2021-hepatitis-b-und-hepatitis-c-koennen-besiegt-werden-3139379,http://news.abbvie.de/pressreleases/moeglichst-beschwerdefrei-leben-mit-ced-wie-das-gelingen-kann-und-worauf-patient-stern-innen-achten-sollten-3241994,http://nachrichten-heute.net/426328-nachrichten-heute-so-gelingt-crowdfunding-nachhaltige-nudelproduktion.html,http://natko.de/welt-ced-tag-am-19-mai-chronisch-entzuendliche-darmerkrankungen-so-gelingt-das-arztgespraech,http://news.abbvie.de/contact_people,http://nachrichten-heute.net/390572-grossdemonstrationen-am-19-mai-in-49-staedten.html,http://news.abbvie.de/contact_people/tag/science-rocks,http://abbvie-germany.mynewsdesk.com/pressreleases/moeglichst-beschwerdefrei-leben-mit-ced-wie-das-gelingen-kann-und-worauf-patient-stern-innen-achten-sollten-3241994,http://natko.de/deutscher-lebertag-2021-hepatitis-b-und-hepatitis-c-koennen-besiegt-werden,http://natko.de/durch-die-weihnachtszeit-mit-einer-ced-so-koennen-patientinnen-die-herausforderungen-besser-meistern,http://waschen-wie-walter.de/deutscher-lebertag-2021-hepatitis-b-und-hepatitis-c-koennen-besiegt-werden,http://blogspan.net/presse/deutscher-lebertag-2021-hepatitis-b-und-hepatitis-c-koennen-besiegt-werden/503015,http://wehrmed.de/humanmedizin/4-bundesweites-plus-forum-meets-suchtexperten-gremium.html,http://abbvie-germany.mynewsdesk.com/contact_people,http://news8.de/deutscher-lebertag-2021-hepatitis-b-und-hepatitis-c-koennen-besiegt-werden,http://prmitteilung.de/2021/11/17/deutscher-lebertag-2021-hepatitis-b-und-hepatitis-c-koennen-besiegt-werden,,,,,,
martina.kron@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Martina,Kron,IT / Engineering,Data Analysis,"","","",http://journal.pda.org/content/early/2020/09/30/pdajpst.2020.012096,,,,,,,,,,,,,,,,,,,,,,,,,,,,
debra.touw@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Debra,Touw,Executive,Scientist,"","","",http://sites.lsa.umich.edu/pecoraro-lab/group-members,,,,,,,,,,,,,,,,,,,,,,,,,,,,
keith.gordon@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Keith,Gordon,Management,Senior Scientific Director,"","","",http://resident360.nejm.org/profiles/keith-gordon,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gary.jenkins@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Gary,Jenkins,Management,Manager,"","","",http://dmd.aspetjournals.org/content/early/2020/04/29/dmd.120.090480,,,,,,,,,,,,,,,,,,,,,,,,,,,,
angelique.senden@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Angelique,Senden,,"","","","",http://huisartsgeneeskundemaastricht.nl/agenda/nascholing-hepatitis-c,,,,,,,,,,,,,,,,,,,,,,,,,,,,
andrew.bogdan@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,2,{first}.{last},Andrew,Bogdan,,"","","","",http://pubs.rsc.org/en/content/articlelanding/2019/re/c9re00054b,http://pubs.rsc.org/en/content/articlelanding/2019/re/c9re00054b/unauth,,,,,,,,,,,,,,,,,,,,,,,,,,,
matthew.iles@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,6,{first}.{last},Matthew,Iles,Management,General Manager,"","","",http://mynewsdesk.com/fi/abbvie/pressreleases/suomalaistutkimus-kipu-on-eniten-elaemaenlaatua-heikentaevae-oire-ihosairaus-hs-taudissa-2037642,http://mynewsdesk.com/fi/abbvie/pressreleases/kestaevae-terveydenhuolto-hanke-tuoko-soten-valinnanvapaus-hyoetyae-pitkaeaikaissairaan-hoitoon-1773653,http://mynewsdesk.com/fi/abbvie/pressreleases/abbvie-sijoittui-great-place-to-work-tutkimuksessa-sijalle-7-2834142,http://mynewsdesk.com/fi/abbvie/pressreleases/tuore-kyselytutkimus-tekoaely-pelastaa-terveydenhuollon-ammattilaiset-rutiinitoeiltae-ja-vapauttaa-aikaa-potilaan-kohtaamiselle-2587334,http://mynewsdesk.com/fi/abbvie/pressreleases/tuore-kyselytutkimus-tekoaely-pelastaa-terveydenhuollon-ammattilaiset-rutiinitoeiltae-ja-vapauttaa-aikaa-potilaan-kohtaamiselle-2587339,http://laakariliitto.fi/uutiset/ajankohtaista/kestava-terveydenhuolto-hanke-kansalaiset-mittaavat-omaa-terveyttaan-mittaustietoja-ei-hyodynneta-terveydenhuollossa-riittavasti,,,,,,,,,,,,,,,,,,,,,,,
justin.piro@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Justin,Piro,Education,Research Development,"","","",http://frontiersin.org/articles/10.3389/fphar.2019.00840/abstract,,,,,,,,,,,,,,,,,,,,,,,,,,,,
knut.biber@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Knut,Biber,Education,Research Development,"","","",http://frontiersin.org/articles/10.3389/fphar.2019.00840/abstract,,,,,,,,,,,,,,,,,,,,,,,,,,,,
aparna.shinde@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,2,{first}.{last},Aparna,Shinde,Education,Researcher,"","",+1 508 688 3057,http://nutritioninpill.com/lock-n-block-drug-may-prevent-cancer-from-metastasizing,http://educationtip.eu/lock-n-block-drug-may-prevent-cancer-from-metastasizing,,,,,,,,,,,,,,,,,,,,,,,,,,,
alexandra.enders@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,2,{first}.{last},Alexandra,Enders,,"","","","",http://credoweb.at/event/107061/biologika-circle-sued,http://credoweb.at/event/107060/biologika-circle-ost,,,,,,,,,,,,,,,,,,,,,,,,,,,
ning.sun@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,5,{first}.{last},Ning,Sun,,,,,,http://biorxiv.org/content/10.1101/588707v1.full,http://biorxiv.org/content/10.1101/588707v1.supplementary-material,http://biorxiv.org/content/10.1101/588707v1.article-info,http://biorxiv.org/content/10.1101/588707v1.article-metrics,http://biorxiv.org/content/10.1101/588707v1,,,,,,,,,,,,,,,,,,,,,,,,
stefan.esswein@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,2,{first}.{last},Stefan,E√üwein,,"","","","",http://journal.pda.org/content/early/2016/04/13/pdajpst.2015.006189,http://journal.pda.org/content/early/2016/04/13/pdajpst.2015.006189.abstract,,,,,,,,,,,,,,,,,,,,,,,,,,,
christina.lee@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Christina,Lee,,Government Affairs,"","",+1 224 214 2472,http://lobbying.wi.gov/who/principalinformation/2019reg/information/8455,,,,,,,,,,,,,,,,,,,,,,,,,,,,
rakesh.l.tripathi@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Rakesh,Tripathi,,"","","","",http://journals.iucr.org/f/issues/2017/03/00/tt5093/index.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kenton.longenecker@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Kenton,Longenecker,,"","","","",http://journals.iucr.org/f/issues/2017/03/00/tt5093/index.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jeremy.picard@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Jeremy,Picard,Management,Program Manager,"","","",http://exchange.smrp.org/wisconsinchapter/contactus,,,,,,,,,,,,,,,,,,,,,,,,,,,,
juliette.beaulieu@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Juliette,Beaulieu,,"","","",+1 650 454 2753,http://cholangiocarcinoma.org/db/topic/clinical-trial-abbv-399,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nestor.ortiz@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Nestor,Ortiz,Executive,CSO,"","","",http://nhcsl.org/support/abbvie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
terry.vanvleet@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,5,{first}.{last},Terry,Vanvleet,,,,,,http://pubs.rsc.org/en/content/articlelanding/2020/lc/c9lc01168d,http://pubs.rsc.org/en/content/articlelanding/lc/2020/c9lc01168d,http://pubs.rsc.org/en/content/articlelanding/lc/2020/c9lc00925f,http://pubs.rsc.org/en/content/articlelanding/2020/lc/c9lc00925f,http://pubs.rsc.org/en/content/articlelanding/2020/lc/c9lc01168d/unauth,,,,,,,,,,,,,,,,,,,,,,,,
lindsay.cangemi@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,7,{first}.{last},Lindsay,Cangemi,,"","","",+1 224 244 3808,http://nicolasmelini.com/article/rinvoq-upadacitinib-approved-by-u-s-fda-as-an-oral-treatment-for-adults-with-active-ankylosing-spondylitis,http://news.abbvie.com/news/press-releases/rinvoq-upadacitinib-meets-primary-and-all-ranked-secondary-endpoints-in-phase-3-study-in-psoriatic-arthritis.htm,http://news.abbvie.com/alert-topics/immunology/abbvie-receives-fda-approval-rinvoq-upadacitinib-an-oral-jak-inhibitor-for-treatment-moderate-to-severe-rheumatoid-arthritis.htm,http://news.abbvie.com/news/press-releases/abbvie-submits-regulatory-application-to-fda-for-rinvoq-upadacitinib-for-treatment-adults-with-active-ankylosing-spondylitis.htm,http://news.abbvie.com/news/press-releases/european-commission-approves-abbvies-rinvoq-upadacitinib-for-treatment-psoriatic-arthritis-and-ankylosing-spondylitis.htm,http://news.abbvie.com/news/press-releases/chmp-recommends-approval-upadacitinib-rinvoq-for-treatment-adults-with-active-non-radiographic-axial-spondyloarthritis.htm,http://revistabalance.com/abbvie-artritis-psoriasica-activa,,,,,,,,,,,,,,,,,,,,,,
gerard.notario@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Gerard,Notario,,"","","","",http://drugsincontext.com/wp-content/uploads/2015/02/dic.212270.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
denise.edwards@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Denise,Edwards,Management,Regional Manager,"","","",http://biography.omicsonline.org/falkland-islands/aop-orphan-pharmaceuticals-ag/edwards-denise-1053791,,,,,,,,,,,,,,,,,,,,,,,,,,,,
joanna.jones@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,5,{first}.{last},Joanna,Jones,Writing & communication,Patient Relations,"","","",http://mynewsdesk.com/uk/abbvie-uk/pressreleases/skyriziv-risankizumab-receives-nice-positive-technology-appraisal-guidance-for-the-treatment-of-plaque-psoriasis-in-adults-2908347,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/abbvies-skyriziv-risankizumab-accepted-for-use-within-nhs-scotland-2928830,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/results-from-upadacitinib-phase-3-select-compare-study-published-in-arthritis-and-rheumatology-2896790,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/abbvies-duodopa-r-levodopa-carbidopa-intestinal-gel-recommended-for-use-within-nhs-wales-2460807,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/nice-issues-positive-final-appraisal-document-for-skyriziv-risankizumab-for-the-treatment-of-plaque-psoriasis-in-adults-2897106,,,,,,,,,,,,,,,,,,,,,,,,
laura.logsdon@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Laura,Logsdon,,"","","",+1 844 438 6721,http://parkinsonssupport.weebly.com/calendar.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
fabio.lievano@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,5,{first}.{last},Fabio,Lievano,Medical & health,Director Medical,"","","",http://ssom.luc.edu/pharmacology/facultyandstaff/postdocs,http://ssom.luc.edu/pharmacology/facultyandstaff/affiliatefaculty/kellyalangert,http://ssom.luc.edu/pharmacology/facultyandstaff/graduatestudents,http://ssom.luc.edu/pharmacology/people/affiliate_faculty,http://ssom.luc.edu/pharmacology/facultyandstaff/affiliatefaculty,,,,,,,,,,,,,,,,,,,,,,,,
monica.cheung@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Monica,Cheung,,"","","","",http://lmi.no/2017/09/27/velkommen-drug-safety-forum,,,,,,,,,,,,,,,,,,,,,,,,,,,,
justine.miller@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,7,{first}.{last},Justine,Miller,,Scientist,"","","",http://mskcc.org/research/lab/lorenz-studer,http://mskcc.org/research/ski/labs/lorenz-studer,http://sloankettering.edu/research-areas/labs/lorenz-studer,http://sloankettering.edu/research-areas/labs/members/justine-miller,http://mskcc.org/research/ski/labs/members/justine-miller,http://mskcc.org/research/lab/lorenz-studer/member/justine-miller,http://mskcc.org/research-areas/labs/members/justine-miller,,,,,,,,,,,,,,,,,,,,,,
lisa.maguire@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,0,{first}.{last},Lisa,Maguire,Writing & communication,Director Communications,"","",+61 499 200 550,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anna.kojo@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,4,{first}.{last},Anna,Kojo,Writing & communication,Communications Manager,"",https://fi.linkedin.com/in/annakojo,"",http://mynewsdesk.com/fi/abbvie/pressreleases/abbvie-sijoittui-great-place-to-work-tutkimuksessa-sijalle-7-2834142,http://mynewsdesk.com/fi/abbvie/pressreleases/huonosti-tunnettu-ihosairaus-syoe-elaemaenlaatua-1646464,http://mynewsdesk.com/fi/abbvie,http://mynewsdesk.com/fi/abbvie/pressreleases/abbvie-paransi-sijoitustaan-great-place-to-work-tutkimuksesessa-1799816,,,,,,,,,,,,,,,,,,,,,,,,,
patricia.baum@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,4,{first}.{last},Patricia,Baum,,,,,,http://dac2021.de/ausstellerverzeichnis.php,http://dac2020.de/ausstellerverzeichnis.php,http://hai2019.de/ausstellerverzeichnis.php,http://dac2019.de/ausstellerverzeichnis.php,,,,,,,,,,,,,,,,,,,,,,,,,
matthew.worrall@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,2,{first}.{last},Matthew,Worrall,Writing & communication,Patient Relations,"","",+44 74 6465 2626,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/nearly-two-thirds-put-off-seeing-doctors-due-to-diagnosis-fears-new-quiz-launched-today-to-understand-why-2419234,http://mynewsdesk.com/uk/abbvie-uk,,,,,,,,,,,,,,,,,,,,,,,,,,,
sherry.goodner@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,2,{first}.{last},Sherry,Goodner,,"","","",+1 314 805 5758,http://oscook.org/category/events/page/2,http://oscook.org/neoons-del17p-chronic-lymphocytic-leukemia-march-28th,,,,,,,,,,,,,,,,,,,,,,,,,,,
liz.lloyd@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,5,{first}.{last},Liz,Lloyd,,,,,,http://news.abbvie.com/news/abbvie-news-briefs/abbvie-again-named-world-best-workplace-by-great-place-to-work.htm,http://news.abbvie.com/news/abbvie-news-briefs/abbvie-repeats-as-top50-diversityinc-company.htm,http://news.abbvie.com/news/abbvie-news-briefs/abbvie-recognized-as-fortune-100-best-companies-to-work-for.htm,http://news.abbvie.com/news/abbvie-news-briefs/abbvie-recognized-as-one-of-the-worlds-best-workplaces.htm,http://news.abbvie.com/news/abbvie-news-briefs/abbvie-gives-moms-and-dads-more-time-off-plus-flexibility-to-use-it.htm,,,,,,,,,,,,,,,,,,,,,,,,
jeremy.marro@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,3,{first}.{last},Jeremy,Marro,,"",rcomsante,"","",http://trt-5.org/wp-content/uploads/2022/05/2018-03-08-cp-maviret-final.pdf,http://trt-5.org/wp-content/uploads/2022/05/2019-03-29-cp-maviret.pdf,http://pressentinelle2.blogspot.com/2016/09/ameliorer-laccueil-de-lenfant-au-bloc.html,,,,,,,,,,,,,,,,,,,,,,,,,,
maria.trenhaile@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,4,{first}.{last},Maria,Trenhaile,,,,,,http://research847.rssing.com/chan-14897209/all_p24.html,http://research847.rssing.com/chan-14897209/all_p18.html,http://research847.rssing.com/chan-14897209/all_p19.html,http://research847.rssing.com/chan-14897209/all_p20.html,,,,,,,,,,,,,,,,,,,,,,,,,
anne.lehtonen@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Anne,Lehtonen,Medical & health,Medical Director,"","","",http://mynewsdesk.com/fi/abbvie/pressreleases/suomalaistutkimus-kipu-on-eniten-elaemaenlaatua-heikentaevae-oire-ihosairaus-hs-taudissa-2037642,,,,,,,,,,,,,,,,,,,,,,,,,,,,
eric.blomme@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,4,{first}.{last},Eric,Blomme,Executive,Vice President,"","","",http://aspet.org/2017_glc_annual_meeting,http://frontiersin.org/articles/10.3389/fgene.2012.00213/full,http://aspet.org/aspet/membership-community/aspet-regional-chapters/great-lakes-chapter/great-lakes-chapter-past-meetings/2017-glc-aspet-annual-meeting,http://aspet.org/aspet/membership-community/aspet-regional-chapters/great-lakes-chapter/great-lakes-chapter-past-meetings/2016-glc-aspet-annual-meeting,,,,,,,,,,,,,,,,,,,,,,,,,
masha.trenhaile@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,8,{first}.{last},Masha,Trenhaile,Management,Manager,"","","",http://research847.rssing.com/chan-14897209/all_p123.html,http://research847.rssing.com/chan-14897209/all_p83.html,http://research847.rssing.com/chan-14897209/all_p147.html,http://research847.rssing.com/chan-14897209/all_p78.html,http://research847.rssing.com/chan-14897209/all_p106.html,http://researchpark.illinois.edu/article/december-2015-research-park-announcements,http://hackvie-eu-2018.devpost.com,http://researchpark.illinois.edu/news/december-2015-research-park-announcements,,,,,,,,,,,,,,,,,,,,,
min.zhang@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,5,{first}.{last},Min,Zhang,,"",,,,http://chicagosfn.org/annual-meeting/chicago-chapter-2014-annual-meeting/diversity-in-careers-themed-lunch-tables,http://chicagosfn.org/chapter-information/executive-committee-2016-2017-2,http://chicagosfn.org/chapter-information/executive-committee-2017-2018-2,http://chicagosfn.org/chapter-information/executive-committee-2020-2021,http://chicagosfn.org/chapter-information/executive-committee-2018-2019-2,,,,,,,,,,,,,,,,,,,,,,,,
eileen.murphy@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,5,{first}.{last},Eileen,Murphy,Writing & communication,Media Contact,"","",+1 514 832 7788,http://newswire.ca/news-releases/abbvies-holkira-pak-now-reimbursed-in-ontario-518032581.html,http://newswire.ca/news-releases/abbvies-humira-adalimumab-receives-first-and-only-health-canada-approval-for-moderate-to-severe-hidradenitis-suppurativa-564353901.html,http://newswire.ca/fr/news-releases/donnees-sur-le-psoriasis-des-ongles-maintenant-comprises-dans-la-monographie-dhumira-653014473.html,http://hepatitiscnewdrugs.blogspot.com/2015/06,http://hepatitiscnewdrugs.blogspot.com/2015_06_01_archive.html,,,,,,,,,,,,,,,,,,,,,,,,
emily.faivre@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,1,{first}.{last},Emily,Faivre,,"","","","",http://ingrahamlab.ucsf.edu/content/emily-faivre-phd,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jaquelin.finley@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,22,{first}.{last},Jaquelin,Finley,Executive,Vice President,"","",+1 847 937 3998,http://headquartersof.com/abbvie-headquarters,http://cknby.com/who-we-are/our-stories/btk-protein-good-bad-and-ugly.html,http://cknby.com/who-we-are/our-stories/chembeads-improving-artificial-intelligence-through-human-ingenuity.html,http://cknby.com/who-we-are/our-stories/the-blueprint-of-you-unlocking-potential-whole-genome-sequencing.html,http://headquartersof.com/abbvie-headquarters-info-email-format-and-hr-phone-number,http://news.abbvie.com/news/abbvie-news-briefs/take-tour-inside-abbvies-genomic-research-center.htm,http://news.abbvie.com/news/abbvie-submits-new-drug-application-in-japan-for-its-investigational-all-oral-treatment-for-chronic-hepatitis-c.htm,http://news.abbvie.com/news/abbvie-news-briefs/inside-labs-abbvie-ludwigshafen.htm,http://news.abbvie.com/news/abbvie-news-briefs/inside-abbvies-cambridge-research-center.htm,http://hepatitiscnewdrugs.blogspot.com/2015_04_01_archive.html,http://hepatitiscnewdrugs.blogspot.com/2015_11_01_archive.html,http://hepatitiscnewdrugs.blogspot.com/2015/10/abbvie-announces-new-data-on-studies-of.html,http://hepatitiscresearchandnewsupdates.blogspot.com/2015_04_09_archive.html,http://news.abbvie.com/news/abbvie-announces-top-line-results-from-phase-3-study-all-oral-treatment-for-hepatitis-c-in-japan.htm,http://hcvadvocatenews.blogspot.com/2015/01,http://hepatitiscnewdrugs.blogspot.com/2015/11,http://hcvadvocatenews.blogspot.com/2015/01/abbvie-announces-top-line-results-from.html,http://hcvadvocatenews.blogspot.com/search/label/ribavirin-free,http://biospace.com/article/releases/abbvie-and-neurocrine-biosciences-announce-pdufa-target-date-of-q3-2018-for-elagolix-in-endometriosis-associated-pain,http://hepatitiscnewdrugs.blogspot.com/2015/04,http://hepatitiscadvocate.blogspot.com/2015/01/abbvie-announces-top-line-results-from.html,http://hepatitiscresearchandnewsupdates.blogspot.com/2015/04/abbvie-to-present-new-data-from.html,,,,,,,
adelle.infante@abbvie.com,abbvie.com,AbbVie,US,,,,,91,personal,13,{first}.{last},Adelle,Infante,Writing & communication,Media Contact,"","",+1 847 938 8745,http://news.abbvie.com/news/press-releases/abbvie-harvard-university-form-research-alliance-to-address-emergent-viral-diseases.htm,http://news.abbvie.com/news/abbvie-and-m2gen-announce-new-collaboration-for-oncology-research-information-exchange-network-orien-avatar-research-program.htm,http://news.abbvie.com/news/abbvie-to-expand-oncology-presence-through-acquisition-stemcentrx-and-its-novel-late-stage-rova-t-compound-for-small-cell-lung-cancer.htm,http://missiontherapeutics.com/mission-therapeutics-and-abbvie-sign-dubs-collaboration-in-alzheimers-and-parkinsons-disease,http://scripps.edu/news-and-events/press-room/2018/20180625-calibr-abbvie.html,http://biospace.com/news/abbott-laboratoriess-abbvie-officially-launches/283344/source=yesterdaysmostpopular,http://biospace.com/news/abbott-vasculars-abbvie-officially-launches-with/283344,http://nlvpartners.com/news-june-13-2017,http://investorideas.com/news/2018/biotech/06251nyseabbv.asp,http://biospace.com/news/abbott-laboratoriess-abbvie-officially-launches/283344/source=topbreaking,http://news.bms.com/press-release/partnering-news/abbvie-and-bristol-myers-squibb-announce-clinical-research-collaborati,http://businesswire.com/news/home/20170922005096/en,http://ipharmatrials.com/abbvie-oncology,,,,,,,,,,,,,,,,
productsurveillance_eame@abbvie.com,abbvie.com,AbbVie,US,,,,,90,generic,21,{first}.{last},,,Writing & communication,,,,,http://coolsculpting.nl/disclaimers,http://harpersbazaar.com/nl/beauty/a43981338/filler-faq-kosten-voordelen-nadelen,http://me.juvederm.com/fr/contact-us,http://me.juvederm.com/ar/contact-us,http://me.juvederm.com/fa/contact-us,http://juvederm.nl/faq/waarom-juvederm,http://juvedermit.lt/contact,http://juvedermit.lt/privacy-policy,http://juvederm.ee/kontaktid,http://me.juvederm.com/en/contact-us,http://juvederm.nl/faq/fillers,http://juvederm.nl/social-media-disclaimer,http://juvederm.pl/polityka-prywatnosci,http://juvederm.pl/znajdz-klinike,http://juvederm.pl/oswiadczenie,http://juvederm.pl,http://allerganaesthetics.nl/over/contact,http://juvederm-mena.com,http://coolsculpting.nl/neem-contact-met-ons-op,http://juvederm.nl/faq,http://juvederm.nl/neem-contact-op,,,,,,,,
birgit.schinwald@abbvie.com,abbvie.com,AbbVie,US,,,,,90,personal,10,{first}.{last},,,,,,,,http://bgld.mycity24.at/2018/09/neuer-langenscheidt-zu-psoriasis-glauben-sie-wirklich-dieser-spruch-wuerde-mich-mehr-jucken-als-meine-psoriasis,http://selbsthilfe.at/news/20665/wie-geht-es-menschen-mit-morbus-parkinson-in-oesterreich-neue-umfrage-vom-dachverband-der-parkinson-selbsthilfe-und-abbvie,http://ooe.mycity24.at/2018/09/neuer-langenscheidt-zu-psoriasis-glauben-sie-wirklich-dieser-spruch-wuerde-mich-mehr-jucken-als-meine-psoriasis,http://vbg.mycity24.at/2018/09/neuer-langenscheidt-zu-psoriasis-glauben-sie-wirklich-dieser-spruch-wuerde-mich-mehr-jucken-als-meine-psoriasis,http://wien.mycity24.at/2018/09/neuer-langenscheidt-zu-psoriasis-glauben-sie-wirklich-dieser-spruch-wuerde-mich-mehr-jucken-als-meine-psoriasis,http://tirol.mycity24.at/2018/09/neuer-langenscheidt-zu-psoriasis-glauben-sie-wirklich-dieser-spruch-wuerde-mich-mehr-jucken-als-meine-psoriasis,http://bgld.mycity24.at/2018/10/leben-mit-psoriasis-ist-wie,http://stmk.mycity24.at/2018/09/neuer-langenscheidt-zu-psoriasis-glauben-sie-wirklich-dieser-spruch-wuerde-mich-mehr-jucken-als-meine-psoriasis,http://mycity24.at/2018/09/neuer-langenscheidt-zu-psoriasis-glauben-sie-wirklich-dieser-spruch-wuerde-mich-mehr-jucken-als-meine-psoriasis,http://ktn.mycity24.at/2018/09/neuer-langenscheidt-zu-psoriasis-glauben-sie-wirklich-dieser-spruch-wuerde-mich-mehr-jucken-als-meine-psoriasis,,,,,,,,,,,,,,,,,,,
medinfo.ch@abbvie.com,abbvie.com,AbbVie,US,,,,,90,generic,15,{first}.{last},,,,,,,,http://allerganaesthetics.ch/de/about/contact,http://allerganaesthetics.ch/fr/about/contact,http://bullmed.ch/article/doi/bms.2023.21588,http://medizinonline.com/en/jak-inhibitors-in-inflammatory-rheumatic-diseases,http://medizinonline.com/fr/inhibiteurs-de-jak-dans-les-maladies-rhumatismales-inflammatoires,http://medizinonline.com/it/inibitori-di-jak-nelle-malattie-reumatiche-infiammatorie,http://medizinonline.com/jak-inhibitoren-bei-entzuendlichen-rheumatischen-erkrankungen,http://medizinonline.com/pt-pt/inibidores-jak-em-doencas-reumaticas-inflamatorias,http://congress-info.ch/event/psoriatische-erkrankungen-und-sars-cov-2,http://abbvie-patientcare.ch/login,http://kofam.ch/en/snctp-portal/search/0/study/39800,http://kofam.ch/en/snctp-portal/search/0/study/41624,http://kofam.ch/de/studienportal/suche/0/studie/39799,http://kofam.ch/de/studienportal/suche/0/studie/39949,http://kofam.ch/fr/portail-snctp/etude/39862,,,,,,,,,,,,,,
sebastian.wachtarz@abbvie.com,abbvie.com,AbbVie,US,,,,,90,personal,18,{first}.{last},,,,,,,,http://news.abbvie.de/contact_people/tag/gesundheit-und-versorgung,http://mynewsdesk.com/de/abbvie/pressreleases/digitalkooperation-bessere-versorgung-fuer-patienten-mit-schmerzhafter-hauterkrankung-2388564,http://news.abbvie.de/pressreleases/abbvie-ausgezeichnet-im-wettbewerb-deutschlands-beste-arbeitgeber-3174813,http://news.abbvie.de/contact_people,http://news.abbvie.de/pressreleases/digitalkooperation-bessere-versorgung-fuer-patienten-mit-schmerzhafter-hauterkrankung-2388564,http://abbvie-germany.mynewsdesk.com/pressreleases/abbvie-ausgezeichnet-im-wettbewerb-deutschlands-beste-arbeitgeber-3174813,http://news.abbvie.de/contact_people/tag/science-rocks,http://vfa.de/de/verband-mitglieder/mitgliedsunternehmen/novartispharma.html,http://abbvie-germany.mynewsdesk.com/pressreleases/abbvie-deutschland-belegt-platz-1-beim-corporate-health-award-2021-3149273,http://vfa.de/de/verband-mitglieder/mitgliedsunternehmen/boehringeringelheim.html,http://vfa.de/de/verband-mitglieder/mitgliedsunternehmen/astrazeneca.html,http://vfa.de/de/verband-mitglieder/mitgliedsunternehmen/janssen.html,http://abbvie-germany.mynewsdesk.com,http://abbvie-germany.mynewsdesk.com/contact_people,http://abbvie-germany.mynewsdesk.com/pressreleases/digitalkooperation-bessere-versorgung-fuer-patienten-mit-schmerzhafter-hauterkrankung-2388564,http://mynewsdesk.com/de/pressroom/abbvie,http://presseportal.de/pm/112983/4624698,http://vfa.de/standortkarte,,,,,,,,,,,
abbvieclinicaltrials@abbvie.com,abbvie.com,AbbVie,US,,,,,90,personal,19,{first}.{last},,,,,,,,http://navigator.reaganudall.org/expanded-access/expanded-access-telisotuzumab-vedotin-0,http://prismahealth.org/covid-19/prisma-health-and-statewide-coronavirus-clinical-research/clinical-research-at-prisma-health/treatment-trials-research-at-prisma-health,http://clinicaltrials.gov/ct2/show/nct05283720,http://navigator.reaganudall.org/expanded-access/expanded-access-bimatoprost-durysta,http://navigator.reaganudall.org/expanded-access/expanded-access-elezanumab,http://navigator.reaganudall.org/expanded-access/expanded-access-telisotuzumab-vedotin,http://clinicaltrials.gov/show/nct04468984,http://michaeljfox.org/news/research-roundup-parkinsons-clinical-trials-enrolling-participants,http://clinicaltrials.gov/show/nct04721015,http://clinicaltrials.gov/ct2/show/nct02099058,http://clinicaltrials.gov/ct2/show/nct04417465,http://iffgd.org/research/clinical-trials-and-studies,http://iffgd.org/clinical-trials-studies/nih-other-sponsored-clinical-trials-and-studies.html,http://iffgd.org/clinical-trials-studies/clinical-trials-and-studies.html,http://reaganudall.org/expanded-access/expanded-access-navitoclax,http://reaganudall.org/expanded-access/expanded-access-telisotuzumab-vedotin,http://reaganudall.org/expanded-access/expanded-access-venetoclax,http://hepatitiscnewdrugs.blogspot.com/search/label/clinical%20trials,http://hepatitiscnewdrugs.blogspot.com/2017/05/may-2017-recruiting-and-upcoming.html,,,,,,,,,,
customerservice@abbvie.com,abbvie.com,AbbVie,US,,,,,90,generic,30,{first}.{last},,,Support,,,,,http://atipes.com/mdd-add-on-and-bipolar-i-treatment-vraylar-vraylar-com,http://focusrailsafety.com/www.focusrailsafety.com/contractors/api-chemicals/abbvie-inc,http://beye.com/company-directory,http://beye.com/company/abbvie-inc/products,http://beye.com/product/humira,http://dietsinreview.com/diet_column/11/humira-adalimumab-review,http://mindmaps.dka.global/firms/218,http://farmasiindustri.com/industri/list-of-pharmaceutical-manufacturer-in-united-states-of-america.html,http://farmasiindustri.com/industri/pharmaceutical-manufacturer-in-united-kingdom.html,http://johnsnowlabs.com/marketplace/directory-of-us-and-eu-pharmaceutical-companies,http://madashellboycott.com/mass-petition-blast,http://headquartersof.com/abbvie-headquarters-info-email-format-and-hr-phone-number,http://idealmedhealth.com/pharmaceutical-companies-in-the-world,http://headquartersof.com/abbvie-headquarters,http://idealmedhealth.com/top-100-pharmaceutical-companies,http://commercialvehicleinfo.com/abbvie-patient-portal-login,http://commercialvehicleinfo.com/myabbvie-assist-patient-portal-login,http://e-health-portal.com/myabbvie-assist-patient-portal,http://stopmediabiasnow.com/x010,http://fadiahmad.com/2023/01/pharmaceutical-companies.html,http://idealmedhealth.com/oncology-drugs-companies,http://idealmedhealth.com/pharmaceutical-companies-in-united-kingdom,http://mrc.org/conservatives-fight-back/advertiser/abbvie,http://clinicaltrialsarena.com/contractors/analytical-services/abbvie-inc,http://mary-shomon.com/_files/ugd/b0e990_81cd4bf74b7149d68a3a50644d5241c7.pdf,http://mary-shomon.com/synthroid-levothyroxine,http://letsbehired.com/assistant-scientist-i-clinical-pharmacology,http://letsbehired.com/company/abbvie,http://pharmapproach.com/list-of-pharmaceutical-companies-in-the-united-kingdom-2,http://pharmapproach.com/list-of-pharmaceutical-companies-in-united-states-of-america
kontakt@abbvie.com,abbvie.com,AbbVie,US,,,,,90,generic,14,{first}.{last},,,,,,,,http://felleskatalogen.no/medisin/firmaer/a;jsessionid=jhq9ra4fayh03ejwjff1n5hh3hbl7g5ubghcceza.fkweb-live-web-fkweb-live-2,http://felleskatalogen.no/medisin/firmaer/a;jsessionid=ttio7moefsz6jcryg8p6cfoxtzkedz7fqbrod0iw.fkweb-live-web-cluster-fkweb-live-4,http://legemiddelverket.no/documents/bivirkninger%20og%20sikkerhet/kj%c3%a6re%20helsepersonell-brev/2020/leuprorelin%20dhpc_no.pdf,http://legemiddelverket.no/documents/bivirkninger%20og%20sikkerhet/kj%c3%a6re%20helsepersonell-brev/2021/dhpc%20letter_no_26-may-2021_final%20version%20reviewed%20by%20noma%2003-jun-2021-signed.pdf,http://indremedisineren.no/indremedisineren/pdf/2022-01-indremedisineren.pdf,http://indremedisineren.no/indremedisineren/pdf/2022-03-indremedisineren.pdf,http://duodopa.no/helsepersonell/sikkerhet/bivirkninger,http://duodopa.no,http://felleskatalogen.no/medisin/firmaer/a;jsessionid=i3cr0wry5mscz4-xbo0yxfsdsrzybygbp8dn9eag.fkweb-live-web-cluster-fkweb-live-2,http://duodopa.no/helsepersonell/informasjonsmateriell/guider-skjemaer,http://duodopa.no/helsepersonell/kontakt/supporttjeneste,http://duodopa.no/helsepersonell/sikkerhet,http://felleskatalogen.no/t/medisin/firmaer/a,http://felleskatalogen.no/ir/medisin/firmaer/abbvie-578975-abbvie-as-578976,,,,,,,,,,,,,,,
christine.blindzellner@abbvie.com,abbvie.com,AbbVie,US,,,,,90,personal,26,{first}.{last},,,,,,,,http://news.abbvie.de/contact_people/tag/gesundheit-und-versorgung,http://abbvie-germany.mynewsdesk.com/pressreleases/manage-pd-unterstutzt-neurologen-bei-der-therapieentscheidung-fur-parkinson-patienten-3078205.pdf,http://news.abbvie.de/contact_people/tag/science-rocks,http://pr-presseverteiler.de/21142/welt-parkinson-tag-parkinson-check-de-hilft-fortgeschrittenen-parkinson-zu-verstehen,http://medizin-aspekte.de/therapiemanagement-der-rheumatoiden-arthritis-fokus-auf-komorbiditaeten-richten-63673,http://medizin-aspekte.de/bewerbungsstart-zum-rheumapreis-2016-62983,http://presseportal.de/pm/112983/4514415,http://abbvie-germany.mynewsdesk.com/contact_people,http://abbvie-germany.mynewsdesk.com/pressreleases/abbvie-und-jacobio-forschen-zukuenftig-gemeinsam-an-tumor-inhibitoren-3006317,http://abbvie-germany.mynewsdesk.com/pressreleases/gemeinsam-fuer-parkinson-patienten-2825835,http://abbvie-germany.mynewsdesk.com/pressreleases/manage-pd-unterstutzt-neurologen-bei-der-therapieentscheidung-fur-parkinson-patienten-3078205,http://news.abbvie.de/contact_people,http://news.abbvie.de/pressreleases/gemeinsam-fuer-parkinson-patienten-2825835,http://news.abbvie.de/pressreleases/manage-pd-unterstutzt-neurologen-bei-der-therapieentscheidung-fur-parkinson-patienten-3078205,http://nachrichten.idw-online.de/2018/05/29/deutscher-seniorentag-2018-gesundheitskompetenz-staerken-selbstmanagement-von-patienten-foerdern,http://politikexpress.de/abbvie-ist-erneut-top-employer-foto-1791344.html,http://mittelstandcafe.de/abbvie-ist-erneut-top-employer-foto-1791344.html,http://presseportal.de/pm/112983/3954314,http://presseportal.de/pm/112983/3347174,http://schattenblick.de/infopool/medizin/fakten/mz2tp152.html,http://politikexpress.de/ruckenschmerzen-nicht-auf-die-leichte-schulter-nehmen-foto-1199639.html,http://itiko.de/artikel/1413857/aktuelle-themen-und-debatten-rund-um-original-biologika-biosimilars-jetzt-auf-biologika-info-de-foto.html,http://presseportal.de/pm/112983/3168245,http://politikexpress.de/bewerbungsstart-zum-rheumapreis-2016-die-initiative-rheumapreis-zeichnet-kreative-konzepte-von-und-fur-menschen-mit-rheuma-im-berufsleben-aus-foto-1332656.html,http://presseportal.de/pm/112983/3218686,http://gateo.de/arztliche-therapiefreiheit-im-zeitalter-von-biosimilars-patientenwohl-muss-im-mittelpunkt-stehen-foto-1399496.html,,,
fabian.liboschik@abbvie.com,abbvie.com,AbbVie,US,,,,,90,personal,20,{first}.{last},,,,,,,,http://news.abbvie.de/contact_people/tag/gesundheit-und-versorgung,http://abbvie-germany.mynewsdesk.com/pressreleases/abbvie-bietet-mitarbeitern-in-ludwigshafen-innovatives-modell-zur-kinderbetreuung-1950422,http://abbvie-germany.mynewsdesk.com/pressreleases/martin-gastens-wird-neuer-geschaeftsfuehrer-fuer-forschung-und-entwicklung-bei-abbvie-deutschland-3242394,http://abbvie-germany.mynewsdesk.com/pressreleases/martin-gastens-wird-neuer-geschaeftsfuehrer-fuer-forschung-und-entwicklung-bei-abbvie-deutschland-3242394.pdf,http://biolabs.io/post/biolabs-global-announces-a-new-partnership-with-abbvie-to-launch-biolabs-heidelberg,http://news.abbvie.de/pressreleases/martin-gastens-wird-neuer-geschaeftsfuehrer-fuer-forschung-und-entwicklung-bei-abbvie-deutschland-3242394,http://biorn.org/post/biolabs-global-announces-a-strategic-partnership-with-abbvie-for-the-upcoming-biolabs-heidelberg,http://news.abbvie.de/contact_people/tag/science-rocks,http://abbvie-germany.mynewsdesk.com/contact_people,http://abbvie-germany.mynewsdesk.com/pressreleases/abbvie-und-turnstone-biologics-geben-weltweite-zusammenarbeit-bei-viro-immuntherapien-in-der-onkologie-bekannt-2233555,http://news.abbvie.de/contact_people,http://news.abbvie.de/pressreleases/abbvie-bietet-mitarbeitern-in-ludwigshafen-innovatives-modell-zur-kinderbetreuung-1950422,http://presseportal.de/pm/112983/3435739,http://presseportal.de/pm/112983/3359091,http://presseportal.de/pm/112983/3433556,http://politikexpress.de/helfende-hande-abbvie-mitarbeiter-packen-an-foto-1371581.html,http://presseportal.de/pm/112983/3317859,http://innovations-intelligenz.de/130-jahre-pharma-forschung-und-herstellung-in-ludwigshafen-mit-blick-in-die-zukunft-foto-1402775.html,http://innovations-intelligenz.de/wissenschaftliche-kooperationen-turbo-fuer-die-arzneimittelforschung-foto-1401750.html,http://presseportal.de/pm/112983/3429356,,,,,,,,,
bilgi@abbvie.com,abbvie.com,AbbVie,US,,,,,90,generic,29,{first}.{last},,,,,,,,http://allerganaesthetics.com.tr/hakkinda/iletisim,http://pharmchoices.com/full-list-of-pharmaceutical-companies-in-turkey,http://eilab.org/synagis-50-mg-ml-im-enjeksiyon-icin-liyofilize-toz-iceren-1-flakonprospektusu,http://ilacarsivi.com/amp/ilac-firmasi/abbvie,http://ilacarsivi.com/ilac/calcijex-1-mcgml-iv-1-mlx-25-ampulkutu_12274,http://ilacarsivi.com/ilac/calcijex-2-mcgml-iv-1-mlx-25-ampulkutu_12275,http://ilacarsivi.com/ilac-firmasi/abbvie,http://ilacbilgibankasi.com/ilac-bilgileri/zemplar-1-mcg-28-yumusak-kapsul,http://ilacbilgibankasi.com/ilac-firmalari,http://ilacbilgibankasi.com/ilac-firmasi/abbvie-tibbi-ilaclar-san-tic-ltd-sti,http://ilacbilgibankasi.com/yabanci-ilac-firmalari,http://ilacbilgibankasi.com/yerli-ilac-firmalari,http://greatplacetowork.com.tr/workplace/item/1768/abbvie,http://bkgd.org/category/e-ile-baslayan-ilaclar,http://bkgd.org/exviera-250-mg-56-film-kapli-tabletprospektusu,http://bkgd.org/page/5,http://bkgd.org/synagis-100mg-ml-i-m-enjeksiyon-icin-liyofilize-toz-iceren-flakonprospektusu,http://bkgd.org/synagis-50-mg-ml-im-enjeksiyon-icin-liyofilize-toz-iceren-1-flakonprospektusu,http://cicekkadin.com/exviera-250-mg-56-film-kapli-tabletprospektusu,http://cicekkadin.com/synagis-100mg-ml-i-m-enjeksiyon-icin-liyofilize-toz-iceren-flakonprospektusu,http://cicekkadin.com/synagis-50-mg-ml-im-enjeksiyon-icin-liyofilize-toz-iceren-1-flakonprospektusu,http://xn--sitead-u9a.com/exviera-250-mg-56-film-kapli-tabletprospektusu,http://xn--sitead-u9a.com/synagis-100mg-ml-i-m-enjeksiyon-icin-liyofilize-toz-iceren-flakonprospektusu,http://xn--sitead-u9a.com/synagis-50-mg-ml-im-enjeksiyon-icin-liyofilize-toz-iceren-1-flakonprospektusu,http://eilab.org/exviera-250-mg-56-film-kapli-tabletprospektusu,http://eilab.org/synagis-100mg-ml-i-m-enjeksiyon-icin-liyofilize-toz-iceren-flakonprospektusu,http://ilacprospektusu.com/ilac/570/venclyxto-50-mg-7-film-kapli-tablet,http://aifd.org.tr/en/about-us/our-members,http://aifd.org.tr/biz-kimiz/uyelerimiz
russia.info@abbvie.com,abbvie.com,AbbVie,US,,,,,90,generic,15,{first}.{last},,,Support,,,,,http://ar-mos.com/public/files/events/7/714/katalog.pdf,http://vspru.ru/media/551786/katalog_9_kongress.pdf,http://imfd.ru/wp-content/uploads/2021/03/izdaniy24022021.pdf,http://imfd.ru/wp-content/uploads/2021/06/matsem27042021.pdf,http://imfd.ru/wp-content/uploads/2021/08/matsem3062020.pdf,http://imfd.ru/wp-content/uploads/2021/10/matsem19102021.pdf,http://imfd.ru/wp-content/uploads/2021/12/matsem24112021.pdf,http://retinoids.ru/uploads/conf-prog-26-27_05_2022.pdf,http://piluli.com.ua/instruktion/venkleksta-kupit-cena-recept-opisanie-i-instrukciya,http://vidal.ru/drugs/mavyret,http://vidal.ru/drugs/ranvec,http://vidal.ru/drugs/venclexta,http://arvt.ru/news/2015-05-01-viekira-pak-russia.html,http://msk24.net/abbvie,http://vidal.ru/drugs/company/919,,,,,,,,,,,,,,
anna.samokhvalova@abbvie.com,abbvie.com,AbbVie,US,,,,,90,personal,12,{first}.{last},,,,,,,,http://aipm.kz/images/article/news/abbvie-1.pdf,http://aipm.kz/images/article/news/abbvie-2.pdf,http://aipm.kz/images/article/news/abbvie-3.pdf,http://aipm.kz/images/article/news/abbvie-4.pdf,http://aipm.kz/images/article/news/abbvie-5.pdf,http://abercade.ru/research/industrynews/11484.html,http://rmj.ru/news/press_reliz_abbvie,http://pharmstd.ru/archivedetails_64_1950.html,http://umedp.ru/press_releases/abbvie_and_rpharm_announced_the_beginning_of_production_of_the_drug_khumira_russia.html,http://healtheconomics.ru/news/item/abbvie-sovmestno-s-vich-soobshchestvom-zapuskaet-mezhdunarodnuyu-informatsionnuyu-kampaniyu-o-zhenshchinakh-zhivushchikh-s-vich,http://ztema.ru/soobshestvo/blogs/8551-pacienty-s-neinfekcionnym-uveitom-(vospaleniem-sosudistoy-obolochki-glaza)-poluchayut-novye-vozmojnosti-terapii-blagodarya-genno-injenernomu-biologicheskom,http://dislife.ru/materials/662,,,,,,,,,,,,,,,,,
switzerland@abbvie.com,abbvie.com,AbbVie,US,,,,,90,generic,12,{first}.{last},,,,,,,,http://oakburystudios.com/abvei/27883258,http://en.greatplacetowork.ch/workplace/item/1097/abbvie+ag,http://swisshepa.org/it/chi-siamo/finanziamento-dellassociazione/sponsor,http://swisshepa.org/en/about-us/financing-of-the-association/sponsors,http://swisshepa.org/fr/a-propos-de-nous/financement-de-lassociation/parrains,http://swisshepa.org/ueber-uns/finanzierung-des-vereins/sponsoren,http://news-med.com/index.php/annuaire/viewadresse/fr/26/25/39891,http://news-med.com/index.php/annuaire/viewadresse/fr/99/25/39891,http://acneinversa.ch/it/impressum,http://acneinversa.ch/fr/impressum,http://acneinversa.ch/impressum,http://greatplacetowork.ch/workplace/item/434/abbvie+ag,,,,,,,,,,,,,,,,,
medinfoanz@abbvie.com,abbvie.com,AbbVie,US,,,,,90,generic,14,{first}.{last},,,,,,,,http://afqgc.cpimech.com/what-company-is-abbvie/65361301,http://usanz.org.au/publicassets/895ad69d-ac3f-ed11-9116-0050568796d8/lucrinavailability_sept-2022.pdf,http://usanz.org.au/publicassets/d593efba-502a-ed11-9114-0050568796d8/lucrintemporaryshortagenz_aug-2022_final.pdf,http://allerganaesthetics.com.au/about/report-an-adverse-event,http://allerganaesthetics.com.au/providers/medical-information,http://maviret.co.nz/about-maviret,http://maviret.co.nz,http://maviret.co.nz/about-hepatitis-c,http://maviret.co.nz/find-a-pharmacy,http://abbvie.com.au/responsibility/grants-and-donations.html,http://maviret.co.nz/taking-maviret,http://abbvie.co.nz/our-science/products/hp-products.html,http://aucustomerservice.com/abbvie-pharmaceuticals-customer-service-contact-number-email-id-website,http://abbvie.com.au/contactus.html,,,,,,,,,,,,,,,
info.de@abbvie.com,abbvie.com,AbbVie,US,,,,,90,generic,29,{first}.{last},,,Support,,,,,http://publichealth.com.ng/german-pharmaceutical-companies,http://mynewsdesk.com/de/pressroom/abbvie,http://mynewsdesk.com/de/abbvie/pressreleases/digitalkooperation-bessere-versorgung-fuer-patienten-mit-schmerzhafter-hauterkrankung-2388564,http://news.abbvie.de/contact_people/tag/science-rocks,http://neuro-depesche.de/firmen/abbvie-deutschland-gmbh-co-kg,http://pharmaforum-sw.de/sites/default/files/2019-10/kurzprofil_abbvie_deutschland_gmbh_und_co__kg_0.pdf,http://pharmaforum-sw.de/sites/default/files/2019-10/pharmaforum13_abbvie.pdf,http://visionatline.nl/bedrijf/abbvie-deutschland-gmh-co-kg,http://news.abbvie.de/pressreleases/sag-ichs-chronisch-krank-im-job-2644371,http://news.abbvie.de/latest_media,http://webkiosk.con-nexi.de/connexi-2016-05-aids-und-hepatitis/55692812/10,http://invivo-landen.be/1767/49/german/crushing/industries,http://news.abbvie.de/pressreleases/abbvie-ausgezeichnet-im-wettbewerb-deutschlands-beste-arbeitgeber-3174813,http://news.abbvie.de/contact_people,http://naturpharmazie.de/firmen/abbvie-deutschland-gmbh-co-kg,http://praxis-depesche.de/firmen/abbvie-deutschland-gmbh-co-kg,http://isostar24.de/a-seiten/abbvie-adresse-hauptsitz.html,http://pharmchoices.com/pharmaceutical-companies-in-hessen-germany,http://abbvie-germany.mynewsdesk.com/contact_people,http://abbvie-germany.mynewsdesk.com/pressreleases/abbvie-ausgezeichnet-im-wettbewerb-deutschlands-beste-arbeitgeber-3174813,http://abbvie-germany.mynewsdesk.com/pressreleases/abbvie-deutschland-belegt-platz-1-beim-corporate-health-award-2021-3149273,http://indice.eu/pt/medicamentos/laboratorios/abbvie-deutschland-gmbh-e-co-kg/informacao-geral,http://shop.wehrmed.de/partner/313-abbvie-deutschland-gmbh-co-kg.html,http://abbvie-germany.mynewsdesk.com/pressreleases/digitalkooperation-bessere-versorgung-fuer-patienten-mit-schmerzhafter-hauterkrankung-2388564,http://abbvie-germany.mynewsdesk.com/pressreleases/sag-ichs-chronisch-krank-im-job-2644371,http://neuro-bremen.de/abbvie-deutschland-gmbh-co-kg,http://wehrmed.de/anbieter/abbvie-deutschland-gmbh-co-kg.html,http://pharmapproach.com/list-of-pharmaceutical-companies-in-germany,http://bmcev.de/der-bmc/mitgliederverzeichnis/abbvie-deutschland-gmbh-co-kg
abbviemediarelations@abbvie.com,abbvie.com,AbbVie,US,,,,,90,generic,14,{first}.{last},,,Writing & communication,,,,,http://headquartersof.com/abbvie-headquarters,http://stopmediabiasnow.com/x010,http://cknby.com/who-we-are/our-stories/abbvie-volunteers-return-to-serving.html,http://cknby.com/who-we-are/our-stories/day-in-the-life-putting-patients-first-each-and-every-day.html,http://cknby.com/who-we-are/our-stories/how-were-advancing-our-vision-equity-and-inclusion.html,http://cknby.com/who-we-are/our-stories/living-with-an-illness.html,http://cknby.com/who-we-are/our-stories/make-complicated-simple-inside-world-human-factors-engineers.html,http://news.abbvie.com/news/press-releases/st-jude-childrens-research-hospital-unveils-45000-square-foot-family-commons.htm,http://stjude.org/media-resources/news-releases/2023-medicine-science-news/st-jude-unveils-45000-square-foot-family-commons.html,http://headquartersof.com/abbvie-headquarters-info-email-format-and-hr-phone-number,http://news.abbvie.com/media-resources/video,http://news.abbvie.com/media-resources,http://news.abbvie.com/media-resources/images,http://news.abbvie.com/pr-contacts,,,,,,,,,,,,,,,
david.freundel@abbvie.com,abbvie.com,AbbVie,US,,,,,90,personal,17,{first}.{last},,,,,,,,http://headquartersof.com/abbvie-headquarters,http://cknby.com/who-we-are/our-stories/hepatitis-c-mysterious-virus-that-met-its-match.html,http://cknby.com/who-we-are/our-stories/living-with-unknowns-alzheimers-disease.html,http://headquartersof.com/abbvie-headquarters-info-email-format-and-hr-phone-number,http://news.abbvie.com/news/abbvie-announces-new-data-evaluating-venetoclax-in-variety-hematologic-malignancies-at-22nd-european-hematology-association-congress.htm,http://news.abbvie.com/news/abbvie-receives-chmp-positive-opinion-for-venclyxto-venetoclax-tablets-for-appropriate-patients-with-difficult-to-treat-chronic-lymphocytic-leukaemia.htm,http://news.abbvie.com/news/press-releases/abbvie-announces-positive-phase-3-data-for-atogepant-in-migraine-prevention.htm,http://news.abbvie.com/news/abbvie-receives-us-fda-approval-viekira-pak-ombitasvirparitaprevirritonavir-tablets-dasabuvir-tablets-for-treatment-chronic-genotype-1-hepatitis-c.htm,http://news.abbvie.com/news/biogen-idec-and-abbvie-announce-positive-top-line-results-from-phase-3-study-investigating-daclizumab-high-yield-process-in-multiple-sclerosis.htm,http://pharmaadvancement.com/drug-development/research-development/abbvie-receives-u-s-fda-rare-pediatric-disease-designation-for-investigational-abt,http://hepatitiscresearchandnewsupdates.blogspot.com/2015_04_24_archive.html,http://hepatitiscresearchandnewsupdates.blogspot.com/2015,http://hepatitiscresearchandnewsupdates.blogspot.com/2015/04,http://hepatitiscresearchandnewsupdates.blogspot.com/2015/04/us-fda-grants-priority-review-to-abbvie.html,http://biospace.com/news/positive-survival-data-for-bristol-myers-squibb/300109,http://hepatitis193.rssing.com/chan-12783580/all_p84.html,http://hepatitiscresearchandnewsupdates.blogspot.com,,,,,,,,,,,,
christos.economou@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Christos,Economou,,,,,,http://chem.yale.edu/event/abbvie-recruiting-yale-virtual-event-monday-june-26-9-am,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kenichi.endo@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Kenichi,Endo,,,,,,http://miyagi-byouinyaku.jp/wp-content/uploads/2023/07/fbc2957bdee3671956d19dc15d49c80d.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
melanie.archambault@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Melanie,Archambault,,,,,,http://alberta.cmha.ca/are-you-living-with-bipolar-i-disorder-share-you-story,,,,,,,,,,,,,,,,,,,,,,,,,,,,
thea.larsen@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Thea,Larsen,,,,,,http://gigtforeningen.dk/media/5318/donationskontrakt-abbvie-livskvalitetsuderseogelse.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anna.m.lundstrom@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Anna,Lundstrom,,,,,,http://swemodis.se/wp-content/uploads/2009/10/inbjudan2014.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jianzhen.chan@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Jianzhen,Chan,,,,,,http://haematology.org.my/2022/09/optimizing-treatment-strategies-for-leukemia-in-japac-29th-september-2022,,,,,,,,,,,,,,,,,,,,,,,,,,,,
eric.matheson@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Eric,Matheson,,,,,,http://physicians.northernhealth.ca/cme/event-calendar/migraine-learning-compendium,,,,,,,,,,,,,,,,,,,,,,,,,,,,
trevor.sharp@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Trevor,Sharp,,,,,,http://spnp.enpnetwork.com/nurse-practitioner-news/218873-spnpa-april-18th-meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,
michael.r.robinson@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Michael,Robinson,,,,,,http://eyes.cochrane.org/sites/eyes.cochrane.org/files/public/uploads/01_waring_2022_required.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
yuji.yamaguchi@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Yuji,Yamaguchi,,,,,,http://miyagi-byouinyaku.jp/wp-content/uploads/2023/04/8de0b70ca53c4d5249daa017a4da0a5c-1.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
eileen.button@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Eileen,Button,,,,,,http://psoh.org/corporate-members.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
faith.stanton@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Faith,Stanton,,,,,,http://psoh.org/corporate-members.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sanjay.narayan@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Sanjay,Narayan,,,,,,http://phrma.org/-/media/project/phrma/phrma-org/phrma-refresh/certifications/compliance-officers-03-09-2023.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
vaishali.patel@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Vaishali,Patel,,,,,,http://journals.lww.com/prsgo/fulltext/2023/03000/clinical_and_healthcare_resource_use_outcomes.44.aspx,,,,,,,,,,,,,,,,,,,,,,,,,,,,
carol.bao@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Carol,Bao,,,,,,http://ispor.org/docs/default-source/intl2022/rwe-in-regulatory-evaluation-of-medical-devicesfinal.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cheng.tan@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Cheng,Tan,,,,,,http://unboundmedicine.com/medline/citation/24406670/effect_of_binders_on_the_release_rates_of_direct_molded_verapamil_tablets_using_twin_screw_extruder_in_melt_granulation_,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kate.ferrario@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Kate,Ferrario,,,,,,http://mygcsg.com/gcsg-2023-us-conference/speakers,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jay.lucas@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Jay,Lucas,,,,,,http://mygcsg.com/gcsg-2023-us-conference/speakers,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kathy.kosch@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Kathy,Kosch,,,,,,http://mystelizabeth.com/notre-dame,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jacob.andersen@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Jacob,Andersen,,,,,,http://abbvie.dk/kontakt.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
joao.n.belo@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Joao,Belo,,,,,,http://headquartersof.com/abbvie-headquarters,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sara.weitz@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Sara,Weitz,,,,,,http://cknby.com/who-we-are/our-stories/putting-our-people-first-abbvies-family-benefits.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kai.schoenig@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Kai,Schoenig,,,,,,http://excellence-oncology.com/partnerportal-abbvie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
catherine.daigle@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Catherine,Daigle,,,,,,http://deptobsgyn.umontreal.ca/calendrier/jc-de-chirurgie-gynecologique-minimalement-invasive,,,,,,,,,,,,,,,,,,,,,,,,,,,,
donna.r.davila@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Donna,Davila,,,,,,http://globe.setac.org/setac-sacramento-session-summaries,,,,,,,,,,,,,,,,,,,,,,,,,,,,
parul.singh@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Parul,Singh,,,,,,http://mann.usc.edu/program/fellowship-programs/current-fellows,,,,,,,,,,,,,,,,,,,,,,,,,,,,
valerio.carriero@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Valerio,Carriero,,,,,,http://pres.eu/pres2021/supporters.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
snardulli@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Sally,Nardulli,Management,Project Manager,com,"","",http://mygcsg.com/gcsg-2021-us-virtual-conference/speakers,,,,,,,,,,,,,,,,,,,,,,,,,,,,
andrew.long@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Andrew,Long,,,,,,http://bmcrheumatol.biomedcentral.com/articles/10.1186/s41927-018-0031-x,,,,,,,,,,,,,,,,,,,,,,,,,,,,
edward.ronan@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Edward,Ronan,,,,,,http://hgfound.org/abbvie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
daniel.bow@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Daniel,Bow,,,,,,http://dmd.aspetjournals.org/content/early/2021/07/30/dmd.121.000487,,,,,,,,,,,,,,,,,,,,,,,,,,,,
aris.vasilopoulos@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Aris,Vasilopoulos,,,,,,http://news.wisc.edu/new-chemistry-makes-magic-drug-improvements-easier,,,,,,,,,,,,,,,,,,,,,,,,,,,,
alexander.krueger@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Alexander,Kr√ºger,,,,,,http://immittelstand.de/2019/12/22/abbvie-entwicklungsingenieur-wmd-medizin-und-kombinationsprodukte-2019-12-21,,,,,,,,,,,,,,,,,,,,,,,,,,,,
melanie.labelle@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Melanie,Labelle,,,,,,http://clinicaltrials.gov/show/nct02506179,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ajay.shah@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Ajay,Shah,,,,,,http://mygcsg.com/profile/96,,,,,,,,,,,,,,,,,,,,,,,,,,,,
stacie.lambert@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Stacie,Lambert,,,,,,http://jitc.biomedcentral.com/articles/10.1186/s40425-018-0422-y,,,,,,,,,,,,,,,,,,,,,,,,,,,,
matthew.j.goebel@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,1,{first}.{last},Matthew,G√∂bel,,,,,,http://news.abbvie.com/news/abbvie-news-briefs/environmental-sustainability-at-abbvie.htm,,,,,,,,,,,,,,,,,,,,,,,,,,,,
wang.ying@abbvie.com,abbvie.com,AbbVie,US,,,,,89,personal,2,{first}.{last},Wang,Ying,,,,,,http://pubs.rsc.org/en/content/articlelanding/2017/re/c7re00058h/unauth,http://pubs.rsc.org/en/content/articlelanding/2017/re/c7re00058h,,,,,,,,,,,,,,,,,,,,,,,,,,,
philipp.huwe@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Philipp,Huwe,,,,,,http://news.abbvie.com/pr-contacts,,,,,,,,,,,,,,,,,,,,,,,,,,,,
aaron.featherston@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Aaron,Featherston,,,,,,http://chem.yale.edu/event/abbvie-recruiting-yale-virtual-event-monday-june-26-9-am,,,,,,,,,,,,,,,,,,,,,,,,,,,,
dave.dolgin@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Dave,Dolgin,,,,,,http://ispeboston.org/download/educational_presentations/2013/2013-03-21-c-q-ddolgin.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
shuai.hao@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Shuai,Hao,,,,,,http://nejsds.nestat.org/journal/nejsds/to-appear,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jens.herrfurth@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Jens,Herrfurth,,,,,,http://gastroclub.org/industrie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jennifer.schaar@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Jennifer,Schaar,,,,,,http://careeducation.ca/abbvie-at-whu-2023-virtual-booth,,,,,,,,,,,,,,,,,,,,,,,,,,,,
mitchell.brin@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Mitchell,Brin,,,,,,http://n.neurology.org/content/neurology/101/2/e103.full.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
antonio.dellacroce@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Antonio,Dellacroce,,,,,,http://formifarma.pt/antonio-della-croce-xii,,,,,,,,,,,,,,,,,,,,,,,,,,,,
stefanie.hauck@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Stefanie,Hauck,,,,,,http://pharmaforum-sw.de/sites/default/files/2019-10/pf2017_01_hauck.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
michelle.calhoun@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Michelle,Calhoun,,,,,,http://lifescienceleadermag.epubxp.com/i/469672-cmo-2015/57,,,,,,,,,,,,,,,,,,,,,,,,,,,,
martin.heinrich@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Martin,Heinrich,,,,,,http://mscjena.de/pdf/termine/2019-03-07_termine_adac.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sam.pearson@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Sam,Pearson,,,,,,http://ipasshortcut.com/article/new-treatment-for-debilitating-rheumatic-diseases-listed-on-the-pbs,,,,,,,,,,,,,,,,,,,,,,,,,,,,
georgios.papageorgiou@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Georgios,Papageorgiou,,,,,,http://abbvie.gr/content/dam/abbvie-dotcom/gr/documents/deltio_typoy_abbvie_kampania_skipad_atopiki_dermatitida_29032023_3.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
rafael.dasilva@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Rafael,Dasilva,,,,,,http://alergiausp.com.br/landing-abbvie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gregory.webster@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Gregory,Webster,,,,,,http://dissolutiontech.com/issues/202005/dt202005_a02.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jeff.sava@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Jeff,Sava,,,,,,http://infectiousdiseases.wustl.edu/events/event/id-society-of-st-louis-in-person-reception-with-exhibitors-january-26-2022,,,,,,,,,,,,,,,,,,,,,,,,,,,,
timothy.richmond@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Timothy,Richmond,,,,,,http://hrpolicy.org/biographies/centeradvbd/anita-graham,,,,,,,,,,,,,,,,,,,,,,,,,,,,
robert.mclaughlin@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Robert,Mclaughlin,,,,,,http://biorxiv.org/content/10.1101/2021.12.07.471513v1,,,,,,,,,,,,,,,,,,,,,,,,,,,,
paul.e.kroeger@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Paul,Kr√∂ger,,,,,,http://morimotolab.org/postdoctoral-fellows,,,,,,,,,,,,,,,,,,,,,,,,,,,,
erika.kawazoe@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Erika,Kawazoe,,,,,,http://bph.org.br/empresas/ciencias-da-vida/abbvie-farmaceutica-ltda,,,,,,,,,,,,,,,,,,,,,,,,,,,,
diana.thornbury@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Diana,Thornbury,,,,,,http://visitupnorth.com/vrp/unit/sunset_beach_hideaway,,,,,,,,,,,,,,,,,,,,,,,,,,,,
charlotte.glenn@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Charlotte,Glenn,,,,,,http://improvecarenow.org/current_research,,,,,,,,,,,,,,,,,,,,,,,,,,,,
wesley.hughes@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Wesley,Hughes,,,,,,http://healthandmedical.co.za/view/abbvie-pty-ltd,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tao.wang@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Tao,Wang,,,,,,http://journal.pda.org/content/early/2022/02/15/pdajpst.2022.012744,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kirk.willis@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Kirk,Willis,,,,,,http://txpnpa.enpnetwork.com/nurse-practitioner-news/215695-pnpa-meeting-february-24-2022-needs-rsvp-by-2-21-22,,,,,,,,,,,,,,,,,,,,,,,,,,,,
wang.jing@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Wang,Jing,,,,,,http://careers.iscb.org/jobs/view/7479,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lana.brost@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Lana,Brost,,,,,,http://ce.mayo.edu/node/119351,,,,,,,,,,,,,,,,,,,,,,,,,,,,
katharine.nichols@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Katharine,Nichols,,,,,,http://cknby.com/who-we-are/our-stories/listen-with-curiosity-lead-with-compassion.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
eduardo.nogueira@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Eduardo,Nogueira,,,,,,http://peeplookup.com/email-search,,,,,,,,,,,,,,,,,,,,,,,,,,,,
rossella.lambiase@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Rossella,Lambiase,,,,,,http://bandi.miur.it/bandi.php/public/fellowship/id_fellow/64875,,,,,,,,,,,,,,,,,,,,,,,,,,,,
mceccarelli@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Michele,Ceccarelli,,"","","","",http://biorxiv.org/content/10.1101/546069v2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
andrew.kaplan@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Andrew,Kaplan,,,,,,http://bitcoincpmadnetworkwofukama.blogspot.com/2017/01/nfl-network-colleen-wolfe.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
debbie.cardoni@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Debbie,Cardoni,,,,,,http://clinicaltrials.gov/ct2/show/nct02611713,,,,,,,,,,,,,,,,,,,,,,,,,,,,
paul.l.richardson@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Paul,Richardson,,,,,,http://pubs.rsc.org/en/content/articlelanding/2019/md/c8md00412a/unauth,,,,,,,,,,,,,,,,,,,,,,,,,,,,
takahiro.irie@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Takahiro,Irie,,,,,,http://ehimes.johas.go.jp/wp/news/7385,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sabrina.javaux@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Sabrina,Javaux,,,,,,http://infostatsante.org/emploi/data-steward-charge-de-donnees-data-manager-hf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
stephen.fortino@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},Stephen,Fortino,,,,,,http://chartwellcherokeeprojectgraduation.com/committee-members.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
james.metz@abbvie.com,abbvie.com,AbbVie,US,,,,,88,personal,1,{first}.{last},James,Metz,,,,,,http://sujitpal.blogspot.com/2013/07/bayesian-network-inference-with-r-and.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jonathan.keller@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Jonathan,Keller,,,,,,http://ncsaua.org/docs/meetings/ncs2010v/ncs-2020-exhibit-guide.aspx,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ulrike.weiss@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Ulrike,Wei√ü,,,,,,http://langenachtderunternehmen.at/system/bnprofile/crm/profile/80.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
marc.valentin@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Marc,Valentin,,,,,,http://eithealth.eu/news-article/get-help-now-improving-health-in-the-workplace,,,,,,,,,,,,,,,,,,,,,,,,,,,,
franziska.theobald@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Franziska,Theobald,,,,,,http://vfa.de/download/forschung-fuer-das-leben-2013.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
norbert.steinbach@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Norbert,Steinbach,,,,,,http://pharmaforum-sw.de/sites/default/files/2019-10/pharmaforum13_cv_steinbach.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sarah.mudd@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Sarah,Mudd,,,,,,http://projects.itn.pt/fmendes_2022/mudd_drugdisc_2017.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
samar.lima@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Samar,Lima,,,,,,http://alergiausp.com.br/landing-abbvie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
birgit.reuss@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Birgit,Reu√ü,,,,,,http://nhtc.de/wp-content/uploads/2023/07/foerderverein_beitrittserklaerung_2015-05-19.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ahmed.salem@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Ahmed,Salem,,,,,,http://jcancer.org/v14p1151.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sara.orndoff@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Sara,Orndoff,,,,,,http://psoh.org/corporate-members.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
francisco.nava@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,0,{first}.{last},Francisco,Nava,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
flavio.normando@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Normando,Flavio,,,,,,http://sifoweb.it/images/congressi-nazionali/2018/programma_definitivi_sifo_2018_2511.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sam.ranganathan@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Sam,Ranganathan,,,,,,http://lcldnet.org/about/corporation-membership/laura-schumacher,,,,,,,,,,,,,,,,,,,,,,,,,,,,
rajeev.gokhale@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Rajeev,Gokhale,,,,,,http://unboundmedicine.com/medline/citation/24406670/effect_of_binders_on_the_release_rates_of_direct_molded_verapamil_tablets_using_twin_screw_extruder_in_melt_granulation_,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nicole.muraca@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Nicole,Muraca,,,,,,http://mygcsg.com/gcsg-2023-us-conference/speakers,,,,,,,,,,,,,,,,,,,,,,,,,,,,
manish.kelkar@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Manish,Kelkar,,,,,,http://mastcenter.org/about/leadership,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kimberly.hollis@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Kimberly,Hollis,,,,,,http://wgami.com/members,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tim.schuetter@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Tim,Schuetter,,,,,,http://pharmasalmanac.com/articles/unique-manufacturing-challenges-associated-with-sterile-eye-ointments,,,,,,,,,,,,,,,,,,,,,,,,,,,,
keith.f.mcdaniel@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Keith,Mcdaniel,,,,,,http://atpase-receptor.com/index.php/mivebresib,,,,,,,,,,,,,,,,,,,,,,,,,,,,
victor.sun@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Victor,Sun,,,,,,http://advancesinrheumatology.biomedcentral.com/articles/10.1186/s42358-022-00247-2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
richard.giovenco@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Richard,Giovenco,,,,,,http://addictolyon.fr/post/soir%c3%a9e-abbvie-vhc-vih-et-chemsex-le-04-10-2022-%c3%a0-clermont-ferrand,,,,,,,,,,,,,,,,,,,,,,,,,,,,
isabelle.blanchet@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Isabelle,Blanchet,,,,,,http://vofis.info/mitglieder,,,,,,,,,,,,,,,,,,,,,,,,,,,,
philip.mcquain@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Philip,Mcquain,,,,,,http://vsronline.org/2022-exhibit-directory,,,,,,,,,,,,,,,,,,,,,,,,,,,,
james.henson@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},James,Henson,,,,,,http://mygcsg.com/the-2019-global-clinical-supplies-group-us-conference/speakers,,,,,,,,,,,,,,,,,,,,,,,,,,,,
herve.geneste@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Herve,Geneste,,,,,,http://beilstein-journals.org/bjoc/articles/18/20,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tim.hein@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Tim,Hein,,,,,,http://ce.bswhealth.com/content/abbvie-2021-julian-wells-exhibit-gold-level,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ping.huang@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Ping,Huang,,,,,,http://bioprocessintl.com/2019/an-integrated-bioprocess-for-antibodies-from-harvest-to-purified-bulk-in-six-hours,,,,,,,,,,,,,,,,,,,,,,,,,,,,
zsolt.hepp@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Zsolt,Hepp,,,,,,http://journals.lww.com/joem/fulltext/2018/08000/absenteeism_and_indirect_economic_burden.8.aspx,,,,,,,,,,,,,,,,,,,,,,,,,,,,
thomas.moeller@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,2,{first}.{last},Thomas,M√∂ller,,,,,,http://frontiersin.org/articles/10.3389/fphar.2019.00840/full,http://frontiersin.org/articles/10.3389/fphar.2019.00840/abstract,,,,,,,,,,,,,,,,,,,,,,,,,,,
caroline.rivard@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Caroline,Rivard,,,,,,http://thapos.com/sports/profile/skis,,,,,,,,,,,,,,,,,,,,,,,,,,,,
fiona.hancock@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Fiona,Hancock,,,,,,http://internationalbusinessnewsweek.blogspot.com/2013/01/hsbc-plymouth-international-business.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
laurinda.cooker@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Laurinda,Cooker,,,,,,http://eurekalert.org/pub_releases/2015-04/eaft-psf042415.php,,,,,,,,,,,,,,,,,,,,,,,,,,,,
mpatel@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,2,{first}.{last},Maulik,Patel,,"","","","",http://jitc.bmj.com/content/6/1/50,http://jitc.biomedcentral.com/articles/10.1186/s40425-018-0422-y,,,,,,,,,,,,,,,,,,,,,,,,,,,
elizabeth.m.haydock@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Elizabeth,Haydock,,,,,,http://smore.com/we3q6,,,,,,,,,,,,,,,,,,,,,,,,,,,,
william.mccraw@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},William,Mccraw,,,,,,http://434jobs4vets.blogspot.com/2013/05/various-job-leads.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tamer.hanna@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Tamer,Hanna,,,,,,http://agilemanifesto.org/display/000000334.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
eileen.cook@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Eileen,Cook,,,,,,http://hbanet.org/news/2017/03/1/congratulations-hba-chicago-march-volunteer,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tiffany.cincotta@abbvie.com,abbvie.com,AbbVie,US,,,,,87,personal,1,{first}.{last},Tiffany,Cincotta,,,,,,http://beu15.biopartner.co.uk/page/activities,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jennifer.guillot@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Jennifer,Guillot,,,,,,http://mondedesgrandesecoles.fr/abbvie-france-un-parcours-de-sante-sous-le-signe-de-linnovation,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kathleen.mcguire@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Kathleen,Mcguire,,,,,,http://malariajournal.biomedcentral.com/articles/10.1186/s12936-017-1896-7,,,,,,,,,,,,,,,,,,,,,,,,,,,,
carola.vogt@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Carola,Vogt,,,,,,http://gastroclub.org/industrie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
joleen.tay@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Joleen,Tay,,,,,,http://haematology.org.my/2021/06,,,,,,,,,,,,,,,,,,,,,,,,,,,,
leonie.hammer@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Leonie,Hammer,,,,,,http://kompetenznetz-darmerkrankungen.de/europe-studie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
georg.terstappen@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Georg,Terstappen,,,,,,http://pharmaforum-sw.de/sites/default/files/2019-10/vortrag_georg_c__terstappen_pharmaforum_ipscs_in_drug_discovery_for_pharmaforum_0.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
annette.bussmann@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Annette,Bussmann,,,,,,http://pharmaforum-sw.de/sites/default/files/2019-10/pf2019_tagungsband_web_0.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lavoie.nathalie@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,3,{first}.{last},Nathalie,Lavoie,,,,,,http://armrs.com/compagnies,http://armrs.com/nos-membres,http://armrs.com/recherche-avancee,,,,,,,,,,,,,,,,,,,,,,,,,,
alan.hartford@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Alan,Hartford,,,,,,http://bayesian.org/wp-content/uploads/2018/01/1712.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
erik.matheson@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Erik,Matheson,,,,,,http://physicians.northernhealth.ca/cme/event-calendar/migraine-learning-compendium,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nicole.nussle@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Nicole,Nussle,,,,,,http://fvpra.com/members,,,,,,,,,,,,,,,,,,,,,,,,,,,,
david.powers@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},David,Powers,,,,,,http://pharm.ucsf.edu/wells/people/alumni,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kevin.strack@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Kevin,Strack,,,,,,http://sticks-and-stones.com/sxs-bln/ausstellerinnen-2023/abbvie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
axel.meyer@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Axel,Meyer,,,,,,http://pubs.rsc.org/en/content/articlehtml/2021/na/d0na00879f,,,,,,,,,,,,,,,,,,,,,,,,,,,,
brian.martin@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Brian,Martin,,,,,,http://data-science-nights.org/uploads/8/4/8/7/84875762/data_science_nights.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
courtney.tomeo@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Courtney,Tomeo,,,,,,http://psoh.org/corporate-members.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
melanie.lang@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Melanie,Lang,,,,,,http://efpia.eu/media/288506/efpia-health-collaboration-guide_2017_v13.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
marie-claude.laliberte@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Marie,Laliberte,,,,,,http://jptcp.com/index.php/jptcp/article/download/641/553/1828,,,,,,,,,,,,,,,,,,,,,,,,,,,,
david.olivos@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},David,Olivos,,,,,,http://d101tm.org/clubs-by-city,,,,,,,,,,,,,,,,,,,,,,,,,,,,
xiu.huang@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,2,{first}.{last},Xiu,Huang,,,,,,http://dirk.eddelbuettel.com/cranberries/cran/new,http://dirk.eddelbuettel.com/cranberries/cran/new/index.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
anneke.denhollander@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Anneke,Denhollander,,,,,,http://mechentel.de/2023/01/20/systemgenomik-bei-altersbedingter-makuladegeneration,,,,,,,,,,,,,,,,,,,,,,,,,,,,
james.barnes@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},James,Barnes,,,,,,http://jitc.bmj.com/content/6/1/50,,,,,,,,,,,,,,,,,,,,,,,,,,,,
david.masica@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},David,Masica,,,,,,http://biorxiv.org/content/10.1101/2021.12.07.471513v1,,,,,,,,,,,,,,,,,,,,,,,,,,,,
amy.soli@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Amy,Soli,,,,,,http://midwestsetac.org/chapter-governance.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
amber.rispoli@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Amber,Rispoli,,,,,,http://vaderm.org/2022-exhibit-directory,,,,,,,,,,,,,,,,,,,,,,,,,,,,
teresa.carter@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Teresa,Carter,,,,,,http://vaderm.org/2022-exhibit-directory,,,,,,,,,,,,,,,,,,,,,,,,,,,,
samir.tari@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Samir,Tari,,,,,,http://foiseye.org/membership-directory,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sigrid.kern@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Sigrid,Kern,,,,,,http://oemccv.at/single-post/ist-telemedizin-gekommen-um-zu-bleiben,,,,,,,,,,,,,,,,,,,,,,,,,,,,
maria.torres@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Maria,Torres,,,,,,http://ce.bswhealth.com/content/abbvie-2021-julian-wells-exhibit-gold-level,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jeffrey.waite@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Jeffrey,Waite,,,,,,http://ontariorheum.ca/sponsors/abbvie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
isobel.lakatos@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Isobel,Lakatos,,,,,,http://clinicaltrials.gov/ct2/show/results/nct01901653,,,,,,,,,,,,,,,,,,,,,,,,,,,,
aaron.crawford@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Aaron,Crawford,,,,,,http://ipinfo.io/as7018/208.71.4.0/22,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jeffrey.pan@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Jeffrey,Pan,,,,,,http://asmedigitalcollection.asme.org/biomechanical/article-abstract/139/12/121011/442557/design-and-fabrication-of-a-three-dimensional,,,,,,,,,,,,,,,,,,,,,,,,,,,,
liz.shae@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Liz,Shae,,,,,,http://news.abbvie.com/news/press-releases/abbvie-presents-results-from-several-studies-and-clinical-trials-investigating-medicines-across-more-than-15-cancers-at-2019-asco-and-eha-meetings.htm,,,,,,,,,,,,,,,,,,,,,,,,,,,,
phil.cox@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Phil,Cox,,,,,,http://chem.wsu.edu/faculty/phil-cox,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ramon.espaillat@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Ramon,Espaillat,,,,,,http://healthunlocked.com/thyroiduk/posts/135745879/gluten-and-aluminum-content-in-synthroid%c2%ae-levothyroxine-sodium-tablets,,,,,,,,,,,,,,,,,,,,,,,,,,,,
joseph.oros@abbvie.com,abbvie.com,AbbVie,US,,,,,86,personal,1,{first}.{last},Joseph,Oros,,,,,,http://bryanthus66.rssing.com/chan-58765125/all_p42.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
yoosook.kim@abbvie.com,abbvie.com,AbbVie,US,,,,,85,generic,7,{first}.{last},,,,,,,,http://jakartanews.net/news/273903393/abbvie-employees-volunteer-to-make-an-impact-on-over-1300-lives-in-asia-with-8th-annual-week-of-possibilities-to-support-local-communities,http://singaporestar.com/news/273903393/abbvie-employees-volunteer-to-make-an-impact-on-over-1300-lives-in-asia-with-8th-annual-week-of-possibilities-to-support-local-communities,http://philippinetimes.com/news/273903393/abbvie-employees-volunteer-to-make-an-impact-on-over-1300-lives-in-asia-with-8th-annual-week-of-possibilities-to-support-local-communities,http://thetokyonews.net/news/273903393/abbvie-employees-volunteer-to-make-an-impact-on-over-1300-lives-in-asia-with-8th-annual-week-of-possibilities-to-support-local-communities,http://vietnamnews.net/news/273903393/abbvie-employees-volunteer-to-make-an-impact-on-over-1300-lives-in-asia-with-8th-annual-week-of-possibilities-to-support-local-communities,http://malaysiasun.com/news/273903393/abbvie-employees-volunteer-to-make-an-impact-on-over-1300-lives-in-asia-with-8th-annual-week-of-possibilities-to-support-local-communities,http://vietnamtribune.com/news/273903393/abbvie-employees-volunteer-to-make-an-impact-on-over-1300-lives-in-asia-with-8th-annual-week-of-possibilities-to-support-local-communities,,,,,,,,,,,,,,,,,,,,,,
tecnovigilancia@abbvie.com,abbvie.com,AbbVie,US,,,,,85,personal,9,{first}.{last},,,,,,,,http://garantianatrelle.com/contact,http://garantianatrelle.com/about,http://juvederm.com.br/seguranca,http://allerganaesthetics.com.br/coolsculpting,http://allerganaesthetics.com.br/juvederm,http://allerganaesthetics.com.br/profissionais-de-saude/contato,http://allerganaesthetics.com.br/sobre/contatos,http://allerganaesthetics.com.br/sobre/farmacovigilancia,http://juvederm.com.br,,,,,,,,,,,,,,,,,,,,
ams@abbvie.com,abbvie.com,AbbVie,US,,,,,85,personal,4,{first}.{last},,,,,,,,http://allerganaesthetics.de/impressum,http://allerganaesthetics.de/ueber-uns/kontakt,http://coolsculpting.de/impressum,http://juvederm.de/impressum,,,,,,,,,,,,,,,,,,,,,,,,,
corpjat_abv@abbvie.com,abbvie.com,AbbVie,US,,,,,85,personal,8,{first}.{last},,,,,,,,http://bioinformaticscro.com/bioinformatics-jobs/page/22,http://careers.abbvie.com/de/stellenbeschreibung/berlin/werkstudent-all-genders-government-affairs-public-health-and-policy-berlin-12-monate-20-stunden-woc/40729/29330794672,http://careers.abbvie.com/de/stellenbeschreibung/ludwigshafen-am-rhein/initiativbewerbung-maintenance-elektriker-all-genders/40729/29330778240,http://careers.abbvie.com/nl/banen/hoofddorp/business-data-analyst/43289/50367115712,http://careers.abbvie.com/nl/banen/zwolle/short-term-supply-chain-planner/43289/50326514544,http://careers.abbvie.com/zh-hans/%e5%b7%a5%e4%bd%9c/-/practice-development-manager-allergan-aesthetics/43288/50345093616,http://sg.jobkowi.com/view/460074/scientist-purification,http://govtjobs2u.com/abbvie-has-job-vacancy-for-product-specialist-in-riyadh-saudi-arabia,,,,,,,,,,,,,,,,,,,,,
internetnameregistrar@abbvie.com,abbvie.com,AbbVie,US,,,,,85,generic,7,{first}.{last},,,,,,,,http://websiteurl.org/domain/botox.com/lsfk63a637af411f2,http://websiteurl.org/domain/botoxspasticity.com/nt1t63a6380cb2b11,http://yapl.ru/su/allergan.su,http://yapl.ru/su/botox.su,http://mysitevalue.eu/ra.com,http://robbiesblog.com/domain-names-owned-by-abbvie/7659,http://vaniqa.com.websiteoutlook.com,,,,,,,,,,,,,,,,,,,,,,
elena.dianova@abbvie.com,abbvie.com,AbbVie,US,,,,,85,personal,9,{first}.{last},,,,,,,,http://bloodjournal.ru/wp-content/uploads/2020/03/13.pdf,http://aptekakursk.ru/novosti/766-10-let-do-tseli-udastsya-li-pobedit-gepatit-s-v-rossii,http://aptekakursk.ru/novosti/766-10-let-do-tseli-udastsya-li-pobedit-gepatit-s-v-rossii.html,http://bloodjournal.ru/en/abbvie-company-press-release,http://bloodjournal.ru/press-reliz-kompanii-abbvie,http://ria-ami.ru/2018/12/novye-dannye-po-primeneniyu-preparata-venkleksta-v-kombinacii-s-rituksimabom,http://umedp.ru/news/ministerstvo_zdravookhraneniya_rf_odobrilo_terapiyu_preparatom_venkleksta.html,http://umedp.ru/news/v_rossii_zaregistrirovan_preparat_maviret_glekaprevir_pibrentasvir_dlya_lecheniya_khronicheskogo_gep.html,http://umedp.ru/press_releases/in_russia_now_there_is_a_new_opportunity_of_therapy_of_plaque_psoriasis_in_children_4_years.html,,,,,,,,,,,,,,,,,,,,
qaisrael@abbvie.com,abbvie.com,AbbVie,US,,,,,85,personal,5,{first}.{last},,,,,,,,http://ynet.co.il/laisha/article/sjcsc38un,http://ynet.co.il/laisha/article/sk6hrfhkh,http://juvederm.co.il,http://juvederm.co.il/%d7%9e%d7%93%d7%99%d7%a0%d7%99%d7%95%d7%aa-%d7%a4%d7%a8%d7%98%d7%99%d7%95%d7%aa-%d7%90%d7%aa%d7%a8-%d7%90%d7%9c%d7%a8%d7%92%d7%9f,http://juvederm.co.il/%d7%aa%d7%a0%d7%90%d7%99-%d7%a9%d7%99%d7%9e%d7%95%d7%a9-%d7%90%d7%aa%d7%a8-%d7%90%d7%9c%d7%a8%d7%92%d7%9f,,,,,,,,,,,,,,,,,,,,,,,,
ilke.limoncu@abbvie.com,abbvie.com,AbbVie,US,,,,,85,personal,10,{first}.{last},,,,,,,,http://cknby.com/who-we-are/our-stories/day-in-life-meet-director-clearing-path-for-patient-access.html,http://cknby.com/who-we-are/our-stories/ready-set-launch-abbvie-opens-new-facility-in-the-bay-area.html,http://cknby.com/who-we-are/our-stories/then-and-now-renaissance-in-blood-cancer-treatment.html,http://news.abbvie.com/news/press-releases/abbvie-highlights-blood-cancer-data-from-its-growing-oncology-pipeline-at-64th-ash-annual-meeting.htm,http://biotech-365.com/author/biotech365/page/3,http://biotech-365.com/category/business-wire/page/2,http://news.abbvie.com/news/press-releases/abbvie-announces-us-fda-granted-breakthrough-therapy-designation-btd-to-telisotuzumab-vedotin-teliso-v-for-previously-treated-non-small-cell-lung-cancer.htm,http://news.abbvie.com/news/press-releases/abbvie-to-showcase-breadth-oncology-portfolio-and-pipeline-at-2021-asco-and-eha-annual-congresses.htm,http://news.abbvie.com/news/press-releases/abbvie-discontinues-rovalpituzumab-tesirine-rova-t-research-and-development-program.htm,http://news.abbvie.com/news/press-releases/abbvie-completes-new-licensing-agreement-to-address-growing-demand-for-hiv-treatments-in-africa.htm,,,,,,,,,,,,,,,,,,,
talentacquisition.de@abbvie.com,abbvie.com,AbbVie,US,,,,,85,generic,10,{first}.{last},,,,,,,,http://m.quoka.de/stellenmarkt/reinigung/sc_33.html,http://m.quoka.de/stellenangebote/stellenangebote/c3001a236544572/examinierte-pflegekraft-unbefristet.html,http://m.quoka.de/stellenmarkt/vollzeit/sc_33.html,http://sticks-and-stones.com/sxs-berlin/aussteller-berlin-22/abbvie,http://sticks-and-stones.com/sxs-bln/ausstellerinnen-2023/abbvie,http://careers.abbvie.com/en/job/regensburg/au-endienstmitarbeiter-all-genders-hcv-im-gebiet-aschaffenburg-wurzburg-kulmbach/14/44611915168,http://m.quoka.de/kleinanzeigen/cat_0_cno_28308169.html,http://sticks-and-stones.com/abbvie,http://docplayer.org/1466525-die-jobmesse-zukunft-lege-den-grund-stein-fuer-deine-10-00-16-00-uhr-gebaeude-a-ernst-boehe-strasse-4.html,http://kununu.com/de/abbvie5,,,,,,,,,,,,,,,,,,,
recepcja.poland@abbvie.com,abbvie.com,AbbVie,US,,,,,85,generic,8,{first}.{last},,,,,,,,http://farmacja-polska.org.pl/czlonkowie/abbvie-sp-z-o-o,http://hematoonkologia.pl/murano,http://hematoonkologia.pl/murano/index/strona/2,http://hematoonkologia.pl/murano/index/strona/3,http://hematoonkologia.pl/murano/index/strona/4,http://hematoonkologia.pl/murano/index/strona/5,http://bazalekow.leksykon.com.pl/leki-produkowane-przez-firm%c4%99-abbvie-polska-25359068.html,http://leksykon.com.pl/leki-produkowane-przez-firm%c4%99-abbvie-polska-25359068.html,,,,,,,,,,,,,,,,,,,,,
gentry.lassiter@abbvie.com,abbvie.com,AbbVie,US,,,,,85,personal,10,{first}.{last},,,,,,,,http://droiaventures.com/2020/12/02/frontier-medicines-and-abbvie-establish-global-partnership-to-discover-and-develop-novel-therapies-and-e3-degraders-against-difficult-to-drug-targets,http://frontiermeds.com/newsroom/press-releases/chemical-engineering-news-names-frontier-medicines-one-its-10-chemistry,http://news.abbvie.com/news/press-releases/abbvie-data-at-eha-annual-congress-highlight-depth-and-breadth-transformative-blood-cancer-portfolio.htm,http://news.abbvie.com/news/press-releases/abbvie-and-frontier-medicines-establish-global-partnership-to-discover-and-develop-novel-therapies-and-e3-degraders-against-difficult-to-drug-targets.htm,http://news.abbvie.com/news/press-releases/abbvie-and-allergan-aesthetics-to-present-new-research-across-dermatology-portfolio-at-2022-aad-annual-meeting.htm,http://frontiermeds.com/press_release/chemical-engineering-news-names-frontier-medicines-one-of-its-10-chemistry-start-ups-to-watch,http://frontiermeds.com/news-media/press-releases/chemical-engineering-news-names-frontier-medicines-one-its-10-chemistry,http://news.abbvie.com/news/press-releases/abbvie-announces-us-fda-granted-breakthrough-therapy-designation-btd-to-telisotuzumab-vedotin-teliso-v-for-previously-treated-non-small-cell-lung-cancer.htm,http://news.abbvie.com/pr-contacts,http://businesswire.com/news/home/20150429005230/en/fda-accepts-biologics-license-application-zinbryta-daclizumab,,,,,,,,,,,,,,,,,,,
innovationcenter@abbvie.com,abbvie.com,AbbVie,US,,,,,85,generic,10,{first}.{last},,,,,,,,http://researchpark.illinois.edu/directory/ui-china-executive-leadership-programs,http://researchpark.illinois.edu/directory/grainger-inc,http://researchpark.illinois.edu/directory/simnext,http://researchpark.illinois.edu/directory/aptimmune-biologics-inc,http://researchpark.illinois.edu/tenant-directory,http://research847.rssing.com/chan-14897209/all_p155.html,http://research847.rssing.com/chan-14897209/all_p154.html,http://research847.rssing.com/chan-14897209/all_p27.html,http://research847.rssing.com/chan-14897209/all_p43.html,http://research847.rssing.com/chan-14897209/latest.php,,,,,,,,,,,,,,,,,,,
larry.peepo@abbvie.com,abbvie.com,AbbVie,US,,,,,85,personal,10,{first}.{last},,,,,,,,http://biospace.com/news/abbott-vasculars-abbvie-officially-launches-with/283344,http://biospace.com/article/releases/abbott-vascular-s-b-abbvie-b-officially-launches-with-creation-of-175-jobs-patients-,http://news.abbvie.com/news/abbvie-celebrates-launch-as-new-biopharmaceutical-company-with-employees-patients.htm,http://news.abbvie.com/news/abbvie-to-acquire-pharmacyclics-including-its-blockbuster-product-imbruvica-creating-an-industry-leading-hematological-oncology-franchise.htm,http://ipharmatrials.com/abbvie-oncology,http://newswire.ca/news-releases/abbvie-celebrates-launch-as-new-biopharmaceutical-company-with-employees-patients-511779981.html,http://news.abbvie.com/news/abbvie-to-expand-oncology-presence-through-acquisition-stemcentrx-and-its-novel-late-stage-rova-t-compound-for-small-cell-lung-cancer.htm,http://biospace.com/news/abbott-vasculars-abbvie-officially-launches-with/283344/source=yesterdaysmostpopular,http://biospace.com/news/abbott-laboratoriess-abbvie-officially-launches/283344/source=topbreaking,http://biospace.com/news/abbott-laboratoriess-abbvie-officially-launches/283344/source=yesterdaysmostpopular,,,,,,,,,,,,,,,,,,,
aurelie.andrieux-bonneau@abbvie.com,abbvie.com,AbbVie,US,,,,,84,personal,2,{first}.{last},Aurelie,Bonneau,,,,,,http://trt-5.org/wp-content/uploads/2022/05/2018-03-08-cp-maviret-final.pdf,http://trt-5.org/wp-content/uploads/2022/05/2019-03-29-cp-maviret.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
brown-andrew.brown@abbvie.com,abbvie.com,AbbVie,US,,,,,84,personal,2,{first}.{last},Brown,Brown,,,,,,http://lauderdalelakedistrict.com/documents/draft-august-2022-district-dialogue-221027115518.pdf,http://lauderdalelakedistrict.com/news,,,,,,,,,,,,,,,,,,,,,,,,,,,
ana-paula.barboza@abbvie.com,abbvie.com,AbbVie,US,,,,,84,personal,1,{first}.{last},Ana,Barboza,,,,,,http://news.abbvie.com/pr-contacts,,,,,,,,,,,,,,,,,,,,,,,,,,,,
judy.li@abbvie.com,abbvie.com,AbbVie,US,,,,,84,personal,1,{first}.{last},Judy,Li,,,,,,http://cholangiocarcinoma.org/db/topic/clinical-trial-abbv-399,,,,,,,,,,,,,,,,,,,,,,,,,,,,
haney.choi@abbvie.com,abbvie.com,AbbVie,US,,,,,84,personal,1,{first}.{last},Choi,Haney,,,,,,http://clinicaltrials.gov/ct2/show/nct03740230,,,,,,,,,,,,,,,,,,,,,,,,,,,,
joanna.ho@abbvie.com,abbvie.com,AbbVie,US,,,,,83,personal,1,{first}.{last},Joanna,Ho,,,,,,http://mann.usc.edu/program/fellowship-programs/current-fellows,,,,,,,,,,,,,,,,,,,,,,,,,,,,
joy.jackson-guilford@abbvie.com,abbvie.com,AbbVie,US,,,,,83,personal,2,{first}.{last},Joy,Guilford,,,,,,http://theleadershipalliance.org/index.php/where-we-do-it,http://theleadershipalliance.org/where-we-do-it,,,,,,,,,,,,,,,,,,,,,,,,,,,
suzanne.el-hadi@abbvie.com,abbvie.com,AbbVie,US,,,,,83,personal,1,{first}.{last},Suzanne,Hadi,,,,,,http://onkonytt.no/kliniske-onkologiske-studier-i-norge,,,,,,,,,,,,,,,,,,,,,,,,,,,,
meng-da.hsieh@abbvie.com,abbvie.com,AbbVie,US,,,,,83,personal,2,{first}.{last},Meng,Hsieh,,,,,,http://aihaaccreditedlabs.org/lab-accreditation-programs/industrial-hygiene/ihlap-approved-pt-programs,http://aihaaccreditedlabs.org/proficiencytestingprograms/pages/ihlap-approved-pt-programs.aspx,,,,,,,,,,,,,,,,,,,,,,,,,,,
molly.james-lundak@abbvie.com,abbvie.com,AbbVie,US,,,,,83,personal,1,{first}.{last},Molly,Lundak,,,,,,http://prnewsonline.com/cutting-communications-data-wilderness-moving-data-insights,,,,,,,,,,,,,,,,,,,,,,,,,,,,
au-coolsculpting@abbvie.com,abbvie.com,AbbVie,US,,,,,82,personal,5,{first}.{last},,,,,,,,http://coolsculpting.com.au/-/media/files/coolsculpting-faq-brochure.ashx,http://coolsculpting.com.au/contact-us,http://coolsculpting.com.au/terms-and-conditions,http://allerganaesthetics.com.au/about/report-an-adverse-event,http://allergan.com.au/en-au/products/drug-safety,,,,,,,,,,,,,,,,,,,,,,,,
chriscruz@abbvie.com,abbvie.com,AbbVie,US,,,,,82,personal,1,{first}.{last},,,,,,,,http://hepfree.nyc/ny-hep-c-telemedicine-workgroup-meeting-notes-11-19-2020,,,,,,,,,,,,,,,,,,,,,,,,,,,,
medicalquestions@abbvie.com,abbvie.com,AbbVie,US,,,,,82,generic,7,{first}.{last},,,Support,,,,,http://juvederm.ca/en,http://juvederm.ca/fr/safety,http://ibspatient.org/community/topic/75920-abbvie-canada-has-reversed-the-decision-to-discontinue-viberzi,http://ibspatient.org/community/topic/77919-viberzi-in-canada,http://juvederm.ca,http://juvederm.ca/fr/find-a-clinic,http://juvederm.ca/fr,,,,,,,,,,,,,,,,,,,,,,
shannelle.fowler@abbvie.com,abbvie.com,AbbVie,US,,,,,82,personal,8,{first}.{last},,,,,,,,http://news.abbvie.com/news/press-releases/second-phase-3-induction-study-confirms-upadacitinib-rinvoq-improved-clinical-endoscopic-and-histologic-outcomes-in-ulcerative-colitis-patients.htm,http://cknby.com/who-we-are/our-stories/btk-protein-good-bad-and-ugly.html,http://cknby.com/who-we-are/our-stories/navigating-ulcerative-colitis-as-a-child.html,http://cknby.com/who-we-are/our-stories/the-power-love-in-ibd.html,http://news.abbvie.com/news/press-releases/new-england-journal-medicine-publishes-results-from-phase-3-induction-and-maintenance-programs-evaluating-upadacitinib-rinvoq-in-crohns-disease.htm,http://news.abbvie.com/news/press-releases/us-fda-approves-rinvoq-upadacitinib-as-once-daily-pill-for-moderately-to-severely-active-crohns-disease-in-adults.htm,http://news.abbvie.com/news/press-releases/abbvie-presents-data-from-extensive-portfolio-at-american-college-rheumatology-convergence-2022.htm,http://news.abbvie.com/pr-contacts,,,,,,,,,,,,,,,,,,,,,
birgitta.bjornek@abbvie.com,abbvie.com,AbbVie,US,,,,,82,personal,7,{first}.{last},,,,,,,,http://news.abbvie.se,http://tamro.se/nyheter/nytt-samarbete-mellan-tamro-och-lakemedelsforetag-ska-stimulera-egenmonitorering-i-cancervarden,http://neurologiisverige.se/manage-pd,http://forumspetspatient.ringla.nu/nyheter/spetspatienter-och-parkwell-pa-varldskongressen-i-kyoto-japan,http://mynewsdesk.com/se/abbvie,http://news.abbvie.se/contact_people,http://mynewsdesk.com/se/abbvie/pressreleases/vr-doktorn-staerker-patienter-i-moetet-med-vaarden-2834260,,,,,,,,,,,,,,,,,,,,,,
pricing@abbvie.com,abbvie.com,AbbVie,US,,,,,82,generic,5,{first}.{last},,,Writing & communication,,,,,http://bedfordshirelutonandmiltonkeynes.icb.nhs.uk/our-publications/archive/beds-ccg-board-papers/2019/21-nov-2019/gov-body-pack-in-public,http://bedfordshirelutonandmiltonkeynes.icb.nhs.uk/our-publications/archive/beds-ccg-board-papers/2020/bccg-gov-body-papers-jan-20,http://nice.org.uk/guidance/ta663,http://nice.org.uk/guidance/ta665,http://nice.org.uk/guidance/ta596,,,,,,,,,,,,,,,,,,,,,,,,
abbviecontractmfg@abbvie.com,abbvie.com,AbbVie,US,,,,,82,personal,5,{first}.{last},,,,,,,,http://rolfaulinger.com/www.rolfaulinger.com/about/who-we-are,http://conference.contractpharma.com/sponsors,http://headquartersof.com/abbvie-headquarters,http://drug-dev.com/company-profiles/abbvie-contract-manufacturing2,http://contactdetailswala.com/business/abbvie-contact-details,,,,,,,,,,,,,,,,,,,,,,,,
goldenticket@abbvie.com,abbvie.com,AbbVie,US,,,,,82,personal,6,{first}.{last},,,,,,,,http://mbcbiolabs.com/newsletters-2018/newsletter-march-2018,http://mbcbiolabs.com/abbvie-golden-ticket/abbvie-golden-ticket-2018,http://mbcbiolabs.com/abbvie-golden-ticket/abbvie-golden-ticket-2020,http://bayareaglobalhealth.org/events/2021/10/14/7abbvie,http://mbcbiolabs.com/newsletters-2021/newsletter-october-2021,http://mbcbiolabs.com/newsletters-2020/newsletter-february-2020,,,,,,,,,,,,,,,,,,,,,,,
prensa.es@abbvie.com,abbvie.com,AbbVie,US,,,,,82,generic,4,{first}.{last},,,Writing & communication,,,,,http://ejecutivos.es/index.php/quienesquien/abbvie,http://ejecutivos.es/quienesquien/abbvie,http://somospacientes.com/abbvie,http://estrategiasdeinversion.com/actualidad/noticias/empresas/adalimumab-el-primer-anticuerpo-monoclonal-completamente-n-190210,,,,,,,,,,,,,,,,,,,,,,,,,
abbviegrants@abbvie.com,abbvie.com,AbbVie,US,,,,,82,personal,6,{first}.{last},,,,,,,,http://cknby.com/science/independent-educational-grants.html,http://cknby.com/science/independent-educational-grants/how-to-apply.html,http://cknby.com/science/independent-educational-grants/request-types.html,http://cknby.com/science/independent-educational-grants/requestor-training-guide.html,http://cknby.com/societal-impact/for-the-well-being-of-our-patients/independent-healthcare-grants.html,http://worldbestopportunities.com/samsung-foundation-grants,,,,,,,,,,,,,,,,,,,,,,,
stefanie.prodouz@abbvie.com,abbvie.com,AbbVie,US,,,,,82,personal,8,{first}.{last},,,,,,,,http://hepatitiscresearchandnewsupdates.blogspot.com/2014,http://hepatitiscresearchandnewsupdates.blogspot.com/2014_11_11_archive.html,http://hepatitiscresearchandnewsupdates.blogspot.com/2015/04/us-fda-grants-priority-review-to-abbvie.html,http://hepatitiscresearchandnewsupdates.blogspot.com/2015_04_24_archive.html,http://hepatitiscresearchandnewsupdates.blogspot.com/2015,http://news.abbvie.com/news/abbvie-to-present-results-from-phase-2-pearl-i-study-in-genotype-4-chronic-hepatitis-c-patients-at-liver-meeting-2014.htm,http://news.abbvie.com/news/us-fda-grants-priority-review-to-abbvie-for-investigational-all-oral-interferon-free-therapy-for-treatment-genotype-4-chronic-hepatitis-c.htm,http://hepatitis193.rssing.com/chan-12783580/all_p84.html,,,,,,,,,,,,,,,,,,,,,
office.at@abbvie.com,abbvie.com,AbbVie,US,,,,,82,generic,6,{first}.{last},,,,,,,,http://rheumalis.org/ueber-uns/rheumalis-sponsoren/sponsoren/name/abbvie,http://rheumalis.org/ueber-uns/rheumalis-sponsoren/sponsoren,http://greatplacetowork.at/beste-arbeitgeber/workplace/69/abbvie+gmbh,http://acne-inversa.at/impressum,http://greatplacetowork.at/workplace/item/69/abbvie+gmbh,http://crohn-colitis-info.at/impressum,,,,,,,,,,,,,,,,,,,,,,,
ukmedinfo@abbvie.com,abbvie.com,AbbVie,US,,,,,82,generic,6,{first}.{last},,,Support,,,,,http://medicines.org.uk/emc/product/9080/smpc,http://medicines.org.uk/emc/product/221,http://medicines.org.uk/emc/product/1315,http://medicines.org.uk/emc/medicine/20786,http://medicines.org.uk/emc/company/3216,http://mims.co.uk/manufacturers/abbvie-ltd,,,,,,,,,,,,,,,,,,,,,,,
creynolds@abbvie.com,abbvie.com,AbbVie,US,,,,,81,personal,2,{first}.{last},,,,,,,,http://b.hpclcnet.org/officers-directors,http://hpclcnet.org/officers-directors,,,,,,,,,,,,,,,,,,,,,,,,,,,
jpark@abbvie.com,abbvie.com,AbbVie,US,,,,,81,personal,1,{first}.{last},,,,,,,,http://mann.usc.edu/program/fellowship-programs/current-fellows,,,,,,,,,,,,,,,,,,,,,,,,,,,,
clara.courtain@abbvie.com,abbvie.com,AbbVie,US,,,,,81,personal,8,{first}.{last},,,,,,,,http://schallware.de/en/rental/653,http://schallware.de/en/rental/597,http://schallware.de/rental/653,http://schallware.de/rental/597,http://vermietung.schallware.de/en/rental/653,http://vermietung.schallware.de/rental/653,http://vermietung.schallware.de/en/rental/597,http://vermietung.schallware.de/rental/597,,,,,,,,,,,,,,,,,,,,,
qa-affiliate-ger@abbvie.com,abbvie.com,AbbVie,US,,,,,81,personal,7,{first}.{last},,,,,,,,http://allerganaesthetics.de/produkte/harmonyca,http://allerganaesthetics.de/produkte/juvederm,http://allerganaesthetics.de/ueber-uns/kontakt,http://allerganaesthetics.de/harmonyca,http://allerganaesthetics.de/juvederm,http://coolsculpting.de/impressum,http://juvederm.de/impressum,,,,,,,,,,,,,,,,,,,,,,
medinfo.germany@abbvie.com,abbvie.com,AbbVie,US,,,,,81,generic,6,{first}.{last},,,,,,,,http://allerganaesthetics.de/impressum,http://allerganaesthetics.de/ueber-uns/kontakt,http://coolsculpting.de/impressum,http://allerganaesthetics.com/about/contact,http://juvederm.de/impressum,http://vfa.de/de/patienten/ansprechpartner-der-pharmaunternehmen,,,,,,,,,,,,,,,,,,,,,,,
namjin.chung@abbvie.com,abbvie.com,AbbVie,US,,,,,81,personal,7,{first}.{last},,,,,,,,http://eurekalert.org/pub_releases/2019-08/mali-man082019.php,http://regenhealthsolutions.info/2019/08/23/new-articles-in-the-crispr-journal,http://biorxiv.org/content/10.1101/588707v1.full,http://biorxiv.org/content/10.1101/588707v1.supplementary-material,http://biorxiv.org/content/10.1101/588707v1.article-info,http://biorxiv.org/content/10.1101/588707v1.article-metrics,http://biorxiv.org/content/10.1101/588707v1,,,,,,,,,,,,,,,,,,,,,,
france.infomed@abbvie.com,abbvie.com,AbbVie,US,,,,,81,generic,6,{first}.{last},,,,,,,,http://allerganaesthetics.fr/nos-produits/juvederm,http://allerganaesthetics.fr/nos-produits/keller-funnel-2,http://trt-5.org/wp-content/uploads/2022/05/infoviekiraxexviera23122015.pdf,http://allerganaesthetics.fr/professionnel-de-sante/nous-contacter,http://allerganaesthetics.fr/a-propos/contactez-nous,http://allerganaesthetics.fr/coolsculpting,,,,,,,,,,,,,,,,,,,,,,,
abbvie_jpn_info_clingov@abbvie.com,abbvie.com,AbbVie,US,,,,,81,generic,6,{first}.{last},,,,,,,,http://abbvie.co.jp/patients/clinical-trials-about/clinical-trials-results.html,http://abbvie.co.jp/research-development/clinical-trials-about/clinical-trials-results.html,http://phrma-jp.org/library/clinicaltrials-gov20211001,http://clinicaltrials.gov/ct2/show/study/nct02906488,http://clinicaltrials.gov/ct2/show/nct02906488,http://clinicaltrials.gov/ct2/show/nct02590263,,,,,,,,,,,,,,,,,,,,,,,
francesco.marincola@abbvie.com,abbvie.com,AbbVie,US,,,,,81,personal,6,{first}.{last},,,,,,,,http://jitc.bmj.com/content/6/1/63.info,http://jitc.bmj.com/content/6/1/63.responses,http://jitc.bmj.com/content/6/1/63.share,http://jitc.bmj.com/content/6/1/63,http://jitc.bmj.com/content/6/1/63.citation-tools,http://translational-medicine.biomedcentral.com/articles/10.1186/s12967-017-1274-9,,,,,,,,,,,,,,,,,,,,,,,
ta_italy@abbvie.com,abbvie.com,AbbVie,US,,,,,81,generic,5,{first}.{last},,,,,,,,http://placement.uniroma2.it/2016/03/21/abbvie-laureati-in-economia-ingegneria-gestionale,http://placement.uniroma2.it/tag/universita/page/5,http://placement.uniroma2.it/tag/finance/page/4,http://placement.uniroma2.it/tag/abbvie,http://jobadvisor.it/p/company-profile/abbvie,,,,,,,,,,,,,,,,,,,,,,,,
farmacovigilanciaspain@abbvie.com,abbvie.com,AbbVie,US,,,,,81,generic,5,{first}.{last},,,,,,,,http://abbviecare.es/que-es-abbvie-care,http://allerganaesthetics.es/normas-redes-sociales,http://allerganaesthetics.es/sobre/contacto,http://empresia.es/empresa/abbvie-spain,http://telefonogratuito.com/abbvie,,,,,,,,,,,,,,,,,,,,,,,,
bulkpharma@abbvie.com,abbvie.com,AbbVie,US,,,,,81,personal,5,{first}.{last},,,,,,,,http://headquartersof.com/abbvie-headquarters,http://headquartersof.com/abbvie-headquarters-info-email-format-and-hr-phone-number,http://contactdetailswala.com/business/abbvie-contact-details,http://thailandmedical.news/pages/thailand_international_drugs_pharmaceutical_companies,http://thailandmedical.news/pages/intermedical_drug_lising,,,,,,,,,,,,,,,,,,,,,,,,
presse.de@abbvie.com,abbvie.com,AbbVie,US,,,,,81,generic,7,{first}.{last},,,Writing & communication,,,,,http://news.abbvie.de/contact_people/tag/gesundheit-und-versorgung,http://news.abbvie.de/contact_people/tag/science-rocks,http://abbvie-germany.mynewsdesk.com/contact_people,http://news.abbvie.de/contact_people,http://idw-online.de/en/institution1975,http://idw-online.de/de/institution1975,http://presseportal.de/pm/112983/3073422,,,,,,,,,,,,,,,,,,,,,,
abbvie_device_tracking@abbvie.com,abbvie.com,AbbVie,US,,,,,80,generic,7,{first}.{last},,,,,,,,http://northtexascosmeticsurgery.com/wp-content/uploads/2021/12/natrelle-and-inspira-augmentation.pdf,http://dubuqueplasticsurgery.com/uploads/implant-information.pdf,http://rxabbvie.com/pdf/natrelle_silicone_aug.pdf,http://rxabbvie.com/pdf/natrelle_silicone_aug_mand.pdf,http://rxabbvie.com/pdf/natrelle_silicone_aug_spa.pdf,http://rxabbvie.com/pdf/natrelle_silicone_recon.pdf,http://rxabbvie.com/pdf/natrelle_silicone_recon_spa.pdf,,,,,,,,,,,,,,,,,,,,,,
nz-coolsculpting@abbvie.com,abbvie.com,AbbVie,US,,,,,80,personal,4,{first}.{last},,,,,,,,http://coolsculpting.com.au/-/media/files/coolsculpting-faq-brochure.ashx,http://coolsculpting.com.au/contact-us,http://allerganaesthetics.com.au/about/report-an-adverse-event,http://allergan.co.nz/en-nz/products/drug-safety,,,,,,,,,,,,,,,,,,,,,,,,,
kristin.pawliw@abbvie.com,abbvie.com,AbbVie,US,,,,,80,personal,5,{first}.{last},,,,,,,,http://nicolasmelini.com/article/rinvoq-upadacitinib-approved-by-u-s-fda-as-an-oral-treatment-for-adults-with-active-ankylosing-spondylitis,http://news.abbvie.com/news/press-releases/abbvie-showcases-its-leadership-in-rheumatology-research-with-new-data-across-multiple-inflammatory-joint-diseases-at-eular-2022-congress.htm,http://news.abbvie.com/news/press-releases/abbvie-presents-data-from-extensive-portfolio-at-american-college-rheumatology-convergence-2022.htm,http://news.abbvie.com/news/press-releases/chmp-recommends-approval-upadacitinib-rinvoq-for-treatment-adults-with-active-non-radiographic-axial-spondyloarthritis.htm,http://news.abbvie.com/news/press-releases/rinvoq-upadacitinib-approved-by-european-commission-as-an-oral-treatment-for-adults-with-active-non-radiographic-axial-spondyloarthritis.htm,,,,,,,,,,,,,,,,,,,,,,,,
meddevicecomplaintsapac@abbvie.com,abbvie.com,AbbVie,US,,,,,80,generic,5,{first}.{last},,,,,,,,http://allerganaesthetics.com.au/about/report-an-adverse-event,http://juvederm.com.ph,http://archiebronsonoutfit.net/patient-shares-her-experience-with-juvederm.html,http://allergan.co.nz/en-nz/products/drug-safety,http://allergan.com.au/en-au/products/drug-safety,,,,,,,,,,,,,,,,,,,,,,,,
hlich@abbvie.com,abbvie.com,AbbVie,US,,,,,80,personal,1,{first}.{last},,,,,,,,http://ecv.de/beitrag/technopharm/etablierung_eines_systematischen_scale-up-prinzips_im_life_cycle_management_von_extrusionsprozessen,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pisarna@abbvie.com,abbvie.com,AbbVie,US,,,,,80,personal,6,{first}.{last},,,,,,,,http://revma-info.si/aktualno,http://revma-info.si/pogosta-vprasanja,http://revma-info.si/revme,http://revma-info.si/pravno-obvestilo,http://revma-info.si,http://zemljevid.najdi.si/podjetje/6383726000/abbvie-biofarmacevtska-druzba-doo,,,,,,,,,,,,,,,,,,,,,,,
christian.schaertl@abbvie.com,abbvie.com,AbbVie,US,,,,,80,personal,9,{first}.{last},,,,,,,,http://news.abbvie.de/contact_people/tag/gesundheit-und-versorgung,http://news.abbvie.de/pressreleases/neues-magazin-fuer-betroffene-von-psoriasis-2825409.pdf,http://abbvie-germany.mynewsdesk.com/pressreleases/neues-magazin-fuer-betroffene-von-psoriasis-2825409.pdf,http://news.abbvie.de/contact_people/tag/science-rocks,http://abbvie-germany.mynewsdesk.com/contact_people,http://abbvie-germany.mynewsdesk.com/pressreleases/neues-magazin-fuer-betroffene-von-psoriasis-2825409,http://news.abbvie.de/contact_people,http://news.abbvie.de/pressreleases/neues-magazin-fuer-betroffene-von-psoriasis-2825409,http://presseportal.de/pm/112983/3896119,,,,,,,,,,,,,,,,,,,,
anzpv@abbvie.com,abbvie.com,AbbVie,US,,,,,80,personal,4,{first}.{last},,,,,,,,http://allerganaesthetics.com.au/about/report-an-adverse-event,http://allergan.co.nz/en-nz/products/drug-safety,http://abbvie.co.nz/contactus.html,http://abbvie.com.au/contactus.html,,,,,,,,,,,,,,,,,,,,,,,,,
mail.dk@abbvie.com,abbvie.com,AbbVie,US,,,,,80,generic,4,{first}.{last},,,Support,,,,,http://pharmchoices.com/full-list-of-pharmaceutical-companies-in-denmark,http://pro.medicin.dk/adresser/medicinvirksomheder/10543,http://min.medicin.dk/adresser/medicinvirksomheder/10543,http://abbvie.dk/kontakt.html,,,,,,,,,,,,,,,,,,,,,,,,,
muriel.haraoui@abbvie.com,abbvie.com,AbbVie,US,,,,,80,personal,8,{first}.{last},,,,"",,,,http://news.dailymushroom.co/abbvie-announces-new-formulary-listings-for-its-hepatitis-c-treatment-maviret,http://news.dailymushroom.co/maviret-glecaprevir-pibrentasvir-approved-by-health-canada-for-pediatric-patients-with-chronic-hepatitis-c,http://newswire.ca/news-releases/abbvie-s-maviret-tm-now-listed-on-the-nova-scotia-and-manitoba-formularies-828225080.html,http://newswire.ca/news-releases/abbvie-reaches-an-agreement-with-the-pan-canadian-pharmaceutical-alliance-pcpa-for-its-hepatitis-c-treatment-maviret-tm--822598355.html,http://newswire.ca/fr/news-releases/maviret-mc-d-abbvie-maintenant-rembourse-au-quebec-874103274.html,http://newswire.ca/news-releases/abbvie-s-maviret-tm-now-reimbursed-in-quebec-873313375.html,http://iricor.ca/fr/iricor-et-luniversite-de-montreal-concluent-une-collaboration-de-recherche-avec-abbvie-pour-decouvrir-des-neoantigenes-specifiques-de-tumeur,http://iricor.ca/iricor-and-universite-de-montreal-enter-into-research-collaboration-with-abbvie-to-discover-tumor-specific-neoantigens,,,,,,,,,,,,,,,,,,,,,
mk.steel@abbvie.com,abbvie.com,AbbVie,US,,,,,80,personal,7,{first}.{last},,,,,,,,http://cknby.com/who-we-are/our-stories/navigating-the-hidden-side-of-cancer.html,http://cknby.com/who-we-are/our-stories/the-hardest-hit-how-nonprofits-rise-to-challenge-covid-19.html,http://cknby.com/who-we-are/our-stories/the-value-of-education-from-a-dim-reality-to-a-bright-future.html,http://news.abbvie.com/news/press-releases/abbvie-announces-100-million-donation-to-ronald-mcdonald-house-charities-to-support-hospitalized-children-and-their-families.htm,http://news.abbvie.com/news/press-releases/abbvie-donates-55-million-to-three-education-nonprofits-supporting-underserved-youth-in-chicago-across-america.htm,http://news.abbvie.com/news/press-releases/abbvie-donates-40-million-to-rebuild-north-chicago-middle-school.htm,http://news.abbvie.com/presskits/abbvie-to-rebuild-north-chicago-middle-school-press-kit.htm,,,,,,,,,,,,,,,,,,,,,,
markeisha.marshall@abbvie.com,abbvie.com,AbbVie,US,,,,,80,personal,8,{first}.{last},,,,,,,,http://thescipreneur.com/abbvie-receives-fda-approval-of-mavyret-for-the-treatment-of-chronic-hepatitis-c,http://news.abbvie.com/news/abbvies-investigational-pan-genotypic-regimen-glecaprevirpibrentasvir-gp-shows-high-svr-rates-in-chronic-hepatitis-c-patients-with-severe-chronic-kidney-disease.htm,http://news.abbvie.com/news/us-fda-grants-priority-review-to-abbvie-for-its-investigational-regimen-glecaprevirpibrentasvir-gp-for-treatment-chronic-hepatitis-c-in-all-major-genotypes-gt1-6.htm,http://news.abbvie.com/news/abbvies-investigational-hcv-regimen-receives-us-fda-breakthrough-therapy-designation.htm,http://news.abbvie.com/news/minimal-residual-disease-negativity-data-measure-undetectable-disease-added-to-venclexta-venetoclax-tablets-label.htm,http://news.abbvie.com/news/abbvie-submits-new-drug-application-to-us-fda-for-its-investigational-regimen-glecaprevirpibrentasvir-gp-for-treatment-all-major-genotypes-chronic-hepatitis-c.htm,http://businesswire.com/news/home/20180302005168/en/biogen%c2%a0and-abbvie-announce%c2%a0the-voluntary%c2%a0worldwide-withdrawal-marketing-authorizations,http://businesswire.com/news/home/20170620006274/en/sheknows-media-takes-health-wellness-theme-blogher17,,,,,,,,,,,,,,,,,,,,,
sohei.yamaguchi@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://oacet.or.jp/img_file/seminar/168863067511355-1.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
polandmedinfo@abbvie.com,abbvie.com,AbbVie,US,,,,,79,generic,5,{first}.{last},,,Support,,,,,http://hematoonkologia.pl/murano/index/strona/5,http://hematoonkologia.pl/murano,http://hematoonkologia.pl/murano/index/strona/2,http://hematoonkologia.pl/murano/index/strona/3,http://hematoonkologia.pl/murano/index/strona/4,,,,,,,,,,,,,,,,,,,,,,,,
kazuki.tomisawa@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://gunma-byoyaku.gr.jp/info/wp-content/uploads/2022/12/68eba308b1371aea63722f87dfcb944f.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gpopharm@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://e-abbvie.com/upload_images/pdf/abbvie%20us%20llc%20standard%20terms%20and%20conditions_08.1.23.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
drugtraceability@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://e-abbvie.com/upload_images/pdf/abbvie%20us%20llc%20standard%20terms%20and%20conditions_08.1.23.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
trace@abbvie.com,abbvie.com,AbbVie,US,,,,,79,generic,1,{first}.{last},,,,,,,,http://e-abbvie.com/upload_images/pdf/abbvie%20us%20llc%20standard%20terms%20and%20conditions_08.1.23.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
daniel.granfeldt@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://nyemetoder.no/documents/bestillerforum%20rhf%20-%20%28%20innkallinger%20og%20referater%29/bestillerforum%2021.11.2022.%20sakspapirer_offentlige.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
contactustriage@abbvie.com,abbvie.com,AbbVie,US,,,,,79,generic,2,{first}.{last},,,Support,,,,,http://allerganaesthetics.com/about/contact,http://allerganaesthetics.com/providers/contact,,,,,,,,,,,,,,,,,,,,,,,,,,,
jaakko.kopra@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://medicaljournalssweden.se/actadv/article/download/4447/14508/45195,,,,,,,,,,,,,,,,,,,,,,,,,,,,
b.chen@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://biella-case.it/ala-moana-center-directory.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gabe.konyves@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://cosprc.ca/allergan-an-abbvie-company-would-like-to-cordially-invite-you-to-women-in-ophthalmology-dinner,,,,,,,,,,,,,,,,,,,,,,,,,,,,
agn-coolsculpting.apacsupport@abbvie.com,abbvie.com,AbbVie,US,,,,,79,generic,3,{first}.{last},,,Support,,,,,http://cosmopolitan.com.hk/beauty/coolsculpting-elite-treatment-2023,http://coolsculpting.kr,http://coolsculpting.kr/findclinic,,,,,,,,,,,,,,,,,,,,,,,,,,
reception-wavre@abbvie.com,abbvie.com,AbbVie,US,,,,,79,generic,1,{first}.{last},,,Writing & communication,,,,,http://amcham.be/our-members/abbvie-sa,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nancy.vangeys@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,2,{first}.{last},,,,,,,,http://cloud.abbviemail.com/healthcare-heroes-fr,http://cloud.abbviemail.com/healthcare-heroes-nl,,,,,,,,,,,,,,,,,,,,,,,,,,,
pa-reception@abbvie.com,abbvie.com,AbbVie,US,,,,,79,generic,2,{first}.{last},,,Writing & communication,,,,,http://allerganaesthetics.fr/conditions-generales-dutilisation,http://coolsculpting-france.com/conditions-generales-d-utilisation,,,,,,,,,,,,,,,,,,,,,,,,,,,
pa-medinfo@abbvie.com,abbvie.com,AbbVie,US,,,,,79,generic,1,{first}.{last},,,Support,,,,,http://sfemc.fr/partenaires/abbvie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
saudi.qa@abbvie.com,abbvie.com,AbbVie,US,,,,,79,generic,2,{first}.{last},,,,,,,,http://cknby.com/contact-center/locations/saudi-arabia.html,http://cknby.com/regions/middle-east/saudi-arabia.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
greekmedinfo@abbvie.com,abbvie.com,AbbVie,US,,,,,79,generic,1,{first}.{last},,,Support,,,,,http://onetoone-congress.gr/_files/ugd/2f85e1_919d4bd3336d47248b7fd63dd74f909e.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
iknowibd@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://lond.jp/recruit/sustainablilty-csr/36,,,,,,,,,,,,,,,,,,,,,,,,,,,,
infonederland@abbvie.com,abbvie.com,AbbVie,US,,,,,79,generic,3,{first}.{last},,,Support,,,,,http://allerganaesthetics.nl/over/contact,http://coolsculpting.nl/neem-contact-met-ons-op,http://juvederm.nl/neem-contact-op,,,,,,,,,,,,,,,,,,,,,,,,,,
bepv@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,5,{first}.{last},,,,,,,,http://hs-online.be,http://hs-online.be/affections-associees,http://hs-online.be/brochure-dinformation,http://hs-online.be/contact-2,http://hs-online.be/nl/zorgverlener,,,,,,,,,,,,,,,,,,,,,,,,
medinfo.turkey@abbvie.com,abbvie.com,AbbVie,US,,,,,79,generic,3,{first}.{last},,,,,,,,http://allerganaesthetics.com.tr/saglik-mensuplari/coolsculpting,http://allerganaesthetics.com.tr/saglik-mensuplari/juvederm,http://allerganaesthetics.com.tr/saglik-mensuplari/botox,,,,,,,,,,,,,,,,,,,,,,,,,,
canada.grants.committee@abbvie.com,abbvie.com,AbbVie,US,,,,,79,generic,2,{first}.{last},,,,,,,,http://allergan.ca/en-ca/about/grants-and-donations,http://allergan.ca/fr-ca/about/grants-and-donations,,,,,,,,,,,,,,,,,,,,,,,,,,,
david.stresser@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,3,{first}.{last},,,,,,,,http://eurekaselect.com/journal/72/editorial-board,http://benthamscience.com/journals/drug-metabolism-and-bioanalysis-letters/editorial-board,http://dmd.aspetjournals.org/content/early/2021/12/02/dmd.121.000638,,,,,,,,,,,,,,,,,,,,,,,,,,
mi.asia@abbvie.com,abbvie.com,AbbVie,US,,,,,79,generic,1,{first}.{last},,,,,,,,http://coolsculpting.hk/%e8%81%af%e7%b5%a1%e6%88%91%e5%80%91,,,,,,,,,,,,,,,,,,,,,,,,,,,,
elaheh.shirneshan@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://jpro.springeropen.com/articles/10.1186/s41687-021-00378-y,,,,,,,,,,,,,,,,,,,,,,,,,,,,
valerie.ruslavage@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://cme.ahn.org/content/abbvie-medical-affairs-virtual-exhibit-hall-pancreatic-cancer-virtual-conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jieyi.wang@abbvie.com,abbvie.com,AbbVie,US,,,,,79,generic,1,{first}.{last},,,,,,,,http://bmccancer.biomedcentral.com/articles/10.1186/s12885-016-2138-z,,,,,,,,,,,,,,,,,,,,,,,,,,,,
arcadi.kolchak@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://accesshub.pdc.wa.gov/node/16061,,,,,,,,,,,,,,,,,,,,,,,,,,,,
yoshihiko.sakamoto@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://kpshp.jp/events/event/%e7%ac%ac5%e5%9b%9e%e7%80%ac%e6%88%b8%e5%86%85%e7%97%85%e9%99%a2%e8%96%ac%e5%ad%a6%e7%a0%94%e7%a9%b6%e4%bc%9a,,,,,,,,,,,,,,,,,,,,,,,,,,,,
frykirk.swenson@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://ce.icep.wisc.edu/e-22312-abbvie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
raphaele.thiebautmillot@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://cythem.fr,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ibia.malats@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,2,{first}.{last},,,,,,,,http://h1bdata.com/page/2,http://h1bdata.com,,,,,,,,,,,,,,,,,,,,,,,,,,,
medinfobaltics@abbvie.com,abbvie.com,AbbVie,US,,,,,79,generic,1,{first}.{last},,,,,,,,"http://medpred.org/forum/index.php/topic,10863.0.html",,,,,,,,,,,,,,,,,,,,,,,,,,,,
kaisa.raitio@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,5,{first}.{last},,,,,,,,http://mynewsdesk.com/fi/abbvie/pressreleases/suomalaistutkimus-kipu-on-eniten-elaemaenlaatua-heikentaevae-oire-ihosairaus-hs-taudissa-2037642,http://mynewsdesk.com/fi/abbvie/pressreleases/kestaevae-terveydenhuolto-hanke-tuoko-soten-valinnanvapaus-hyoetyae-pitkaeaikaissairaan-hoitoon-1773653,http://mynewsdesk.com/fi/abbvie/pressreleases/abbvie-sijoittui-great-place-to-work-tutkimuksessa-sijalle-7-2834142,http://mynewsdesk.com/fi/abbvie/pressreleases/tuore-kyselytutkimus-tekoaely-pelastaa-terveydenhuollon-ammattilaiset-rutiinitoeiltae-ja-vapauttaa-aikaa-potilaan-kohtaamiselle-2587334,http://mynewsdesk.com/fi/abbvie/pressreleases/tuore-kyselytutkimus-tekoaely-pelastaa-terveydenhuollon-ammattilaiset-rutiinitoeiltae-ja-vapauttaa-aikaa-potilaan-kohtaamiselle-2587339,,,,,,,,,,,,,,,,,,,,,,,,
tomas.csibrei@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://uvostat.sk/dodavatel/23573,,,,,,,,,,,,,,,,,,,,,,,,,,,,
service@abbvie.com,abbvie.com,AbbVie,US,,,,,79,generic,2,{first}.{last},,,Support,,,,,http://allerganaesthetics.ca/en/contact,http://allerganaesthetics.ca/fr/contact,,,,,,,,,,,,,,,,,,,,,,,,,,,
lucas.chaviraschramm@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://wrapnn.enpnetwork.com/nurse-practitioner-news/207155-august-22-2019-industry-sponsored-monthly-dinner-meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,
francescaeugenia.civardi@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,4,{first}.{last},,,,,,,,http://placement.uniroma2.it/2019/05/23/abbvie-laureati-in-economia-giurisprudenza,http://placement.uniroma2.it/tag/abbvie,http://placement.uniroma2.it/tag/campoverde-di-aprilia,http://placement.uniroma2.it/tag/contract-management-intern,,,,,,,,,,,,,,,,,,,,,,,,,
sonia.tanlimco@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://jitc.bmj.com/content/6/1/50,,,,,,,,,,,,,,,,,,,,,,,,,,,,
melvin.munsaka@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,2,{first}.{last},,,,,,,,http://bayesianscientific.org,http://bayesianscientific.org/subgroup/safety,,,,,,,,,,,,,,,,,,,,,,,,,,,
orphandrugs.enquiries@abbvie.com,abbvie.com,AbbVie,US,,,,,79,generic,2,{first}.{last},,,Writing & communication,,,,,http://ema.europa.eu/en/medicines/human/orphan-designations/eu311915,http://ema.europa.eu/en/medicines/human/orphan-designations/eu3121001,,,,,,,,,,,,,,,,,,,,,,,,,,,
christina.bankhardt@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://wiki.dnb.de/display/nestor/ag+recht,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cfcareforward@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,2,{first}.{last},,,,,,,,http://patientsupport.creoninfo.com/login,http://patientsupport.creoninfo.com/register,,,,,,,,,,,,,,,,,,,,,,,,,,,
eu-clinical-trials@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,2,{first}.{last},,,,,,,,http://nomenclator.org/estudio-para-evaluar-la-seguridad-y-el-efecto-de-3-productos-en-investigacion-abt450.ec,http://nomenclator.org/estudio-abierto-aleatorizado-para-evaluar-la-seguridad-y-el-efecto-de-tres-farmacos.ec,,,,,,,,,,,,,,,,,,,,,,,,,,,
abbvie.madrid.webinfo@abbvie.com,abbvie.com,AbbVie,US,,,,,79,generic,2,{first}.{last},,,Support,,,,,http://abbviecare.es/que-es-abbvie-care,http://isporspainchapter.org/events/jornada-post-ispor,,,,,,,,,,,,,,,,,,,,,,,,,,,
ebu.abv@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,2,{first}.{last},,,,,,,,http://headquartersof.com/abbvie-headquarters,http://contactdetailswala.com/business/abbvie-contact-details,,,,,,,,,,,,,,,,,,,,,,,,,,,
kieko.ishikawa@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://news.abbvie.com/news/press-releases/abbvie-announces-approval-maviret-glecaprevirpibrentasvir-for-treatment-chronic-hepatitis-c-in-all-major-genotypes-gt1-6-in-japan.htm,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tineke.vanhooland@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://fr.slideshare.net/sebastiaankennes/versie-final-fr,,,,,,,,,,,,,,,,,,,,,,,,,,,,
xiaotian.zhu@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://dirk.eddelbuettel.com/cranberries/2015/04/20,,,,,,,,,,,,,,,,,,,,,,,,,,,,
janis.lazdins@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,3,{first}.{last},,,,,,,,http://acucentrs.lv/ru/aktualno/page/13,http://acucentrs.lv/ru/seminar-v-02-09-2017,http://acucentrs.lv/seminars-02-09-2017,,,,,,,,,,,,,,,,,,,,,,,,,,
theresia.bredenwall@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,4,{first}.{last},,,,"",,,,http://mynewsdesk.com/se/abbvie,http://news.abbvie.se,http://news.abbvie.se/contact_people,http://mynewsdesk.com/se/abbvie/pressreleases/paaskyndad-handlaeggning-foer-abbvies-kommande-hepatit-c-laekemedel-glekaprevir-slash-pibrentasvir-1763089,,,,,,,,,,,,,,,,,,,,,,,,,
catherine.pinsonnault@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,4,{first}.{last},,,,,,,,http://hepatitiscnewdrugs.blogspot.com/2016/02/feb-2016-update-upcoming-and-recruiting.html,http://hepatitiscnewdrugs.blogspot.com/2016/06/june-recruiting-and-upcoming-hepatitis.html,http://hepatitiscnewdrugs.blogspot.com/2016/06,http://hepatitiscnewdrugs.blogspot.com/2016_06_01_archive.html,,,,,,,,,,,,,,,,,,,,,,,,,
info-sk@abbvie.com,abbvie.com,AbbVie,US,,,,,79,generic,1,{first}.{last},,,Support,,,,,http://pharmchoices.com/full-list-of-pharmaceutical-companies-in-slovakia,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jan.peter.de.geus@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://static.ioetube.nl/oud-nereus/donateur_worden,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tze-john.tang@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,4,{first}.{last},,,,,,,,http://abbvie-ir-hackvie-2019.devpost.com,http://disruptsf2015.devpost.com/forum_topics/5159-abbvie-challenge-1-wearable-to-monitor-people-suffering-from-neurological-diseases,http://disruptsf2015.devpost.com/forum_topics/5160-abbvie-challenge-3-platform-the-integrated-multiple-sources-of-data-to-rapidly-identify-emerging-research-or-novel-treatments,http://disruptsf2015.devpost.com/forum_topics/5161-abbvie-challenge-2-a-gamified-patient-experience-to-empower-people-living-with-chronic-disease,,,,,,,,,,,,,,,,,,,,,,,,,
safety-cz@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://mamlupenku.cz/vase-dotazy,,,,,,,,,,,,,,,,,,,,,,,,,,,,
shailendra.bordawekar@abbvie.com,abbvie.com,AbbVie,US,,,,,79,personal,1,{first}.{last},,,,,,,,http://aiche.confex.com/aiche/2013/webprogram/authorb.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
customerserviceanz@abbvie.com,abbvie.com,AbbVie,US,,,,,79,generic,3,{first}.{last},,,Support,,,,,http://afqgc.cpimech.com/what-company-is-abbvie/65361301,http://aucustomerservice.com/abbvie-pharmaceuticals-customer-service-contact-number-email-id-website,http://abbvie.com.au/contactus.html,,,,,,,,,,,,,,,,,,,,,,,,,,
keiji.fukumoto@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,1,{first}.{last},,,,,,,,http://kna.or.jp/wp/wp-content/uploads/2023/07/4d4899f727fb498449ff32e1998c1f28.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
elisabeth.jarnaess@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,1,{first}.{last},,,,,,,,http://legemiddelverket.no/documents/bivirkninger%20og%20sikkerhet/kj%c3%a6re%20helsepersonell-brev/2020/leuprorelin%20dhpc_no.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
marte.sneeggen@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,1,{first}.{last},,,,,,,,http://legemiddelverket.no/documents/bivirkninger%20og%20sikkerhet/kj%c3%a6re%20helsepersonell-brev/2021/dhpc%20letter_no_26-may-2021_final%20version%20reviewed%20by%20noma%2003-jun-2021-signed.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
20abbviemediarelations@abbvie.com,abbvie.com,AbbVie,US,,,,,78,generic,1,{first}.{last},,,Writing & communication,,,,,http://cknby.com/who-we-are/our-stories/a-journey-of-sight-progress.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
melina.thomaidou@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,1,{first}.{last},,,,,,,,http://abbvie.gr/content/dam/abbvie-dotcom/gr/documents/deltio_typoy_abbvie_kampania_skipad_atopiki_dermatitida_29032023_3.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gry.stine.kopperud@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,1,{first}.{last},,,,,,,,http://nyemetoder.no/documents/forslag/id2015_009_adalimumab.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anne.lejon@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,1,{first}.{last},,,,,,,,http://klekoon.com/joce/joue-appel-offre-suede-harnosand-produits-pharmaceutiques-10320838.htm,,,,,,,,,,,,,,,,,,,,,,,,,,,,
bria.scudder@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,1,{first}.{last},,,,,,,,http://lobbying.wi.gov/who/lobbyistinformation/2023reg/information/10393,,,,,,,,,,,,,,,,,,,,,,,,,,,,
frauke.pohlki@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,1,{first}.{last},,,,,,,,http://pharmaforum-sw.de/pohlki,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sarah.kongpachith@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,1,{first}.{last},,,,,,,,http://jitc.bmj.com/content/6/1/50,,,,,,,,,,,,,,,,,,,,,,,,,,,,
britt.reat@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,2,{first}.{last},,,,,,,,http://txtabs.org/annual-meeting/virtual-exhibitor,http://ntexas.org/annual-meeting/virtual-exhibitor,,,,,,,,,,,,,,,,,,,,,,,,,,,
pharmacovigilance.at@abbvie.com,abbvie.com,AbbVie,US,,,,,78,generic,1,{first}.{last},,,,,,,,http://allerganaesthetics.at/uber/kontakt,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cs_facial_france@abbvie.com,abbvie.com,AbbVie,US,,,,,78,generic,3,{first}.{last},,,,,,,,http://allerganaesthetics.fr/a-propos/service-clients,http://allerganaesthetics.fr/professionnel-de-sante/nous-contacter,http://allerganaesthetics.fr/professionnel-de-sante/resources,,,,,,,,,,,,,,,,,,,,,,,,,,
pa-materio_vigilance@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,5,{first}.{last},,,,,,,,http://allerganaesthetics.fr/juvederm,http://allerganaesthetics.fr/a-propos/contactez-nous,http://allerganaesthetics.fr/a-propos/materiovigilance,http://allerganaesthetics.fr/professionnel-de-sante/nous-contacter,http://allerganaesthetics.fr/coolsculpting,,,,,,,,,,,,,,,,,,,,,,,,
isabelle.petatthiolas@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,1,{first}.{last},,,,,,,,http://turismo-pirineosorientales.es/thiolas-isabelle/argeles-sur-mer/hlolar066v5289dx,,,,,,,,,,,,,,,,,,,,,,,,,,,,
michael.snabes@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,2,{first}.{last},,,,,,,,http://icpemeeting.secure-platform.com/a/gallery/rounds/3/details/1723,http://icpemeeting.secure-platform.com/a/gallery/rounds/3/details/1726,,,,,,,,,,,,,,,,,,,,,,,,,,,
uk_medinfo@abbvie.com,abbvie.com,AbbVie,US,,,,,78,generic,5,{first}.{last},,,Support,,,,,http://juvederm.co.uk/locator-disclaimer,http://juvederm.co.uk,http://juvederm.co.uk/find-a-clinic,http://juvederm.co.uk/locator-terms-conditions-of-use,http://juvederm.co.uk/contact-us,,,,,,,,,,,,,,,,,,,,,,,,
orders.kr@abbvie.com,abbvie.com,AbbVie,US,,,,,78,generic,1,{first}.{last},,,Sales,,,,,http://coolsculpting.nl/neem-contact-met-ons-op,,,,,,,,,,,,,,,,,,,,,,,,,,,,
drugsafety.pv@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,2,{first}.{last},,,,,,,,http://cosmopolitan.com.hk/beauty/shiga-lin-allergan,http://botox.com.hk,,,,,,,,,,,,,,,,,,,,,,,,,,,
frpv@abbvie.com,abbvie.com,AbbVie,US,,,,,78,generic,5,{first}.{last},,,,,,,,http://allerganaesthetics.fr/nos-produits/vistabel,http://allerganaesthetics.fr/a-propos/contactez-nous,http://allerganaesthetics.fr/a-propos/prharmacovigilance,http://allerganaesthetics.fr/professionnel-de-sante/nous-contacter,http://allerganaesthetics.fr/vistabel,,,,,,,,,,,,,,,,,,,,,,,,
li.wang1@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,3,{first}.{last},,,,,,,,http://francophonia-liban.org/midwest-isa-chapter/30039178,http://icsa.org/about/current-leadership,http://icsa.org/membership/midwest-chapter,,,,,,,,,,,,,,,,,,,,,,,,,,
safety.turkey@abbvie.com,abbvie.com,AbbVie,US,,,,,78,generic,5,{first}.{last},,,Legal,,,,,http://allerganaesthetics.com.tr/urunlerimiz/juvederm,http://allerganaesthetics.com.tr/juvederm,http://allerganaesthetics.com.tr/saglik-mensuplari/coolsculpting,http://allerganaesthetics.com.tr/saglik-mensuplari/juvederm,http://allerganaesthetics.com.tr/saglik-mensuplari/botox,,,,,,,,,,,,,,,,,,,,,,,,
productsurveillance_turkey@abbvie.com,abbvie.com,AbbVie,US,,,,,78,generic,1,{first}.{last},,,Writing & communication,,,,,http://allerganaesthetics.com.tr/saglik-mensuplari/botox,,,,,,,,,,,,,,,,,,,,,,,,,,,,
meapv@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,1,{first}.{last},,,,,,,,http://lyneye.co.za/wrinkle-relaxing-treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gary.gintant@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,2,{first}.{last},,,,,,,,http://axionbiosystems.com/sites/default/files/blinova_cipa_phase_ii_cellrep2018.pdf,http://fda.gov/drugs/news-events-human-drugs/cardiomyocytes-mechanistic-cardiovascular-safety-liabilities,,,,,,,,,,,,,,,,,,,,,,,,,,,
evangelos.mavrommatis@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,1,{first}.{last},,,,,,,,http://cme.ahn.org/content/abbvie-medical-affairs-virtual-exhibit-hall-pancreatic-cancer-virtual-conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,
marianne.ostrogorski@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,1,{first}.{last},,,,,,,,http://cknby.com/who-we-are/our-stories/day-in-the-life-putting-patients-first-each-and-every-day.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
david.riesop@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,2,{first}.{last},,,,,,,,http://journal.pda.org/content/early/2021/11/15/pdajpst.2021.012633/tab-article-info,http://journal.pda.org/content/early/2021/11/15/pdajpst.2021.012633,,,,,,,,,,,,,,,,,,,,,,,,,,,
medical_info_spain@abbvie.com,abbvie.com,AbbVie,US,,,,,78,generic,2,{first}.{last},,,,,,,,http://colegioenfermeriahuesca.org/alerta-sobre-medicamentos-que-contienen-leuprorelina-de-liberacion-prolongada,http://colegiooficialdeenfermeriadehuelva.es/leuprorelina-de-liberacion-prolongada-reducir-el-riesgo-de-errores-de-manipulacion-que-puedan-resultar-en-una-falta-de-eficacia,,,,,,,,,,,,,,,,,,,,,,,,,,,
amandine.baufayt@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,4,{first}.{last},,,,,,,,http://abbvie.prezly.com,http://abbvie.prezly.com/fr,http://abbvie.prezly.com/parlons-en-le-podcast-belge-qui-donne-la-parole-aux-patients,http://abbvie.prezly.com/praat-erover-de-belgische-podcast-die-patienten-een-stem-geeft,,,,,,,,,,,,,,,,,,,,,,,,,
abbvie.serbia@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,3,{first}.{last},,,,,,,,http://pharmchoices.com/full-list-of-pharmaceutical-companies-in-serbia,http://inovia.rs/members,http://inovia.rs/clanice,,,,,,,,,,,,,,,,,,,,,,,,,,
kathleen.murauski@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,1,{first}.{last},,,,,,,,http://diversifychemistry.com/industrial-entries,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pharmacovigilance.ch@abbvie.com,abbvie.com,AbbVie,US,,,,,78,generic,2,{first}.{last},,,,,,,,http://allerganaesthetics.ch/de/about/contact,http://allerganaesthetics.ch/fr/about/contact,,,,,,,,,,,,,,,,,,,,,,,,,,,
cheryl.pitcher@abbvie.com,abbvie.com,AbbVie,US,,,,,78,generic,5,{first}.{last},,,,,,,,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/skyriziv-risankizumab-receives-nice-positive-technology-appraisal-guidance-for-the-treatment-of-plaque-psoriasis-in-adults-2908347,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/abbvies-skyriziv-risankizumab-accepted-for-use-within-nhs-scotland-2928830,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/results-from-upadacitinib-phase-3-select-compare-study-published-in-arthritis-and-rheumatology-2896790,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/abbvies-duodopa-r-levodopa-carbidopa-intestinal-gel-recommended-for-use-within-nhs-wales-2460807,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/nice-issues-positive-final-appraisal-document-for-skyriziv-risankizumab-for-the-treatment-of-plaque-psoriasis-in-adults-2897106,,,,,,,,,,,,,,,,,,,,,,,,
abbviefoundation@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,4,{first}.{last},,,,,,,,http://cknby.com/societal-impact/for-the-strength-of-our-communities.html,http://cknby.com/societal-impact/for-the-strength-of-our-communities/serving-communities-through-philanthropy.html,http://cknby.com/sustainability/philanthropy.html,http://insidephilanthropy.com/grants-a/abbviefoundation,,,,,,,,,,,,,,,,,,,,,,,,,
mariadelcarmen.estrada@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,4,{first}.{last},,,,,,,,http://emprefinanzas.com.mx/2020/05/24/la-enfermedad-inflamatoria-intestinal-tiene-un-alto-impacto-emocional-y-fisico,http://emprefinanzas.com.mx/2020/06/05/la-hidradenitis-supurativa-tarda-hasta-ocho-anos-en-ser-diagnosticada,http://emprefinanzas.com.mx/2020/07/31/pacientes-con-insuficiencia-renal-en-riesgo-de-contraer-hepatitis-c,http://emprefinanzas.com.mx/2020/06/16/necesario-un-abordaje-multidisciplinario-en-las-enfermedades-autoinmunes,,,,,,,,,,,,,,,,,,,,,,,,,
elena.karpilovski@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,5,{first}.{last},,,,,,,,http://news.abbvie.se/pressreleases/positivt-chmp-utlaatande-foer-il-23-haemmaren-risankizumab-skyrizi-foer-behandling-av-vuxna-med-aktiv-psoriasisartrit-3137803,http://news.abbvie.se/contact_people,http://news.abbvie.se,http://mynewsdesk.com/se/abbvie,http://mynewsdesk.com/se/abbvie/pressreleases/vr-doktorn-staerker-patienter-i-moetet-med-vaarden-2834260,,,,,,,,,,,,,,,,,,,,,,,,
aert-it-support@abbvie.com,abbvie.com,AbbVie,US,,,,,78,generic,1,{first}.{last},,,Support,,,,,http://abbvieaereporting.com,,,,,,,,,,,,,,,,,,,,,,,,,,,,
shelly.benhaddouche@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,2,{first}.{last},,,,,,,,http://ohparkinson.com/speakers,http://ohparkinson.com/speakers-list-resources,,,,,,,,,,,,,,,,,,,,,,,,,,,
hematoday@abbvie.com,abbvie.com,AbbVie,US,,,,,78,generic,1,{first}.{last},,,,,,,,http://bhs.be/meetings/educational-day-rare-hematological-diseases/1797548391,,,,,,,,,,,,,,,,,,,,,,,,,,,,
murielle.roschi@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,1,{first}.{last},,,,,,,,http://talendo.ch/en/events/abbvie-virtueller-infoanlass-19-8-2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tom.muneyyirci@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,1,{first}.{last},,,,,,,,http://hepfree.nyc/project-succeed-hiv-hcv-meeting-highlights-10-11-18-2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
akshanth.r.polepally@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,1,{first}.{last},,,,,,,,http://ascpt.org/resources/ascpt-news/view/articleid/23359/ascpt-news-february-28-2019,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chrysoula.diakatou@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,2,{first}.{last},,,,,,,,http://merimna.org.gr/abbvie-running-team-stirizei-merimna,http://merimna.org.gr/merimna-news/abbvie-running-team-stirizei-merimna,,,,,,,,,,,,,,,,,,,,,,,,,,,
accesstodata@abbvie.com,abbvie.com,AbbVie,US,,,,,78,generic,1,{first}.{last},,,,,,,,http://vivli.org/ourmember/abbvie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ramanuj.achari@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,1,{first}.{last},,,,,,,,http://clinicaltrialsgps.com/search-clinical-trials/trial-48262,,,,,,,,,,,,,,,,,,,,,,,,,,,,
elena.demskaya@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,2,{first}.{last},,,,,,,,http://pharmateca.ru/ru/archive/article/32487,http://pharmateca.ru/en/archive/article/32487,,,,,,,,,,,,,,,,,,,,,,,,,,,
uk.customerservices.internal@abbvie.com,abbvie.com,AbbVie,US,,,,,78,generic,1,{first}.{last},,,,,,,,http://gov.uk/drug-device-alerts/chirocaine-5mg-ml-solution-for-injection-concentrate-abbvie-limited-clda-15-a-05-30-july-2015,,,,,,,,,,,,,,,,,,,,,,,,,,,,
creononcourse@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,2,{first}.{last},,,,,,,,http://patientsupport.creoninfo.com/login,http://patientsupport.creoninfo.com/register,,,,,,,,,,,,,,,,,,,,,,,,,,,
anzgrantsandsponsorships@abbvie.com,abbvie.com,AbbVie,US,,,,,78,generic,1,{first}.{last},,,,,,,,http://abbvie.co.nz/responsibility/grants-and-donations/funding-educational-event-attendance.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
wendy.hork@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,2,{first}.{last},,,,,,,,http://research847.rssing.com/chan-14897209/all_p107.html,http://research847.rssing.com/chan-14897209/all_p105.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
thersia.bredenwall@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,2,{first}.{last},,,,,,,,http://mynewsdesk.com/se/abbvie/pressreleases/patientdelaktighet-och-industrisamverkan-foer-oekad-vaardkvalitet-2564605,http://mynewsdesk.com/se/akademiska_sjukhuset/pressreleases/patientdelaktighet-och-industrisamverkan-foer-oekad-vaardkvalitet-2557673,,,,,,,,,,,,,,,,,,,,,,,,,,,
abbvie.reach@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,1,{first}.{last},,,,,,,,http://cknby.com/who-we-are/operating-with-integrity/responsible-supply-chain/supplier-resources.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anna.kruglova@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,2,{first}.{last},,,,,,,,http://epidemiology-journal.ru/en/archive/article/36336,http://epidemiology-journal.ru/ru/archive/article/36336,,,,,,,,,,,,,,,,,,,,,,,,,,,
mohamad.shebley@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,1,{first}.{last},,,,,,,,http://dmd.aspetjournals.org/content/early/2017/05/08/dmd.116.074518,,,,,,,,,,,,,,,,,,,,,,,,,,,,
reeta.heino@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,3,{first}.{last},,,,,,,,http://mynewsdesk.com/fi/abbvie/pressreleases/abbvie-sijoittui-great-place-to-work-2020-tutkimuksessa-sijalle-8-2972769,http://mynewsdesk.com/fi/abbvie/pressreleases/abbvie-sijoittui-great-place-to-work-tutkimuksessa-sijalle-7-2834142,http://mynewsdesk.com/fi/abbvie/pressreleases/abbvie-paransi-sijoitustaan-great-place-to-work-tutkimuksesessa-1799816,,,,,,,,,,,,,,,,,,,,,,,,,,
abbvieitalyinfomed@abbvie.com,abbvie.com,AbbVie,US,,,,,78,generic,1,{first}.{last},,,,,,,,http://europharma.kz/brufen-600-mg-no-30-sashe,,,,,,,,,,,,,,,,,,,,,,,,,,,,
transparencyreporting@abbvie.com,abbvie.com,AbbVie,US,,,,,78,generic,3,{first}.{last},,,,,,,,http://cknby.com/our-company/ethics-compliance/physician-payments.html,http://cknby.com/who-we-are/operating-with-integrity/transparency-in-payment.html,http://bostonons.org/post/bons-members-only-~-new-evidence-in-first-line-aml-exploring-outcomes,,,,,,,,,,,,,,,,,,,,,,,,,,
morry.smulevitz@abbvie.com,abbvie.com,AbbVie,US,,,,,78,personal,4,{first}.{last},,,,,,,,http://prnewsonline.com/13-pr-pros-reveal-best-practices-internal-communications-times-change,http://prnewsonline.com/how-pr-can-play-a-role-in-training-employees-to-be-brand-ambassadors,http://prnewsonline.com/four-timeless-values-journalism-will-propel-media-pitching,http://news.abbvie.com/news/abbvie-receives-us-fda-approval-viekira-pak-ombitasvirparitaprevirritonavir-tablets-dasabuvir-tablets-for-treatment-chronic-genotype-1-hepatitis-c.htm,,,,,,,,,,,,,,,,,,,,,,,,,
arthur.r.gomtsyan@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://basicmedicalkey.com/clinical-and-preclinical-experience-with-trpv1-antagonists-as-potential-analgesic-agents,,,,,,,,,,,,,,,,,,,,,,,,,,,,
milla.hedqvist@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://sfai.se/wp-content/uploads/files/sfai_4_2013.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
satoshi.maeno@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://kurume-med.or.jp/wp/wp-content/uploads/2023/06/20230608-gakujutu6gatu-2.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
linn.mandahl@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://lif.se/contentassets/ce6e9b6b318a44e197c8ac9838bf862e/ar-2021-lakemedelsindustriforeningen-lif---signerad.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
akihito.tsukinari@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://sasebo-ishikai.com/member/kenshukai-koenkai,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hege.edvardsen@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://helse-nord.no/499fa5/siteassets/documents/styret/styremoter/styremoter-2020/20201028/styresak-131-2020-nasjonal-infrastruktur-for-kliniske-studier---tettere-kobling-til-naringslivet.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
stefania.bossiner@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://auser.it/agenzia-dinformazione-auser/agenzia-di-informazione-auser-anno-19-numero-41-2-novembre-2016,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pharmacovigilance.hu@abbvie.com,abbvie.com,AbbVie,US,,,,,77,generic,1,{first}.{last},,,,,,,,http://eoptika.hu/optive-10-ml-szemcsepp.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ranjeeta.sinvhal@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://radiopharmaconnect.srsweb.org/doi/full/10.22541/au.167808272.26909752/v1,,,,,,,,,,,,,,,,,,,,,,,,,,,,
finland.medinfo@abbvie.com,abbvie.com,AbbVie,US,,,,,77,generic,2,{first}.{last},,,Support,,,,,http://pharmacafennica.fi/supportmaterial/download/118250554/fi,http://pharmacafennica.fi/supportmaterial/download/118250554/sv,,,,,,,,,,,,,,,,,,,,,,,,,,,
zapq@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,2,{first}.{last},,,,,,,,http://cknby.com/contact-center/locations/south-africa-and-sub-saharan-africa.html,http://cknby.com/regions/africa/south-africa-and-sub-saharan-africa.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
dong.ye@abbvie.com,abbvie.com,AbbVie,US,,,,,77,generic,1,{first}.{last},,,,,,,,http://pubs.rsc.org/en/content/articlehtml/2021/na/d0na00879f,,,,,,,,,,,,,,,,,,,,,,,,,,,,
christos.zeglinas@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://eligast.gr/wp-content/uploads/2019/03/75.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hongjian.zhu@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,2,{first}.{last},,,,,,,,http://community.amstat.org/houston/home,http://icsa.org/about/committees,,,,,,,,,,,,,,,,,,,,,,,,,,,
philip.karottki@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,5,{first}.{last},,,,,,,,http://creativecircle.dk/yccaarbejder/ud-af-hverdagens-bur,http://creativecircle.dk/profiler/rasmus-dunvad,http://creativecircle.dk/arbejder/gomore,http://creativecircle.dk/profiler/helle-sandby,http://creativecircle.dk/profiler/camilla-borggaard,,,,,,,,,,,,,,,,,,,,,,,,
productqualitycomplaints@abbvie.com,abbvie.com,AbbVie,US,,,,,77,generic,1,{first}.{last},,,Support,,,,,http://liletta.com/help,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ronny.nordvik@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://trondheim-tkd.no/public/10836,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nebal.dahaba@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://mideasteconomist.blog.fc2.com/blog-entry-8646.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lavina.harjani@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://ce.icep.wisc.edu/updates2022,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kevint@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://peeplookup.com/email-search,,,,,,,,,,,,,,,,,,,,,,,,,,,,
stephanie.chiuve@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,2,{first}.{last},,,,,,,,http://icpemeeting.secure-platform.com/a/gallery/rounds/3/details/1723,http://icpemeeting.secure-platform.com/a/gallery/rounds/3/details/1726,,,,,,,,,,,,,,,,,,,,,,,,,,,
pv.mea@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,4,{first}.{last},,,,,,,,http://cknby.com/contact-center/locations/saudi-arabia.html,http://cknby.com/contact-center/locations/south-africa-and-sub-saharan-africa.html,http://cknby.com/regions/africa/south-africa-and-sub-saharan-africa.html,http://cknby.com/regions/middle-east/saudi-arabia.html,,,,,,,,,,,,,,,,,,,,,,,,,
orders.gr@abbvie.com,abbvie.com,AbbVie,US,,,,,77,generic,0,{first}.{last},,,Sales,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
greekpv@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ernaehrungsbuch@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,2,{first}.{last},,,,,,,,http://menschen-mit-krebs.de/8906-arbeitsbuch-sinnvolle-ernaehrung-bei-krebserkrankungen,http://menschen-mit-krebs.de/ernaehrung,,,,,,,,,,,,,,,,,,,,,,,,,,,
abbviesanteetperspectives@abbvie.com,abbvie.com,AbbVie,US,,,,,77,generic,3,{first}.{last},,,,,,,,http://abbviesanteetperspectives.fr/appel-projets/resultats-ensemble-ameliorer-la-prise-en-charge-des-patients-atteints-de-maladies-inflammatoires-chroniques,http://abbviesanteetperspectives.fr/contact,http://abbviesanteetperspectives.fr/presse,,,,,,,,,,,,,,,,,,,,,,,,,,
isabelle.cohen-codar@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://epidemiologie-france.aviesan.fr/fr/epidemiologie-france/fiches/etude-transversale-des-facteurs-affectant-la-vie-des-personnes-traitees-au-long-terme-par-les-medicaments-anti-vih-fran09-014,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hanne.vanspaendonk@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,2,{first}.{last},,,,,,,,http://birdgroup.be/fr/patients-documents,http://birdgroup.be/nl/patients-documents,,,,,,,,,,,,,,,,,,,,,,,,,,,
zagreb.office@abbvie.com,abbvie.com,AbbVie,US,,,,,77,generic,1,{first}.{last},,,,,,,,http://hlk.hr/easyedit/userfiles/lnpdf/ln220_638233969296378410.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
shunsuke.numata@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://kpshp.jp/events/event/%e6%9d%b1%e5%9b%9b%e5%9b%bd%e5%8c%bb%e7%99%82%e3%82%bb%e3%83%9f%e3%83%8a%e3%83%bc-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,
alberslucas.albers@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://ce.mayo.edu/node/119350,,,,,,,,,,,,,,,,,,,,,,,,,,,,
partneringday@abbvie.com,abbvie.com,AbbVie,US,,,,,77,generic,1,{first}.{last},,,,,,,,http://mva.org/event/abbvie-digital-partnering-days,,,,,,,,,,,,,,,,,,,,,,,,,,,,
maya.lipert@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://diversifychemistry.com/industrial-entries,,,,,,,,,,,,,,,,,,,,,,,,,,,,
library@abbvie.com,abbvie.com,AbbVie,US,,,,,77,generic,3,{first}.{last},,,,,,,,http://netminicab.com/heartland-regional-library-system-illinois/75390204,http://librarylearning.org/abbvie-ap4a-4,http://librarylearning.org/directory,,,,,,,,,,,,,,,,,,,,,,,,,,
medinfo.ita@abbvie.com,abbvie.com,AbbVie,US,,,,,77,generic,3,{first}.{last},,,,,,,,http://allerganbeauty.it/prodotti,http://coolsculpting.it/contatti,http://allerganaesthetics.it/medici/contatti,,,,,,,,,,,,,,,,,,,,,,,,,,
nandkishor.k.nere@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://che.uic.edu/profiles/nere-nandkishor,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pierre.chancogne@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,4,{first}.{last},,,,,,,,http://schallware.de/en/rental/555,http://vermietung.schallware.de/en/rental/555,http://vermietung.schallware.de/rental/555,http://schallware.de/rental/555,,,,,,,,,,,,,,,,,,,,,,,,,
kaid.harper@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://aiche.org/conferences/aiche-annual-meeting/2017/proceeding/paper/79g-chemical-reaction-engineering-principles-continuous-flow-photoredox-catalysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,
dermatologybelgium@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,3,{first}.{last},,,,,,,,http://hs-online.be/nl/zorgverlener/register-as-an-hs-specialist-dermatologist,http://hs-online.be/nl/patient/register-as-an-hs-specialist-dermatologist,http://hs-online.be/patient/enregistrez-vous-en-tant-que-dermatologue-specialiste-en-hs,,,,,,,,,,,,,,,,,,,,,,,,,,
israelmedinfo@abbvie.com,abbvie.com,AbbVie,US,,,,,77,generic,2,{first}.{last},,,Support,,,,,http://ibdpassport.com/he/travelling-ibd/travelling-with-medication,http://ibdpassport.com/he/travelling-ibd/traveling-abroad-with-ibd-medication,,,,,,,,,,,,,,,,,,,,,,,,,,,
hilla.banayan@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,2,{first}.{last},,,,,,,,http://clinicaltrials.gov/ct2/show/nct03659669,http://clinicaltrials.gov/ct2/show/nct03987958,,,,,,,,,,,,,,,,,,,,,,,,,,,
nari.talaty@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,2,{first}.{last},,,,,,,,http://pubs.rsc.org/en/content/articlelanding/2019/re/c9re00054b,http://pubs.rsc.org/en/content/articlelanding/2019/re/c9re00054b/unauth,,,,,,,,,,,,,,,,,,,,,,,,,,,
weili.he@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,3,{first}.{last},,,,,,,,http://community.amstat.org/biop/aboutus/sub-committees/fellows141,http://demingconference.org/our-committee,http://community.amstat.org/biop/aboutus/executivecommittee,,,,,,,,,,,,,,,,,,,,,,,,,,
silvija.vaitkiene@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://ifpa.lt/nariai-ir-struktura,,,,,,,,,,,,,,,,,,,,,,,,,,,,
aionline@abbvie.com,abbvie.com,AbbVie,US,,,,,77,generic,5,{first}.{last},,,,,,,,http://acneinversa.ch/fr/recherche%20de%20medecins,http://acneinversa.ch/hilfestellung-fuer-patienten-mit-acne-inversa/arztsuche,http://acneinversa.ch/fr/recherche-de-medecins,http://acneinversa.ch/it/assistenza-per-pazienti-con-idrosadenite-suppurativa/ricerca-del-medico,http://acneinversa.ch/arztsuche,,,,,,,,,,,,,,,,,,,,,,,,
j.kalvass@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,5,{first}.{last},,,,,,,,http://dmd.aspetjournals.org/content/dmd/early/2023/05/15/dmd.123.001326.full.pdf,http://dmd.aspetjournals.org/content/early/2023/05/15/dmd.123.001326,http://dmd.aspetjournals.org/content/early/2023/05/15/dmd.123.001326/tab-e-letters,http://dmd.aspetjournals.org/content/early/2023/05/15/dmd.123.001326/tab-figures-data,http://dmd.aspetjournals.org/content/early/2018/02/05/dmd.117.078915,,,,,,,,,,,,,,,,,,,,,,,,
gpolupron@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,2,{first}.{last},,,,,,,,http://e-abbvie.com/upload_images/pdf/abbvie%20us%20llc%20standard%20terms%20and%20conditions_08.1.23.pdf,http://luprongyn.com/savings-and-support,,,,,,,,,,,,,,,,,,,,,,,,,,,
medicalinfo.za@abbvie.com,abbvie.com,AbbVie,US,,,,,77,generic,2,{first}.{last},,,,,,,,http://cknby.com/contact-center/locations/south-africa-and-sub-saharan-africa.html,http://cknby.com/regions/africa/south-africa-and-sub-saharan-africa.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
office.management@abbvie.com,abbvie.com,AbbVie,US,,,,,77,generic,3,{first}.{last},,,Management,,,,,http://cknby.com/contact-center/locations/romania.html,http://cknby.com/regions/europe/romania.html,http://pharmchoices.com/full-list-of-pharmaceutical-companies-in-romania,,,,,,,,,,,,,,,,,,,,,,,,,,
thomas.woidy@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://roedersheim-gronau.de/gemeinde/vereine,,,,,,,,,,,,,,,,,,,,,,,,,,,,
abbviesustainabilityprogram@abbvie.com,abbvie.com,AbbVie,US,,,,,77,generic,1,{first}.{last},,,,,,,,http://cknby.com/who-we-are/operating-with-integrity/responsible-supply-chain/supplier-resources.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
colleen.wegzyn@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,2,{first}.{last},,,,,,,,http://epidemiology-journal.ru/en/archive/article/36336,http://epidemiology-journal.ru/ru/archive/article/36336,,,,,,,,,,,,,,,,,,,,,,,,,,,
info@abbvie.com,abbvie.com,AbbVie,US,,,,,77,generic,2,{first}.{last},,,Support,,,,,http://mamma.com/us/abbvie-com,http://weltrheumatag-bsa.jimdofree.com/f%c3%b6rderer,,,,,,,,,,,,,,,,,,,,,,,,,,,
farmacovigilanza@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,2,{first}.{last},,,,,,,,http://allerganaesthetics.it/chi-siamo/contatti,http://allerganaesthetics.it/medici/contatti,,,,,,,,,,,,,,,,,,,,,,,,,,,
birgit.brasche@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,3,{first}.{last},,,,,,,,http://idw-online.de/de/news678984,http://presseportal.de/pm/112983/3119311,http://presseportal.de/pm/112983/2930624,,,,,,,,,,,,,,,,,,,,,,,,,,
erica.gruvberg@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,3,{first}.{last},,,,"",,,,http://pressrum.ssci.se/posts/pressreleases/abbvie-satsar-pa-en-hallbar-och-digital-svens,http://mynewsdesk.com/se/abbvie/pressreleases/ny-klinisk-studie-utvaerderar-vaard-paa-distans-vid-parkinsons-sjukdom-telemedicin-kan-goera-vaarden-mer-tillgaenglig-925911,http://ssci.se/sv/aktuellt/abbvie-satsar-p-en-h-llbar-och-digital-svensk-life-science,,,,,,,,,,,,,,,,,,,,,,,,,,
abbvieline@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,1,{first}.{last},,,,,,,,http://encontroriosp2021.sbr.org.br,,,,,,,,,,,,,,,,,,,,,,,,,,,,
eva.sebestova@abbvie.com,abbvie.com,AbbVie,US,,,,,77,personal,2,{first}.{last},,,,,,,,http://cenapr.cz/porotce/eva-sebestova,http://edukafarm.cz/c1401-nova-antivirotika-pro-lecbu-hepatitidy-c-povolena-evropskou-komisi,,,,,,,,,,,,,,,,,,,,,,,,,,,
kundenservice@abbvie.com,abbvie.com,AbbVie,US,,,,,77,generic,1,{first}.{last},,,Support,,,,,http://app.ifi-medizin.de/art,,,,,,,,,,,,,,,,,,,,,,,,,,,,
holden.jastremski@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,1,{first}.{last},,,,,,,,http://community.smartsheet.com/profile/holden%20j,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kz_ppd_pv@abbvie.com,abbvie.com,AbbVie,US,,,,,76,generic,2,{first}.{last},,,,,,,,http://chil.kz/aux/editiondownload/117,http://chil.kz/aux/editiondownload/135,,,,,,,,,,,,,,,,,,,,,,,,,,,
onkologie.de@abbvie.com,abbvie.com,AbbVie,US,,,,,76,generic,1,{first}.{last},,,,,,,,http://onko-update.de/abbvie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hideki.araguchi@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,4,{first}.{last},,,,,,,,http://kumamoto-joseiishi.jp/wp/wp-content/uploads/2021/08/8e3bd735e3cfcb96c04b113259c98a45.pdf,http://kumamoto-joseiishi.jp/wp/wp-content/uploads/2022/06/a250946fc63aa015bcd614b01b16c454.pdf,http://kumamoto-joseiishi.jp/wp/wp-content/uploads/2023/05/f68f2a7d89f18f2e4f233fd3bac2e6a4.pdf,http://kumamoto-joseiishi.jp/wp/wp-content/uploads/2023/06/f68f2a7d89f18f2e4f233fd3bac2e6a4.pdf,,,,,,,,,,,,,,,,,,,,,,,,,
20cso_jpm@abbvie.com,abbvie.com,AbbVie,US,,,,,76,generic,2,{first}.{last},,,,,,,,http://cknby.com/partnerships/partnering-days.html,http://cknby.com/science/partner-with-us/partnering-days.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
iichiro.moteki@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,1,{first}.{last},,,,,,,,http://fukui-byoyaku.com/wp-content/uploads/2022/05/e39614f7b7eb6b0cb6b64b92804ed2fe.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
namita.tundia@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,2,{first}.{last},,,,,,,,http://arthritis-research.biomedcentral.com/articles/10.1186/s13075-019-2037-1,http://arthritis-research.biomedcentral.com/articles/10.1186/s13075-019-2059-8,,,,,,,,,,,,,,,,,,,,,,,,,,,
anne-gaelle.coajou@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,1,{first}.{last},,,,,,,,http://afar.asso.fr/emplois-et-stages/pharmacien-affaires-reglementaires-eye-care-6453e5ce18b04-2023-05-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,
dwaipayan.mukherjee@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,1,{first}.{last},,,,,,,,http://psithority.com/library/search/getentity/182481110,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tyler.pinnery@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,1,{first}.{last},,,,,,,,http://psoh.org/corporate-members.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lv.abbvie@abbvie.com,abbvie.com,AbbVie,US,,,,,76,generic,1,{first}.{last},,,,,,,,http://bral.lv/biedri,,,,,,,,,,,,,,,,,,,,,,,,,,,,
medicalresearchsupport@abbvie.com,abbvie.com,AbbVie,US,,,,,76,generic,2,{first}.{last},,,Support,,,,,http://cknby.com/partnerships/additional-collaboration-opportunities/investigator-initiated-studies-iis.html,http://cknby.com/science/clinical-trials/investigator-initiated-studies.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
productsurveillance_eamea@abbvie.com,abbvie.com,AbbVie,US,,,,,76,generic,1,{first}.{last},,,Writing & communication,,,,,http://juvederm.hu/kapcsolat,,,,,,,,,,,,,,,,,,,,,,,,,,,,
abbvie_jpn_hr_ta_all@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,1,{first}.{last},,,,,,,,http://abbvie.co.jp/work/challenged.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
liletta_intake@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,3,{first}.{last},,,,,,,,http://lilettahcp.com/content/pdf/llt-210384_liletta_replacement%20policy_updated_email_for_veeva.pdf,http://liletta.com/faqs,http://liletta.com/help,,,,,,,,,,,,,,,,,,,,,,,,,,
robert.a.love@abbvie.com,abbvie.com,AbbVie,US,,,,,76,generic,1,{first}.{last},,,,,,,,http://hospitalprofessionalnews.ie/2022/09/20/european-commission-approves-upadacitinib-for-the-treatment-of-adults-with-moderate-to-severely-active-ulcerative-colitis,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pv.ho.nl@abbvie.com,abbvie.com,AbbVie,US,,,,,76,generic,1,{first}.{last},,,,,,,,http://revalidatie.nl/wp-content/uploads/2022/07/ntr_0122-lr_enkel_def-min.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
makenzee.deming@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,1,{first}.{last},,,,,,,,http://montanapsychiatryconference.org/abbvie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
brenda.hinmanmcilroy@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,2,{first}.{last},,,,,,,,http://icpemeeting.secure-platform.com/a/gallery/rounds/3/details/1723,http://icpemeeting.secure-platform.com/a/gallery/rounds/3/details/1726,,,,,,,,,,,,,,,,,,,,,,,,,,,
servizioclienti.abbvie@abbvie.com,abbvie.com,AbbVie,US,,,,,76,generic,1,{first}.{last},,,Support,,,,,http://industrychemistry.com/aziende/abbvie-italia,,,,,,,,,,,,,,,,,,,,,,,,,,,,
mansour.dughbaj@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,1,{first}.{last},,,,,,,,http://mann.usc.edu/program/fellowship-programs/current-fellows,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cs_benelux@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,1,{first}.{last},,,,,,,,http://coolsculpting.nl/neem-contact-met-ons-op,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cyril.ramathal@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,1,{first}.{last},,,,,,,,http://oncotarget.com/article/28162,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sp-farmacovigilancia@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,5,{first}.{last},,,,,,,,http://allerganaesthetics.com.br/botox,http://allerganaesthetics.com.br/latisse,http://allerganaesthetics.com.br/profissionais-de-saude/contato,http://allerganaesthetics.com.br/sobre/contatos,http://allerganaesthetics.com.br/sobre/farmacovigilancia,,,,,,,,,,,,,,,,,,,,,,,,
eyecare-fortbildung@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,2,{first}.{last},,,,,,,,http://eyefox.com/partner/91,http://eyefox.com/partner/91/abbvie-deutschland-gmbh-co-kg,,,,,,,,,,,,,,,,,,,,,,,,,,,
informatiemedicala@abbvie.com,abbvie.com,AbbVie,US,,,,,76,generic,3,{first}.{last},,,Support,,,,,http://cknby.com/contact-center/locations/romania.html,http://cknby.com/regions/europe/romania.html,http://colegfarm.ro/comunicari-directe/venclyxto-venetoclax-comprimate-filmate-actualizarea-recomandarilor-despre-sindromul-de-liza-tumorala-slt-la-pacientii-cu-leucemie-limfocitara-cronica-llc,,,,,,,,,,,,,,,,,,,,,,,,,,
cs-germany@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,4,{first}.{last},,,,,,,,http://allerganaesthetics.de/medizinische-fachkreise/direct,http://allerganaesthetics.de/ueber-uns/kontakt,http://allergandirect.de/de_de/login,http://allerganaesthetics.de/direct,,,,,,,,,,,,,,,,,,,,,,,,,
pt.abbvie.farmacovigilancia@abbvie.com,abbvie.com,AbbVie,US,,,,,76,generic,1,{first}.{last},,,,,,,,http://abbviecare.pt/terms,,,,,,,,,,,,,,,,,,,,,,,,,,,,
communications-canada@abbvie.com,abbvie.com,AbbVie,US,,,,,76,generic,1,{first}.{last},,,,,,,,http://lifesciencesbc.ca/member/abbvie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
veselykatherine.vesely@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,1,{first}.{last},,,,,,,,http://ce.mayo.edu/node/119350,,,,,,,,,,,,,,,,,,,,,,,,,,,,
mitalee.tamhane@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,3,{first}.{last},,,,,,,,http://jpet.aspetjournals.org/content/early/2021/07/01/jpet.120.000483,http://jpet.aspetjournals.org/content/early/2021/07/01/jpet.120.000483/tab-article-info,http://jpet.aspetjournals.org/content/early/2021/07/01/jpet.120.000483/tab-e-letters,,,,,,,,,,,,,,,,,,,,,,,,,,
nea.aspiala@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,1,{first}.{last},,,,,,,,http://psori.fi/nivelpsoriasista-sairastava-kerro-kokemuksistasi,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hrconnect.northamerica@abbvie.com,abbvie.com,AbbVie,US,,,,,76,generic,3,{first}.{last},,,HR,,,,,http://abbvietotalrewardscontacts.com,http://abbvietotalrewardscontacts.com/type/global-from,http://abbvietotalrewardscontacts.com/type/global-to,,,,,,,,,,,,,,,,,,,,,,,,,,
giorgia.calselli@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,3,{first}.{last},,,,,,,,http://placement.uniroma2.it/2021/02/04/abbvie-laureati-in-ingegneria-scienze-2,http://placement.uniroma2.it/tag/junior-data-analyst,http://placement.uniroma2.it/tag/abbvie,,,,,,,,,,,,,,,,,,,,,,,,,,
carla.sanchezfernandez@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,4,{first}.{last},,,,,,,,http://emprefinanzas.com.mx/2020/05/24/la-enfermedad-inflamatoria-intestinal-tiene-un-alto-impacto-emocional-y-fisico,http://emprefinanzas.com.mx/2020/06/05/la-hidradenitis-supurativa-tarda-hasta-ocho-anos-en-ser-diagnosticada,http://emprefinanzas.com.mx/2020/07/31/pacientes-con-insuficiencia-renal-en-riesgo-de-contraer-hepatitis-c,http://emprefinanzas.com.mx/2020/06/16/necesario-un-abordaje-multidisciplinario-en-las-enfermedades-autoinmunes,,,,,,,,,,,,,,,,,,,,,,,,,
medinfo.at@abbvie.com,abbvie.com,AbbVie,US,,,,,76,generic,1,{first}.{last},,,,,,,,http://allerganaesthetics.at/uber/kontakt,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pharmacovigilance.austria@abbvie.com,abbvie.com,AbbVie,US,,,,,76,generic,1,{first}.{last},,,,,,,,http://bioreg.at/amendment-nr-2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
farmacovigilenta_romania@abbvie.com,abbvie.com,AbbVie,US,,,,,76,generic,4,{first}.{last},,,,,,,,http://cknby.com/contact-center/locations/romania.html,http://cknby.com/regions/europe/romania.html,http://colegfarm.ro/comunicari-directe/venclyxto-venetoclax-comprimate-filmate-actualizarea-recomandarilor-despre-sindromul-de-liza-tumorala-slt-la-pacientii-cu-leucemie-limfocitara-cronica-llc,http://colegfarm.ro/comunicari-directe/recomandari-actualizate-pentru-a-reduce-la-minimum-riscurile-de-aparitie-a-afectiunilor-maligne,,,,,,,,,,,,,,,,,,,,,,,,,
abbvie_portugal@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,2,{first}.{last},,,,,,,,http://indice.eu/pt/medicamentos/laboratorios/abbvie-lda/informacao-geral,http://abbviecare.pt/terms,,,,,,,,,,,,,,,,,,,,,,,,,,,
taymar.hartman@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,3,{first}.{last},,,,,,,,http://journal.pda.org/content/early/2019/09/13/pdajpst.2018.009316/tab-article-info,http://journal.pda.org/content/early/2019/09/13/pdajpst.2018.009316/tab-references,http://journal.pda.org/content/early/2019/09/13/pdajpst.2018.009316,,,,,,,,,,,,,,,,,,,,,,,,,,
mari.renlund@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,3,{first}.{last},,,,,,,,http://mynewsdesk.com/fi/pressroom/abbvie,http://psori.fi/pasi-arvo-selvittaa-psoriasiksen-vaikeusasteen,http://mynewsdesk.com/fi/abbvie/pressreleases/nimitysuutinen-mari-renlund-abbvien-market-access-and-external-affairs-directoriksi-2858476,,,,,,,,,,,,,,,,,,,,,,,,,,
jurgita.turuliene@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,1,{first}.{last},,,,,,,,http://uzsaugialietuva.lt/gerieji-pavyzdziai/antazaves-namai,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chaohong.sun@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,3,{first}.{last},,,,,,,,http://rcsb.org/structure/4oq5,http://rcsb.org/structure/4oq6,http://journals.iucr.org/f/issues/2017/03/00/tt5093/index.html,,,,,,,,,,,,,,,,,,,,,,,,,,
elena.chiellino@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,1,{first}.{last},,,,,,,,http://stc.uniroma2.it/news/ricerca-stagisti-qa-analisti-qc,,,,,,,,,,,,,,,,,,,,,,,,,,,,
giuseppina.zarigno@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,5,{first}.{last},,,,,,,,http://placement.uniroma2.it/2019/05/20/abbvie-laureati-in-economia,http://placement.uniroma2.it/tag/logistics-intern,http://placement.uniroma2.it/tag/abbvie,http://placement.uniroma2.it/tag/campoverde-di-aprilia,http://placement.uniroma2.it/2019/04/17/abbvie-laureati-in-ingegneria,,,,,,,,,,,,,,,,,,,,,,,,
an.tran@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,1,{first}.{last},,,,,,,,http://internship.edu.vn/jobs/administrative-assistant,,,,,,,,,,,,,,,,,,,,,,,,,,,,
abbviepaa@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,2,{first}.{last},,,,,,,,http://navigator.reaganudall.org/company-directory/a,http://navigator.reaganudall.org/company-directory,,,,,,,,,,,,,,,,,,,,,,,,,,,
hcofundingapplicationanz@abbvie.com,abbvie.com,AbbVie,US,,,,,76,generic,1,{first}.{last},,,,,,,,http://abbvie.co.nz/responsibility/grants-and-donations/funding-for-ogranisations.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anzhcpfunding@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,1,{first}.{last},,,,,,,,http://abbvie.co.nz/responsibility/grants-and-donations/funding-educational-event-attendance.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
doris.torrestorregrosa@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,3,{first}.{last},,,,,,,,http://news.abbvie.com/news/abbvie-donates-100-million-to-strengthen-access-to-healthcare-housing-for-hurricane-ravaged-puerto-rico.htm,http://news.abbvie.com/news/press-releases/abbvie-donates-100-million-to-strengthen-access-to-healthcare-housing-for-hurricane-ravaged-puerto-rico.htm,http://e.exam-10.com/marketing/12796/index.html,,,,,,,,,,,,,,,,,,,,,,,,,,
patientengagement.de@abbvie.com,abbvie.com,AbbVie,US,,,,,76,generic,2,{first}.{last},,,,,,,,http://abbvie-care.de/facebook,http://abbvie-care.de/nur-mut/acne-inversa,,,,,,,,,,,,,,,,,,,,,,,,,,,
yu.shen@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,1,{first}.{last},,,,,,,,http://coxsignaling.com/index.php/apabetalone,,,,,,,,,,,,,,,,,,,,,,,,,,,,
vija.elstina@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,1,{first}.{last},,,,,,,,http://infekcija.lv/blog/2015/06/17/lihassa-pirma-atklata-sede,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jenny.christensson@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,1,{first}.{last},,,,,,,,http://ringla.nu/goda-exempel/pa-resan-med-barnreumatism,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lanju.zhang@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,3,{first}.{last},,,,,,,,http://francophonia-liban.org/midwest-isa-chapter/30039178,http://icsa.org/membership/midwest-chapter,http://journal.pda.org/content/early/2020/09/30/pdajpst.2020.012096,,,,,,,,,,,,,,,,,,,,,,,,,,
parkour@abbvie.com,abbvie.com,AbbVie,US,,,,,76,personal,2,{first}.{last},,,,,,,,http://aerztezeitung.de/medizin/info-fuer-patienten-mit-parkinson-233323.html,http://aerztezeitung.de/medizin/krankheiten/neuro-psychiatrische_krankheiten/morbus_parkinson/article/877610/magazin-parkour-info-patienten-parkinson.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
datenschutz.de@abbvie.com,abbvie.com,AbbVie,US,,,,,76,generic,1,{first}.{last},,,,,,,,http://abbvie-care.de/login/registrierung,,,,,,,,,,,,,,,,,,,,,,,,,,,,
info.hu@abbvie.com,abbvie.com,AbbVie,US,,,,,76,generic,2,{first}.{last},,,Support,,,,,http://juvederm.hu/kapcsolat,http://szantograf.hu/2017/06/08/evtizednyi-fajdalom-szegyen-es-elszigetelodes-elet-egy-ritka-betegseggel-kezdodik-a-hidradenitisz-szuppurativa-vilaghete,,,,,,,,,,,,,,,,,,,,,,,,,,,
info-cz@abbvie.com,abbvie.com,AbbVie,US,,,,,76,generic,1,{first}.{last},,,Support,,,,,http://spcr.cz/struktura-sp-cr/clenska-zakladna/abecedni-seznam-clenu/clen/6161-abbvie-s-r-o,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gry.kopperud@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://nyemetoder.no/documents/beslutninger/beslutningsforum%2020160425%20-%20innkalling%20og%20saksdokumenter%20offentlig%20utgave.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hidenobu.kawaguchi@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://oacet.or.jp/img_file/seminar/168851872329416-1.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kunio.tonomura@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://kpshp.jp/events/event/4%e6%9c%88%e5%ba%a6%e8%a5%bf%e9%83%a8%e5%9c%b0%e5%8c%ba%e5%ae%9a%e4%be%8b%e7%a0%94%e4%bf%ae%e4%bc%9a-2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
customer.relations@abbvie.com,abbvie.com,AbbVie,US,,,,,75,generic,5,{first}.{last},,,Support,,,,,http://hema-quebec.qc.ca/userfiles/file/media/francais/hopitaux/15-026.pdf,http://hema-quebec.qc.ca/userfiles/file/media/francais/hopitaux/18-001.pdf,http://hema-quebec.qc.ca/userfiles/file/media/francais/hopitaux/19-042.pdf,http://hema-quebec.qc.ca/userfiles/file/media/francais/hopitaux/21-003.pdf,http://hema-quebec.qc.ca/userfiles/file/media/francais/hopitaux/21-005.pdf,,,,,,,,,,,,,,,,,,,,,,,,
cathryn.orava@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://fvpra.com/members,,,,,,,,,,,,,,,,,,,,,,,,,,,,
johannes.vanbrakel@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,2,{first}.{last},,,,,,,,http://portal.ptcma.org.za,http://portal.ptcma.org.za/welcome,,,,,,,,,,,,,,,,,,,,,,,,,,,
abbviecdo@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,2,{first}.{last},,,,,,,,http://cknby.com/contact-center.html,http://cknby.com/who-we-are/operating-with-integrity/responsible-supply-chain/supplier-resources.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
yoshitaka.hamada@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://fukui-byoyaku.com/wp-content/uploads/2022/05/69c48f061318cfb94024cd8bc1b918ce.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hideki.hatsuzaki@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://fukui-byoyaku.com/wp-content/uploads/2023/04/8244a1176fce06d377a8c6b2869c0ee1.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
allyanna.anglim@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://news.abbvie.com/news/press-releases/upadacitinib-rinvoq-meets-primary-and-all-ranked-secondary-endpoints-in-first-phase-3-induction-study-in-ulcerative-colitis.htm,,,,,,,,,,,,,,,,,,,,,,,,,,,,
indroneal.banerjee@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://sdcpha.org/_files/ugd/a33b45_4877de23d652480bb169ba0206d66fa6.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
derett.jepson@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,3,{first}.{last},,,,,,,,http://hepfree.nyc/hep-free-nyc-meeting-highlights-03-29-2023,http://hepfree.nyc/hep-free-nyc-meeting-highlights-09-14-2022,http://hepfree.nyc/hep-free-nyc-meeting-highlights-12-7-2022,,,,,,,,,,,,,,,,,,,,,,,,,,
kendric.cobb@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://nelc-law.org/membership-directory/individual/1073949,,,,,,,,,,,,,,,,,,,,,,,,,,,,
azzah.zaidi@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,2,{first}.{last},,,,,,,,http://txtabs.org/annual-meeting/virtual-exhibitor,http://ntexas.org/annual-meeting/virtual-exhibitor,,,,,,,,,,,,,,,,,,,,,,,,,,,
laura.wetherly@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://pharmiweb.com/press-release/2022-06-29/nice-recommends-abbvie-s-rinvoq-upadacitinib-for-use-in-adults-and-adolescents-12-years-and-older-with-moderate-to-severe-atopic-dermatitis-ecze,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pvabbviemexico@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,2,{first}.{last},,,,,,,,http://abbvie.com.mx/contactus.html,http://abbvie.com.mx/our-company/abbvie-en-mexico.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
gr.complaints@abbvie.com,abbvie.com,AbbVie,US,,,,,75,generic,0,{first}.{last},,,Support,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
customercare.gr@abbvie.com,abbvie.com,AbbVie,US,,,,,75,generic,1,{first}.{last},,,Support,,,,,http://reumazin.gr/sponsors_supporters/abbvie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
camille.beniga@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://mann.usc.edu/program/fellowship-programs/current-fellows,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hendrik.vonbueren@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,2,{first}.{last},,,,,,,,http://dphg.de/mitglieder/dr-hendrik-von-buren,http://dphg.de/profil,,,,,,,,,,,,,,,,,,,,,,,,,,,
margaret.fettiskoenders@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,2,{first}.{last},,,,,,,,http://biomaterials.org/sigs-overview/biomaterials-education,http://biomaterials.org/sigs-and-committees-sigs-and-committees-overview/biomaterials-education,,,,,,,,,,,,,,,,,,,,,,,,,,,
lt.abbvie@abbvie.com,abbvie.com,AbbVie,US,,,,,75,generic,1,{first}.{last},,,,,,,,http://ifpa.lt/nariai-ir-struktura,,,,,,,,,,,,,,,,,,,,,,,,,,,,
weigh2go@abbvie.com,abbvie.com,AbbVie,US,,,,,75,generic,1,{first}.{last},,,,,,,,http://abbvieweigh2go.com/pages/faqs,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anissa.sameur@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://jeunesdavenirs-recrut.fr/fiche-entreprise/6110f0277e8faa0e2e1b670c,,,,,,,,,,,,,,,,,,,,,,,,,,,,
agn-dl-ausdermalinternationalcomplaints@abbvie.com,abbvie.com,AbbVie,US,,,,,75,generic,1,{first}.{last},,,Support,,,,,http://juvederm.ca,,,,,,,,,,,,,,,,,,,,,,,,,,,,
drugsafetyscandi@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,5,{first}.{last},,,,,,,,http://duodopa.no/helsepersonell/sikkerhet/bivirkninger,http://duodopa.no/helsepersonell/informasjonsmateriell/guider-skjemaer,http://duodopa.no/helsepersonell/kontakt/supporttjeneste,http://duodopa.no/helsepersonell/sikkerhet,http://duodopa.no,,,,,,,,,,,,,,,,,,,,,,,,
medinfoscandi@abbvie.com,abbvie.com,AbbVie,US,,,,,75,generic,3,{first}.{last},,,,,,,,http://legemiddelverket.no/documents/bivirkninger%20og%20sikkerhet/kj%c3%a6re%20helsepersonell-brev/2021/dhpc%20letter_no_26-may-2021_final%20version%20reviewed%20by%20noma%2003-jun-2021-signed.pdf,http://duodopa.no/helsepersonell/sikkerhet,http://duodopa.no/helsepersonell/sikkerhet/bivirkninger,,,,,,,,,,,,,,,,,,,,,,,,,,
cathy.dorangrichia@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://wiparkinson.org/pharmaceutical-speaker-resources,,,,,,,,,,,,,,,,,,,,,,,,,,,,
uyentrang.bui@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://journal.pda.org/content/early/2020/09/30/pdajpst.2020.012096,,,,,,,,,,,,,,,,,,,,,,,,,,,,
thorsten.pflanzner@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,5,{first}.{last},,,,,,,,http://journal.pda.org/content/75/2/173.full,http://journal.pda.org/content/75/2/173/tab-article-info,http://journal.pda.org/content/75/2/173/tab-figures-data,http://journal.pda.org/content/75/2/173/tab-references,http://journal.pda.org/content/75/2/173,,,,,,,,,,,,,,,,,,,,,,,,
gregory.willocq@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,2,{first}.{last},,,,,,,,http://iml.lu/en/about-us/board,http://iml.lu/fr/qui-sommes-nous/qui-sommes-nous,,,,,,,,,,,,,,,,,,,,,,,,,,,
kristina.bokenewicz@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,2,{first}.{last},,,,,,,,http://ean.org/congress2021/sponsors/list-of-sponsors,http://ean.org/congress-2020/exhibit/exhibition/list-of-exhibitors,,,,,,,,,,,,,,,,,,,,,,,,,,,
noureldin.saleh@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://proteinformatics.uni-leipzig.de/group/team.php,,,,,,,,,,,,,,,,,,,,,,,,,,,,
abbvie_cic.pt@abbvie.com,abbvie.com,AbbVie,US,,,,,75,generic,1,{first}.{last},,,,,,,,http://abbvie.pt/contactus.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
subvention-grant@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://abbvie.ca/content/abbvie-com/ca/fr/grants-and-donations-form.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
przetargi@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://wssk.wroc.pl/files/auctions/14840370866459.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
acbe@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,4,{first}.{last},,,,,,,,http://abbviecare.be/over-abbvie,http://abbviecare.be/patiententoestemming,http://abbviecare.be,http://abbviecare.be/password-management,,,,,,,,,,,,,,,,,,,,,,,,,
anahita.bhathena@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://webmail.druglib.com/abstract/bh/bhathena-a1_transl-psychiatry_20130000.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ukpaediatricteam@abbvie.com,abbvie.com,AbbVie,US,,,,,75,generic,1,{first}.{last},,,Support,,,,,http://ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001005-pip01-10-m01,,,,,,,,,,,,,,,,,,,,,,,,,,,,
medha.tomlinson@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://uwpa.wisc.edu/2018/08/15/senior-scientist-job-protein-purification-at-abbvie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
romain.fardellone@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,4,{first}.{last},,,,,,,,http://schallware.de/en/rental/555,http://vermietung.schallware.de/en/rental/555,http://vermietung.schallware.de/rental/555,http://schallware.de/rental/555,,,,,,,,,,,,,,,,,,,,,,,,,
rongze.lu@abbvie.com,abbvie.com,AbbVie,US,,,,,75,generic,5,{first}.{last},,,,,,,,http://jitc.bmj.com/content/6/1/63.info,http://jitc.bmj.com/content/6/1/63.responses,http://jitc.bmj.com/content/6/1/63.share,http://jitc.bmj.com/content/6/1/50,http://jitc.bmj.com/content/6/1/63,,,,,,,,,,,,,,,,,,,,,,,,
marykay.hahn@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://trinitykenosha.org/staff-contacts,,,,,,,,,,,,,,,,,,,,,,,,,,,,
infomed.la@abbvie.com,abbvie.com,AbbVie,US,,,,,75,generic,3,{first}.{last},,,Support,,,,,http://sdird.org/eventos/action~agenda/page_offset~-3/request_format~json,http://alergiausp.com.br/landing-abbvie,http://sdird.org/evento/simposio-internacional-hepatitis-virales,,,,,,,,,,,,,,,,,,,,,,,,,,
talentacquisition_abv@abbvie.com,abbvie.com,AbbVie,US,,,,,75,generic,2,{first}.{last},,,,,,,,http://closelyhq.com/catalog/people-ak-81-roshan-akkara-george-akkara-3871936b-ak,http://corporateofficeheadquarters.org/abbvie,,,,,,,,,,,,,,,,,,,,,,,,,,,
conny.tsounis@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://hbio.gr/member/abbvie-pharmaceuticals-sa,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pvisrael@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://medic.co.il/license-holder/abbvie-biopharmaceuticals-ltd,,,,,,,,,,,,,,,,,,,,,,,,,,,,
trusted_trader@abbvie.com,abbvie.com,AbbVie,US,,,,,75,generic,1,{first}.{last},,,,,,,,http://cknby.com/who-we-are/operating-with-integrity/responsible-supply-chain/supplier-resources.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
supplierdiversity@abbvie.com,abbvie.com,AbbVie,US,,,,,75,generic,1,{first}.{last},,,,,,,,http://cknby.com/who-we-are/operating-with-integrity/responsible-supply-chain/supplier-resources.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
francesca.marrani@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,2,{first}.{last},,,,,,,,http://aidic.it/divisioni_working_parties.php,http://aidic.it/italiano/workingparty/quality/quality.htm,,,,,,,,,,,,,,,,,,,,,,,,,,,
ukmediarelations@abbvie.com,abbvie.com,AbbVie,US,,,,,75,generic,5,{first}.{last},,,Writing & communication,,,,,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/skyriziv-risankizumab-receives-nice-positive-technology-appraisal-guidance-for-the-treatment-of-plaque-psoriasis-in-adults-2908347,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/abbvies-skyriziv-risankizumab-accepted-for-use-within-nhs-scotland-2928830,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/results-from-upadacitinib-phase-3-select-compare-study-published-in-arthritis-and-rheumatology-2896790,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/abbvies-duodopa-r-levodopa-carbidopa-intestinal-gel-recommended-for-use-within-nhs-wales-2460807,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/nice-issues-positive-final-appraisal-document-for-skyriziv-risankizumab-for-the-treatment-of-plaque-psoriasis-in-adults-2897106,,,,,,,,,,,,,,,,,,,,,,,,
vitality@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,3,{first}.{last},,,,,,,,http://abbvietotalrewardscontacts.com/type/global-from,http://abbvietotalrewardscontacts.com/type/global-to,http://abbvieweigh2go.com/pages/program-terms,,,,,,,,,,,,,,,,,,,,,,,,,,
frank.oellien@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,1,{first}.{last},,,,,,,,http://warr.com/meet2015archive.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ee.abbvie@abbvie.com,abbvie.com,AbbVie,US,,,,,75,generic,3,{first}.{last},,,,,,,,http://dev.amcham.ee/members/abbvie-biopharmaceuticals-gmbh-eesti-filiaal,http://amcham.ee/members/abbvie-biopharmaceuticals-gmbh-eesti-filiaal,http://rtl.ee/liikmed,,,,,,,,,,,,,,,,,,,,,,,,,,
orders.eu@abbvie.com,abbvie.com,AbbVie,US,,,,,75,generic,1,{first}.{last},,,Sales,,,,,http://juvederm.de/impressum,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nabil.ackad@abbvie.com,abbvie.com,AbbVie,US,,,,,75,personal,4,{first}.{last},,,,,,,,http://hepatitiscnewdrugs.blogspot.com/2016/02/feb-2016-update-upcoming-and-recruiting.html,http://hepatitiscnewdrugs.blogspot.com/2016/06/june-recruiting-and-upcoming-hepatitis.html,http://hepatitiscnewdrugs.blogspot.com/2016/06,http://hepatitiscnewdrugs.blogspot.com/2016_06_01_archive.html,,,,,,,,,,,,,,,,,,,,,,,,,
info.nl@abbvie.com,abbvie.com,AbbVie,US,,,,,75,generic,2,{first}.{last},,,Support,,,,,http://huisartsenservice.nl/gids-dienstverleners,http://apotheekkennisbank.nl/bedrijfsvoering/bedrijvengids/bedrijf/abbvie-bv,,,,,,,,,,,,,,,,,,,,,,,,,,,
webmaster@abbvie.com,abbvie.com,AbbVie,US,,,,,75,generic,2,{first}.{last},,,IT / Engineering,,,,,http://cknby.com/who-we-are/operating-with-integrity/transparency-in-payment/abbvie-inquiry.html,http://hepatitcsizyasam.com/gizlilik_politikasi.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
ksenia.arkhipova@abbvie.com,abbvie.com,AbbVie,US,,,,,74,personal,1,{first}.{last},,,,,,,,http://clinicaltrials.gov/ct2/show/nct04253314,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gabriella.melzi@abbvie.com,abbvie.com,AbbVie,US,,,,,74,personal,1,{first}.{last},,,,,,,,http://moh-it.pure.elsevier.com/en/publications/motor-and-non-motor-outcomes-in-patients-with-advanced-parkinsons,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hidetomi.yamagami@abbvie.com,abbvie.com,AbbVie,US,,,,,74,personal,1,{first}.{last},,,,,,,,http://frontiersin.org/articles/10.3389/fpubh.2019.00039/full,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hyuna.yang@abbvie.com,abbvie.com,AbbVie,US,,,,,74,personal,1,{first}.{last},,,,,,,,http://biorxiv.org/content/early/2015/02/17/013037,,,,,,,,,,,,,,,,,,,,,,,,,,,,
buhyang.kim@abbvie.com,abbvie.com,AbbVie,US,,,,,73,generic,1,{first}.{last},,,,,,,,http://clinicaltrials.gov/ct2/show/nct03740230,,,,,,,,,,,,,,,,,,,,,,,,,,,,
marie-josee.fournelle@abbvie.com,abbvie.com,AbbVie,US,,,,,73,personal,1,{first}.{last},,,,,,,,http://clinicaltrials.gov/ct2/show/nct01960881,,,,,,,,,,,,,,,,,,,,,,,,,,,,
andreia.bornel@abbvie.com,abbvie.com,AbbVie,US,,,,,73,personal,1,{first}.{last},,,,,,,,http://clinicaltrials.gov/ct2/show/study/nct01848561,,,,,,,,,,,,,,,,,,,,,,,,,,,,
isabelle.defoy@abbvie.com,abbvie.com,AbbVie,US,,,,,72,personal,1,{first}.{last},,,,,,,,http://clinicaltrials.gov/ct2/show/nct01960881,,,,,,,,,,,,,,,,,,,,,,,,,,,,
taina.kujanpaa@abbvie.com,abbvie.com,AbbVie,US,,,,,72,personal,1,{first}.{last},,,,,,,,http://mynewsdesk.com/fi/abbvie/pressreleases/kutsu-31-dot-1-kestaevae-terveydenhuolto-hanke-saako-kroonisesti-sairas-valita-vapaasti-1753745,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ukadverseevents@abbvie.com,abbvie.com,AbbVie,US,,,,,72,generic,1,{first}.{last},,,,,,,,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/abbvies-duodopa-r-levodopa-carbidopa-intestinal-gel-recommended-for-use-within-nhs-wales-2460807,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sarahjane.bull@abbvie.com,abbvie.com,AbbVie,US,,,,,71,personal,1,{first}.{last},,,,,,,,http://clinicaltrials.gov/show/nct03310190,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gwenan.white@abbvie.com,abbvie.com,AbbVie,US,,,,,71,personal,1,{first}.{last},,,,,,,,http://mynewsdesk.com/uk/abbvie-uk,,,,,,,,,,,,,,,,,,,,,,,,,,,,
uk_pvvendor@abbvie.com,abbvie.com,AbbVie,US,,,,,71,personal,1,{first}.{last},,,,,,,,http://mynewsdesk.com/uk/abbvie-uk/pressreleases/nice-issues-positive-final-appraisal-document-for-skyriziv-risankizumab-for-the-treatment-of-plaque-psoriasis-in-adults-2897106,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pierreandre.fournier@abbvie.com,abbvie.com,AbbVie,US,,,,,70,personal,1,{first}.{last},,,,,,,,http://clinicaltrials.gov/show/nct03310190,,,,,,,,,,,,,,,,,,,,,,,,,,,,
yinyin.wang@abbvie.com,abbvie.com,AbbVie,US,,,,,70,generic,1,{first}.{last},,,,,,,,http://clinicaltrials.gov/ct2/show/nct03236870,,,,,,,,,,,,,,,,,,,,,,,,,,,,
yuchuan.gong@abbvie.com,abbvie.com,AbbVie,US,,,,,70,personal,1,{first}.{last},,,,,,,,http://pubs.rsc.org/en/content/articlelanding/2013/lc/c3lc41271g,,,,,,,,,,,,,,,,,,,,,,,,,,,,
martha.neagu@abbvie.com,abbvie.com,AbbVie,US,,,,,69,personal,0,{first}.{last},Martha,Neagu,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jane.maruca@abbvie.com,abbvie.com,AbbVie,US,,,,,69,personal,0,{first}.{last},Jane,Maruca,Education,Rn Bsn,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
wendell.valdecantos@abbvie.com,abbvie.com,AbbVie,US,,,,,69,personal,0,{first}.{last},Wendell,Valdecantos,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jaakko.aaltonen@abbvie.com,abbvie.com,AbbVie,US,,,,,69,personal,0,{first}.{last},Jaakko,Aaltonen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kirsti.nyhus@abbvie.com,abbvie.com,AbbVie,US,,,,,69,personal,0,{first}.{last},Kirsti,Nyhus,,"","","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
michael.wichtendahl@abbvie.com,abbvie.com,AbbVie,US,,,,,69,personal,0,{first}.{last},Michael,Wichtendahl,Management,Vendor Management,com,https://www.linkedin.com/in/michael-wichtendahl-18ba5a5/,"",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
helene.villeneuve@abbvie.com,abbvie.com,AbbVie,US,,,,,69,personal,0,{first}.{last},Helene,Villeneuve,,"","","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
stacy.sullivan@abbvie.com,abbvie.com,AbbVie,US,,,,,69,personal,0,{first}.{last},Stacy,Sullivan,Medical & health,Palliative Care,"","",+1 860 414 9379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
katie.bertolino@abbvie.com,abbvie.com,AbbVie,US,,,,,69,personal,0,{first}.{last},Katie,Bertolino,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pamela.hamacher@abbvie.com,abbvie.com,AbbVie,US,,,,,69,personal,0,{first}.{last},Pamela,Hamacher,,"","","",+1 757 434 8966,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
betsy.ortolano@abbvie.com,abbvie.com,AbbVie,US,,,,,69,personal,0,{first}.{last},Betsy,Ortolano,,"","","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jarrod.miles@abbvie.com,abbvie.com,AbbVie,US,,,,,69,personal,0,{first}.{last},Jarrod,Miles,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jonathan.villemaire@abbvie.com,abbvie.com,AbbVie,US,,,,,69,personal,0,{first}.{last},Jonathan,Villemaire,Sales,National Sales Manager,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
maria.andersson@abbvie.com,abbvie.com,AbbVie,US,,,,,69,personal,0,{first}.{last},Maria,Andersson,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
clinton.shard@abbvie.com,abbvie.com,AbbVie,US,,,,,69,personal,0,{first}.{last},Clinton,Shard,,"","","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ross.carroll@abbvie.com,abbvie.com,AbbVie,US,,,,,69,personal,0,{first}.{last},Ross,Carroll,,"","","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anders.sandvik@abbvie.com,abbvie.com,AbbVie,US,,,,,69,personal,0,{first}.{last},Anders,Sandvik,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pepa.morales@abbvie.com,abbvie.com,AbbVie,US,,,,,68,personal,0,{first}.{last},Pepa,Morales,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
paula.fernandez@abbvie.com,abbvie.com,AbbVie,US,,,,,68,personal,0,{first}.{last},Paula,Fernandez,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
alena.paulson@abbvie.com,abbvie.com,AbbVie,US,,,,,68,personal,0,{first}.{last},Alena,Paulson,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
stephen.gauld@abbvie.com,abbvie.com,AbbVie,US,,,,,68,personal,0,{first}.{last},Stephen,Gauld,,"","","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ian.ginsberg@abbvie.com,abbvie.com,AbbVie,US,,,,,68,personal,0,{first}.{last},Ian,Ginsberg,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
li.zhou@abbvie.com,abbvie.com,AbbVie,US,,,,,68,personal,0,{first}.{last},Zhou,Li,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tracy.head@abbvie.com,abbvie.com,AbbVie,US,,,,,68,personal,0,{first}.{last},Tracy,Head,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kristina.moore@abbvie.com,abbvie.com,AbbVie,US,,,,,68,personal,0,{first}.{last},Kristina,Moore,,"","","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
fernando.mendoza@abbvie.com,abbvie.com,AbbVie,US,,,,,68,personal,0,{first}.{last},Fernando,Mendoza,,"","","",+1 312 718 7295,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
miranda.barten@abbvie.com,abbvie.com,AbbVie,US,,,,,68,personal,0,{first}.{last},Miranda,Barten,Education,Learning And Development,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
brittani.hewitt@abbvie.com,abbvie.com,AbbVie,US,,,,,68,personal,0,{first}.{last},Brittani,Hewitt,Medical & health,Medical Affairs,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
irene.sunwoo@abbvie.com,abbvie.com,AbbVie,US,,,,,68,personal,0,{first}.{last},Irene,Sunwoo,,Regulatory Affairs,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sascha.vaupel@abbvie.com,abbvie.com,AbbVie,US,,,,,68,personal,0,{first}.{last},Sascha,Vaupel,Sales,Key Account Manager,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
marcelle.levy@abbvie.com,abbvie.com,AbbVie,US,,,,,68,personal,0,{first}.{last},Marcelle,Levy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jose.bernal@abbvie.com,abbvie.com,AbbVie,US,,,,,68,personal,0,{first}.{last},Jose,Bernal,,"","","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jurgen.dinges@abbvie.com,abbvie.com,AbbVie,US,,,,,68,personal,0,{first}.{last},Jurgen,Dinges,,"","","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jaclyn.anderson@abbvie.com,abbvie.com,AbbVie,US,,,,,67,personal,0,{first}.{last},Jaclyn,Anderson,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
emily.chastain@abbvie.com,abbvie.com,AbbVie,US,,,,,67,personal,0,{first}.{last},Emily,Chastain,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
geir.stokke@abbvie.com,abbvie.com,AbbVie,US,,,,,67,personal,0,{first}.{last},Geir,Stokke,,"","","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
amanda.george@abbvie.com,abbvie.com,AbbVie,US,,,,,67,personal,0,{first}.{last},Amanda,George,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
liz.tang@abbvie.com,abbvie.com,AbbVie,US,,,,,67,personal,0,{first}.{last},Liz,Tang,Executive,Vice President,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cynthia.sassenberg@abbvie.com,abbvie.com,AbbVie,US,,,,,67,personal,0,{first}.{last},Cynthia,Sassenberg,,Regulatory Affairs,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
iain.boomer@abbvie.com,abbvie.com,AbbVie,US,,,,,67,personal,0,{first}.{last},Iain,Boomer,,"","",http://www.linkedin.com/in/iboomer,"",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
karen.gordon@abbvie.com,abbvie.com,AbbVie,US,,,,,67,personal,0,{first}.{last},Karen,Gordon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ellie.pedersen@abbvie.com,abbvie.com,AbbVie,US,,,,,67,personal,0,{first}.{last},Ellie,Pedersen,,Specialist,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
perrine.sokal@abbvie.com,abbvie.com,AbbVie,US,,,,,67,personal,0,{first}.{last},Perrine,Sokal,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
brent.bostrom@abbvie.com,abbvie.com,AbbVie,US,,,,,67,personal,0,{first}.{last},Brent,Bostrom,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sean.turner@abbvie.com,abbvie.com,AbbVie,US,,,,,67,personal,0,{first}.{last},Sean,Turner,Executive,Associate Partner,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pablo.hernandez@abbvie.com,abbvie.com,AbbVie,US,,,,,67,personal,0,{first}.{last},Pablo,Hernandez,,"","","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
eduardo.leyva@abbvie.com,abbvie.com,AbbVie,US,,,,,67,personal,0,{first}.{last},Eduardo,Leyva,Management,General Manager,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hassan.tamimi@abbvie.com,abbvie.com,AbbVie,US,,,,,67,personal,0,{first}.{last},Hassan,Tamimi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
dusan.baksa@abbvie.com,abbvie.com,AbbVie,US,,,,,67,personal,0,{first}.{last},Dusan,Baksa,Operations & logistics,Quality Manager,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
julene.vidic@abbvie.com,abbvie.com,AbbVie,US,,,,,66,personal,0,{first}.{last},Julene,Vidic,Education,Rn Bsn,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cara.chiu@abbvie.com,abbvie.com,AbbVie,US,,,,,66,personal,0,{first}.{last},Cara,Chiu,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
henrique.teixeira@abbvie.com,abbvie.com,AbbVie,US,,,,,66,personal,0,{first}.{last},Henrique,Teixeira,,"","","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gerlinde.baldauf@abbvie.com,abbvie.com,AbbVie,US,,,,,66,personal,0,{first}.{last},Gerlinde,Baldauf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
austin.mullins@abbvie.com,abbvie.com,AbbVie,US,,,,,66,personal,0,{first}.{last},Austin,Mullins,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ammar.alkhafaji@abbvie.com,abbvie.com,AbbVie,US,,,,,66,personal,0,{first}.{last},Ammar,Alkhafaji,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
john.lee@abbvie.com,abbvie.com,AbbVie,US,,,,,66,personal,0,{first}.{last},John,Lee,,"","","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
david.newall@abbvie.com,abbvie.com,AbbVie,US,,,,,66,personal,0,{first}.{last},David,Newall,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
laurent.sammut@abbvie.com,abbvie.com,AbbVie,US,,,,,66,personal,0,{first}.{last},Laurent,Sammut,Management,Commercial Director,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jason.hart@abbvie.com,abbvie.com,AbbVie,US,,,,,66,personal,0,{first}.{last},Jason,Hart,,Access Specialist,"","",+1 855 297 5906,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
janet.stanczak@abbvie.com,abbvie.com,AbbVie,US,,,,,66,personal,0,{first}.{last},Janet,Stanczak,,"","","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tabetha.skarbek@abbvie.com,abbvie.com,AbbVie,US,,,,,66,personal,0,{first}.{last},Tabetha,Skarbek,Executive,Vice President,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
monique.lorenzana@abbvie.com,abbvie.com,AbbVie,US,,,,,66,personal,0,{first}.{last},Monique,Lorenzana,,"","","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sam.smida@abbvie.com,abbvie.com,AbbVie,US,,,,,66,personal,0,{first}.{last},Sam,Smida,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
agnieszka.bobholz@abbvie.com,abbvie.com,AbbVie,US,,,,,66,personal,0,{first}.{last},Agnieszka,Bobholz,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
thao.t.doan@abbvie.com,abbvie.com,AbbVie,US,,,,,66,personal,0,{first}.{last},Thao,Doan,Medical & health,Senior Medical Director,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
rosalind.fernandez@abbvie.com,abbvie.com,AbbVie,US,,,,,65,personal,0,{first}.{last},Rosalind,Fernandez,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sandra.goss@abbvie.com,abbvie.com,AbbVie,US,,,,,65,personal,0,{first}.{last},Sandra,Goss,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
morgan.richard@abbvie.com,abbvie.com,AbbVie,US,,,,,65,personal,0,{first}.{last},Morgan,Richard,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
stefanie.reyes@abbvie.com,abbvie.com,AbbVie,US,,,,,65,personal,0,{first}.{last},Stefanie,Reyes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tracy.henriques@abbvie.com,abbvie.com,AbbVie,US,,,,,65,personal,0,{first}.{last},Tracy,Henriques,Medical & health,Food Safety,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
danielle.frewin@abbvie.com,abbvie.com,AbbVie,US,,,,,65,personal,0,{first}.{last},Danielle,Frewin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
parker.wade@abbvie.com,abbvie.com,AbbVie,US,,,,,65,personal,0,{first}.{last},Parker,Wade,Medical & health,Medical Affairs,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
charles.mattis@abbvie.com,abbvie.com,AbbVie,US,,,,,65,personal,0,{first}.{last},Charles,Mattis,Education,Research Advisor,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
alexandra.nystrand@abbvie.com,abbvie.com,AbbVie,US,,,,,65,personal,0,{first}.{last},Alexandra,Nystrand,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jason.farley@abbvie.com,abbvie.com,AbbVie,US,,,,,65,personal,0,{first}.{last},Jason,Farley,,"","","",+1 234 243 2250,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
julia.felder@abbvie.com,abbvie.com,AbbVie,US,,,,,65,personal,0,{first}.{last},Julia,Felder,Writing & communication,Patient Relations,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
denise.oleske@abbvie.com,abbvie.com,AbbVie,US,,,,,65,personal,0,{first}.{last},Denise,Oleske,Medical & health,Infectious Disease,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
mikael.heimburger@abbvie.com,abbvie.com,AbbVie,US,,,,,65,personal,0,{first}.{last},Mikael,Heimburger,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anna.maroney@abbvie.com,abbvie.com,AbbVie,US,,,,,65,personal,0,{first}.{last},Anna,Maroney,Education,Senior Instructor,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
angela.heisig@abbvie.com,abbvie.com,AbbVie,US,,,,,65,personal,0,{first}.{last},Angela,Heisig,Education,Clinical Professor,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
matthew.ravn@abbvie.com,abbvie.com,AbbVie,US,,,,,65,personal,0,{first}.{last},Matthew,Ravn,Education,Scientist,"","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
vishvas.garg@abbvie.com,abbvie.com,AbbVie,US,,,,,64,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sheila.galloro@abbvie.com,abbvie.com,AbbVie,US,,,,,64,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hr_austria@abbvie.com,abbvie.com,AbbVie,US,,,,,64,generic,0,{first}.{last},,,HR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
finance.norway@abbvie.com,abbvie.com,AbbVie,US,,,,,64,generic,0,{first}.{last},,,Finance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
complaints.za@abbvie.com,abbvie.com,AbbVie,US,,,,,64,generic,0,{first}.{last},,,Support,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
camila.zanqueta@abbvie.com,abbvie.com,AbbVie,US,,,,,64,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tamara.shabaga@abbvie.com,abbvie.com,AbbVie,US,,,,,63,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pieter.dehaese@abbvie.com,abbvie.com,AbbVie,US,,,,,63,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
masara.issa@abbvie.com,abbvie.com,AbbVie,US,,,,,63,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
officemanagement@abbvie.com,abbvie.com,AbbVie,US,,,,,63,generic,0,{first}.{last},,,Management,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
barbara.cristofanelli@abbvie.com,abbvie.com,AbbVie,US,,,,,63,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
stewart.musselle@abbvie.com,abbvie.com,AbbVie,US,,,,,63,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
bryan.beidle@abbvie.com,abbvie.com,AbbVie,US,,,,,62,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
michelle.gjoerlund@abbvie.com,abbvie.com,AbbVie,US,,,,,62,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
judith.kunczier@abbvie.com,abbvie.com,AbbVie,US,,,,,62,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jan.lohne@abbvie.com,abbvie.com,AbbVie,US,,,,,62,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
julie.wilsbacher@abbvie.com,abbvie.com,AbbVie,US,,,,,62,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
barbara.razenberg@abbvie.com,abbvie.com,AbbVie,US,,,,,61,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ramu.sadhukhan@abbvie.com,abbvie.com,AbbVie,US,,,,,61,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
elizabeth.chitouras@abbvie.com,abbvie.com,AbbVie,US,,,,,61,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
emeka.ojinnaka@abbvie.com,abbvie.com,AbbVie,US,,,,,61,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
alexandra.welzbacher@abbvie.com,abbvie.com,AbbVie,US,,,,,61,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
neil.poloso@abbvie.com,abbvie.com,AbbVie,US,,,,,60,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
investigator.inquiry@abbvie.com,abbvie.com,AbbVie,US,,,,,60,generic,0,{first}.{last},,,Finance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ofelia.reyesservin@abbvie.com,abbvie.com,AbbVie,US,,,,,60,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jim.kraschel@abbvie.com,abbvie.com,AbbVie,US,,,,,60,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
elisa.zazza@abbvie.com,abbvie.com,AbbVie,US,,,,,60,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gunilla.forsberg@abbvie.com,abbvie.com,AbbVie,US,,,,,19,personal,0,{first}.{last},Gunilla,Forsberg,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
takuya.sasaki@abbvie.com,abbvie.com,AbbVie,US,,,,,19,personal,0,{first}.{last},Takuya,Sasaki,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jessica.shumaker@abbvie.com,abbvie.com,AbbVie,US,,,,,19,personal,0,{first}.{last},Jessica,Shumaker,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
benjamin.huizenga@abbvie.com,abbvie.com,AbbVie,US,,,,,19,personal,0,{first}.{last},Benjamin,Huizenga,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
laurence.raison@abbvie.com,abbvie.com,AbbVie,US,,,,,19,personal,0,{first}.{last},Laurence,Raison,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anna.zur@abbvie.com,abbvie.com,AbbVie,US,,,,,19,personal,0,{first}.{last},Anna,Zur,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jane.doe@abbvie.com,abbvie.com,AbbVie,US,,,,,18,personal,0,{first}.{last},Jane,Doe,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
colleen.jensen@abbvie.com,abbvie.com,AbbVie,US,,,,,18,personal,0,{first}.{last},Colleen,Jensen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ryan.borger@abbvie.com,abbvie.com,AbbVie,US,,,,,18,personal,0,{first}.{last},Ryan,Borger,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kate.fall@abbvie.com,abbvie.com,AbbVie,US,,,,,18,personal,0,{first}.{last},Kate,Fall,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
maria.delgiacco@abbvie.com,abbvie.com,AbbVie,US,,,,,18,personal,0,{first}.{last},Maria,Delgiacco,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
binu.philip@abbvie.com,abbvie.com,AbbVie,US,,,,,18,personal,0,{first}.{last},Binu,Philip,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jabulile.mahlangu@abbvie.com,abbvie.com,AbbVie,US,,,,,17,personal,0,{first}.{last},Jabulile,Mahlangu,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
maggie.headley@abbvie.com,abbvie.com,AbbVie,US,,,,,17,personal,0,{first}.{last},Maggie,Headley,,"","","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
yuill@abbvie.com,abbvie.com,AbbVie,US,,,,,17,personal,0,{first}.{last},Brian,Yuill,,"","","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
shawn.moon@abbvie.com,abbvie.com,AbbVie,US,,,,,17,personal,0,{first}.{last},Shawn,Moon,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
annamaria.costanzo@abbvie.com,abbvie.com,AbbVie,US,,,,,17,personal,0,{first}.{last},Annamaria,Costanzo,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
marcie.jungles@abbvie.com,abbvie.com,AbbVie,US,,,,,17,personal,0,{first}.{last},Marcie,Jungles,,"","","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
yulia.loenko@abbvie.com,abbvie.com,AbbVie,US,,,,,17,personal,0,{first}.{last},Yulia,Loenko,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
alicia.spagnuolo@abbvie.com,abbvie.com,AbbVie,US,,,,,17,personal,0,{first}.{last},Alicia,Spagnuolo,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
andreas.hildebrandt@abbvie.com,abbvie.com,AbbVie,US,,,,,17,personal,0,{first}.{last},Andreas,Hildebrandt,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
christi.klossner@abbvie.com,abbvie.com,AbbVie,US,,,,,17,personal,0,{first}.{last},Christi,Klossner,,"","","","",,,,,,,,,,,,,,,,,,,,,,,,,,,,,
thieu.nguyen@abbvie.com,abbvie.com,AbbVie,US,,,,,16,personal,0,{first}.{last},Nguyen,Thieu,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
mike.magallanes@abbvie.com,abbvie.com,AbbVie,US,,,,,16,personal,0,{first}.{last},Mike,Magallanes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chris.deluca@abbvie.com,abbvie.com,AbbVie,US,,,,,16,personal,0,{first}.{last},Chris,Deluca,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
julie.arel@abbvie.com,abbvie.com,AbbVie,US,,,,,16,personal,0,{first}.{last},Julie,Arel,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
susan.kelso@abbvie.com,abbvie.com,AbbVie,US,,,,,16,personal,0,{first}.{last},Susan,Kelso,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
birgit.weidemann-roever@abbvie.com,abbvie.com,AbbVie,US,,,,,16,personal,0,{first}.{last},Birgit,Roever,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
matthew.rosebraugh@abbvie.com,abbvie.com,AbbVie,US,,,,,15,personal,0,{first}.{last},Matthew,Rosebraugh,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sarkis.josi@abbvie.com,abbvie.com,AbbVie,US,,,,,15,personal,0,{first}.{last},Josi,Sarkis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
joy.farina@abbvie.com,abbvie.com,AbbVie,US,,,,,15,personal,0,{first}.{last},Joy,Farina,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
elizabeth.h.thompson@abbvie.com,abbvie.com,AbbVie,US,,,,,15,personal,0,{first}.{last},Elizabeth,Thompson,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
daniela.campos@abbvie.com,abbvie.com,AbbVie,US,,,,,15,personal,0,{first}.{last},Daniela,Campos,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
james.norton@abbvie.com,abbvie.com,AbbVie,US,,,,,15,personal,0,{first}.{last},James,Norton,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
christofer.kemp@abbvie.com,abbvie.com,AbbVie,US,,,,,15,personal,0,{first}.{last},Christofer,Kemp,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jennifer.cundiff@abbvie.com,abbvie.com,AbbVie,US,,,,,15,personal,0,{first}.{last},Jennifer,Cundiff,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
fang.jiang@abbvie.com,abbvie.com,AbbVie,US,,,,,15,personal,0,{first}.{last},Fang,Jiang,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
productsurveillance_ukraine@abbvie.com,abbvie.com,AbbVie,US,,,,,14,generic,0,{first}.{last},,,Writing & communication,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
medinfobulgaria@abbvie.com,abbvie.com,AbbVie,US,,,,,14,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
drug-safety.pl@abbvie.com,abbvie.com,AbbVie,US,,,,,14,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
subversion-grant@abbvie.com,abbvie.com,AbbVie,US,,,,,14,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
markie.heller@abbvie.com,abbvie.com,AbbVie,US,,,,,14,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hamsell.alvarezjares@abbvie.com,abbvie.com,AbbVie,US,,,,,14,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jerica.mraksirca@abbvie.com,abbvie.com,AbbVie,US,,,,,14,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gastroenterologie.de@abbvie.com,abbvie.com,AbbVie,US,,,,,14,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sk-complaints@abbvie.com,abbvie.com,AbbVie,US,,,,,14,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
charteip.france@abbvie.com,abbvie.com,AbbVie,US,,,,,14,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
responsibility@abbvie.com,abbvie.com,AbbVie,US,,,,,14,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sivan.rasaby@abbvie.com,abbvie.com,AbbVie,US,,,,,14,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
euyhan.lee@abbvie.com,abbvie.com,AbbVie,US,,,,,14,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
safety-sk@abbvie.com,abbvie.com,AbbVie,US,,,,,14,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
noreply@abbvie.com,abbvie.com,AbbVie,US,,,,,14,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jdoe@abbvie.com,abbvie.com,AbbVie,US,,,,,13,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jane@abbvie.com,abbvie.com,AbbVie,US,,,,,13,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
safety.israel@abbvie.com,abbvie.com,AbbVie,US,,,,,13,generic,0,{first}.{last},,,Legal,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
yoshiyuki.sato@abbvie.com,abbvie.com,AbbVie,US,,,,,13,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
china_pv@abbvie.com,abbvie.com,AbbVie,US,,,,,13,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
mariepierre.hulusi@abbvie.com,abbvie.com,AbbVie,US,,,,,13,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
rheumatologie.de@abbvie.com,abbvie.com,AbbVie,US,,,,,13,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
quejascalidad@abbvie.com,abbvie.com,AbbVie,US,,,,,13,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
productklachten.ho.nl@abbvie.com,abbvie.com,AbbVie,US,,,,,13,generic,0,{first}.{last},,,Writing & communication,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ukgrantsanddonations@abbvie.com,abbvie.com,AbbVie,US,,,,,13,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
uk.transparency@abbvie.com,abbvie.com,AbbVie,US,,,,,13,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
medinfo.ho.nl@abbvie.com,abbvie.com,AbbVie,US,,,,,13,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
whe@abbvie.com,abbvie.com,AbbVie,US,,,,,13,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gtldabuse@abbvie.com,abbvie.com,AbbVie,US,,,,,13,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
fr.transparence@abbvie.com,abbvie.com,AbbVie,US,,,,,13,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cecilia.jadert@abbvie.com,abbvie.com,AbbVie,US,,,,,12,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
managerchris.clark@abbvie.com,abbvie.com,AbbVie,US,,,,,12,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gerit.mulder@abbvie.com,abbvie.com,AbbVie,US,,,,,12,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gbpv@abbvie.com,abbvie.com,AbbVie,US,,,,,12,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
complaints.ch@abbvie.com,abbvie.com,AbbVie,US,,,,,12,generic,0,{first}.{last},,,Support,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
contato@abbvie.com,abbvie.com,AbbVie,US,,,,,12,generic,0,{first}.{last},,,Support,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
letmebeclear@abbvie.com,abbvie.com,AbbVie,US,,,,,12,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pvchina@abbvie.com,abbvie.com,AbbVie,US,,,,,12,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
maria.flodqvist@abbvie.com,abbvie.com,AbbVie,US,,,,,12,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
francecpd@abbvie.com,abbvie.com,AbbVie,US,,,,,12,personal,0,{first}.{last},,,,"",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ben.schroyen@abbvie.com,abbvie.com,AbbVie,US,,,,,12,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
byang@abbvie.com,abbvie.com,AbbVie,US,,,,,12,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
abbviechinapa@abbvie.com,abbvie.com,AbbVie,US,,,,,12,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lisselotte.richardson@abbvie.com,abbvie.com,AbbVie,US,,,,,12,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ctdi@abbvie.com,abbvie.com,AbbVie,US,,,,,11,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kento.kubo@abbvie.com,abbvie.com,AbbVie,US,,,,,11,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
elloyd@abbvie.com,abbvie.com,AbbVie,US,,,,,11,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ruabbviepv@abbvie.com,abbvie.com,AbbVie,US,,,,,11,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kei.takatsu@abbvie.com,abbvie.com,AbbVie,US,,,,,11,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
info.sverige@abbvie.com,abbvie.com,AbbVie,US,,,,,11,generic,0,{first}.{last},,,Support,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
permissions.de@abbvie.com,abbvie.com,AbbVie,US,,,,,11,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
permission.de@abbvie.com,abbvie.com,AbbVie,US,,,,,11,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
quality.austria@abbvie.com,abbvie.com,AbbVie,US,,,,,11,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
presse.at@abbvie.com,abbvie.com,AbbVie,US,,,,,11,generic,0,{first}.{last},,,Writing & communication,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
france.processus.lanceur.alerte@abbvie.com,abbvie.com,AbbVie,US,,,,,11,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
dataconsentgr@abbvie.com,abbvie.com,AbbVie,US,,,,,11,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hcprotechsupport@abbvie.com,abbvie.com,AbbVie,US,,,,,11,generic,0,{first}.{last},,,Support,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
colombia.comunicaciones@abbvie.com,abbvie.com,AbbVie,US,,,,,11,generic,0,{first}.{last},,,Writing & communication,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pv.gulf@abbvie.com,abbvie.com,AbbVie,US,,,,,10,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
natascha.roukema@abbvie.com,abbvie.com,AbbVie,US,,,,,10,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
recepci%c3%b3n.abbvie.cl@abbvie.com,abbvie.com,AbbVie,US,,,,,10,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sm_allerganlatampv@abbvie.com,abbvie.com,AbbVie,US,,,,,10,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sarah.duhane@abbvie.com,abbvie.com,AbbVie,US,,,,,10,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
servizioclienti.medicinaestetica@abbvie.com,abbvie.com,AbbVie,US,,,,,10,generic,0,{first}.{last},,,Support,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
recepcion.abbvieirmar.uy@abbvie.com,abbvie.com,AbbVie,US,,,,,10,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
myan.do@abbvie.com,abbvie.com,AbbVie,US,,,,,10,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
dermatologie.de@abbvie.com,abbvie.com,AbbVie,US,,,,,10,generic,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
legalresources@abbvie.com,abbvie.com,AbbVie,US,,,,,10,generic,0,{first}.{last},,,Legal,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
rajendar.mittapalli@abbvie.com,abbvie.com,AbbVie,US,,,,,10,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
medicalcomplaints@abbvie.com,abbvie.com,AbbVie,US,,,,,10,generic,0,{first}.{last},,,Support,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
medinfosafety@abbvie.com,abbvie.com,AbbVie,US,,,,,10,generic,0,{first}.{last},,,Legal,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
silvana.wardenier@abbvie.com,abbvie.com,AbbVie,US,,,,,10,personal,0,{first}.{last},,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
